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Abstract  
In the U.K. deaths due to liver diseases, especially alcohol related diseases, have risen 
considerably over the last 20 years.  In 2005 up to 13,000 people died from liver related 
diseases within the U.K., including alcohol and viral liver failure and liver cancers.  Worldwide 
hepatitis B affects about 2 billion people, killing 500,000 to 1 million per year.  An effective 
way to treat liver disease is often liver surgery, such as liver resection for cancers and liver 
transplant for failure.  However, the failure of liver regeneration by hepatocyte proliferation 
after resection surgery leads to a high death rate, and a shortage of liver donors means most 
people with liver failure die without access to a transplant.  Therefore, understanding 
hepatocyte proliferation is a key to improving survival after resection surgery and providing 
hepatocytes for cell therapy in place of organ donation.  The mechanism of hepatocyte 
proliferation has been studied both in vivo and in culture by many groups.  However, only 
limited proliferation and preservation of function of primary human and rat hepatocytes, not 
suitable for clinical use, has been achieved on stimulation with growth factors. 
This study focuses on the mechanism of epidermal growth factor (EGF) stimulation of rat 
hepatocyte cell cycle progression and proliferation, including the role of PI3K/Akt/mTOR and 
MEK/ERK signalling pathways, EGF receptor location after activation of downstream proteins 
such as protein kinase B (Akt) and extracellular signal-regulated kinases 1/2 (ERK1/2), and 
their effect on the cell cycle.  Included in this study are some comparisons between the 
stimulation of the EGF receptor (a tyrosine kinase receptor) and the P2Y receptor (a G protein 
coupled receptor). 
The PI3K/Akt/mTOR signalling pathway appears to be necessary for the hepatocyte response 
to EGF, inducing progression to S phase and DNA synthesis, while the MEK/ERK pathway is 
important but not necessary.  The P2Y2 agonist UTP, which also stimulates these two pathways, 
does not result in the cell entering S phase.  This suggests that the activation of these two 
signalling pathways is not sufficient for cell cycle progression.  Furthermore, infection of cells 
with adenovirus to express constitutively active Akt increases hepatocytes proliferation and 
induces cell cycle progression, which generates a window to obtain hepatocytes proliferation in 
culture.   
It has been shown in this thesis that EGF stimulation of ERK phosphorylation continues from 
endosomes, while the evidence suggests that UTP stimulation is restricted to signalling at the 
cell surface.  Furthermore, endocytic EGF/EGFR alone (without stimulation from the cell 
surface) is sufficient to induce cell cycle progression.  This endosomal signalling with EGF but 
not UTP may explain the absence of cell cycle progression following UTP. 
EGF stimulates the appearance of phospho-EGFR in the nucleus.  Furthermore, nuclear EGFR 
has a different apparent molecule weight than the cytoplasmic receptor; this may be due to 
nuclear EGFR having fewer and/or different phosphates.  In vivo work by others has shown that 
in liver regeneration following partial hepatectomy (PH) EGF and full-length activated-EGFR 
were showed to be present in proliferating hepatocytes. 
This thesis describes the mechanism of growth factor (EGF) stimulation of primary rat 
hepatocyte proliferation.  It shows for the first time that endosomal EGF/EGFR alone is 
sufficient to stimulate cell cycle progression, and that EGF induces phospho-EGFR in the 
nucleus in cultured rat hepatocytes.  This thesis also provides the possibility to obtain cultured 
hepatocytes proliferation including over-expression of constitutively active form of Akt and 
translocation to the nucleus of full-length EGFR in the phosphorylated form.  These studies 
improve our understanding of growth factor (e.g. EGF) stimulation of hepatocyte proliferation 
in vitro and help to move closer to the goal of obtaining sufficient functional hepatocytes in 
culture for clinical use, and of drugs that will stimulate hepatocyte proliferation following 
resection surgery. 
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1.1 Liver  
1.1.1 Anatomy 
The weight of an adult human liver is normally around 1.4 to 1.6 kilogram.  It is a soft, 
pinkish-brown organ located on the right side of the upper abdomen.  It is the second 
largest organ and the largest gland within the human body.   
 
1.1.1.1. Lobules 
The hepatic lobule is a small six-sided cylinder which is considered as the functional 
unit of the liver.  At the periphery, the lobule is surrounded by connective tissue and 
vessels including the portal vein, hepatic artery and bile duct.  At the centre, a branch of 
the hepatic vein runs through the middle of the lobule.  Hepatocytes are arranged as 
one-cell-thick cords that radiate from the central vein to the edge of the lobule (Figure 
1.1). 
 
1.1.1.2 Hepatocytes 
The liver consists mainly of hepatocytes which make up 70-80% of the mass of the 
liver.  There are about 2.5 billion hepatocytes in a human liver and approximately every 
5000 cells comprise a lobule.  The hepatocyte is a polygon with 6-8 sides, each side 
contains three surfaces: blood-sinusoidal, bile-canalicular and contiguous surface 
(Figure 1.2).  The volume of the hepatocyte changes with changing environment; for 
example, it increases at low levels of glucose.  
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Figure 1.1 Structure of lobules. 
(Copy from (Cunningham and Van Horn, 2003) 
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Figure 1.2 Structure of Hepatocyte 
 
1.1.1.3 Sinusoids 
The sinusoid is a special small blood vessel which is located in between the cords of 
hepatocytes (Figure 1.1).  The vessel surface consists of endothelicoytes with large 
gaps between each cell.  This structure provides a high permeability to the sinusoid and 
facilitates the exchange of substance between hepatocyte and blood.  Moreover, the 
hepatic sinusoid is also the place where Kupffer cells develop as an important 
protection system for the liver due to their phagocytotic ability. 
 
1.1.1.4 Portal area 
There are 3 to 4 portal areas in each lobule situated at the corner of each lobule.  It is a 
complex composed of branches including the hepatic portal vein, hepatic artery, bile 
duct, lymph-vessel and nerves (Figure 1.1). 
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1.1.1.5 Bile ducts 
A bile duct is a long tube-like structure that conveys bile from liver.  Bile, which is 
necessary for food digestion, is excreted by the liver and carried toward the hepatic 
duct which consists of many small bile ducts.  The hepatic duct joins the cystic duct, 
which leads from the gallbladder, to form the common bile duct, which carries bile into 
the part of intestine called the duodenum (Figure 1.3). 
 
Figure 1.3 Biliary tract 
 
1.1.1.6 Central vein 
The central vein is a blood vessel which runs through the middle of each lobule.  The 
blood comes into the liver through the hepatic portal vein and hepatic artery, then 
drains into the central vein via sinusoids and leaves the liver from the hepatic vein 
(Figure 1.4). 
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Figure 1.4 Flow of blood between liver and other organs  
 
1.1.2 Physiology 
As one of the most important organs, the liver plays a major role in metabolism and has 
a number of critical functions in the body.   
 
1.1.2.1 Metabolism 
The metabolic activity of the liver can be summarized into three major categories: 
carbohydrate metabolism, fat metabolism and protein metabolism.  Carbohydrate 
metabolism is critical in a human to maintain the proper concentration of glucose in 
blood.  This maintenance of correct blood glucose levels also can be distributed to two 
mechanisms: short period of time (hours) and long period of time (days to weeks).  For 
instance, in the short term, after a meal, excess glucose in the blood is rapidly converted 
into glycogen in hepatocytes (a process called glycogenesis); when there is a shortage 
of glucose in the blood, hepatocytes convert glycogen into glucose and replenish the 
blood glucose level (a process called glycogenolysis).  In the long term, the exhausted 
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glycogen sources cause hepatocytes to synthesise glucose from amino acids and non-
hexose carbohydrates. 
 
Liver is not the unique organ for lipid metabolism in the body but it is largely involved 
in the fat metabolism. For example, the liver has an ability to produce energy by 
oxidising triglycerides.  The liver also breaks down a large number of fatty acids and 
produces many acetoacetates for the further metabolism in other tissues.  The liver 
synthesises a large quantity of lipoproteins, cholesterol and phospholipids which are 
then excreted in bile.  Last but not least, the liver is the major organ that converts 
excess carbohydrates and proteins into fatty acids and triglyceride, which are then 
stored in adipose tissue. 
 
The most important steps of protein metabolism occur in the liver.  Protein is 
deaminated and transaminated, followed by conversion of the non-nitrogenous part to 
glucose or lipids by hepatocytes.  
  
1.1.2.2 Glycogen storage 
As the second biggest organ in body, the liver is an important site for storage of a 
multitude of substances including glycogen, vitamin B12, iron and copper.  The storage 
of glycogen, which is critical for the liver regulation of glucose concentration in blood, 
is one of the most important substances.   
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1.1.2.3 Plasma protein synthesis 
The liver is responsible for the synthesis and secretion of all major plasma proteins 
(except for antibodies).  Albumin, which is important in the regulation of blood volume, 
is almost only synthesised in hepatocytes.  Clotting factors, which are responsible for 
blood coagulation, are also produced in the liver.  Moreover, in the early period of 
embryo development, red blood cells are mainly synthesised in the liver. 
 
1.1.2.4 Detoxification 
The liver is the main site for the removal of toxic substances and most medicinal 
products from the body.  For instance, ammonia, which is very toxic and responsible 
for central nervous system disease, is converted into urea in hepatocytes.  
 
1.1.3 Diseases of the liver 
Liver disease is caused by various agents including virus infection, injury, auto-
immunity, hereditary disease, exposure to toxic drugs and alcoholism.  For instance, 
hepatitis, one of the most common liver diseases, is mainly due to infection by the 
hepatitis A, B and C virus etc.  Chronic hepatitis, alcoholism and long-term exposure to 
toxic drugs always results in cirrhosis, in which the liver generates fibrous tissue to 
replace dead hepatocytes.  In order to treat these diseases, a way to regenerate 
functional hepatocytes to replace these virus infected cells or fibroblasts needs to be 
found.   
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1.1.4 Liver transplantation 
Liver transplantation in humans was first performed by Dr Thomas Starzl, who is 
always called „the father of modern transplantation‟, in U.S.A. 1963.  Liver 
transplantation is the only therapy to treat irreversible liver failure such as cirrhosis; 
also it is a potent way to treat serious liver diseases such as liver cancer.  Liver for 
transplant came from non-living donors until 1989; the first living donor liver 
transplantation was performed for paediatric liver transplantation.  In that operation, 
20% of an adult‟s liver was transplanted into a small child.  More recently, adult-to-
adult liver transplantation, a strongly controversial operation, has been done.  However 
at least 14 donors died after the surgery indicating the high risk of the therapy 
(Bramstedt, 2006).   
 
1.2 Liver regeneration 
1.2.1 The definition of liver regeneration 
Interestingly, the liver is the only human internal organ that has a prominent ability for 
regeneration.  In modern science, human liver regeneration was first recorded over 
hundred years before (Ponfick, 1890).  Since then, many scientists have been involved 
in the study of the extraordinary regeneration ability of the liver following injury or 
resection.  Although the full mechanism still remains unclear, some scientific advances 
have been achieved. 
 
In both rodents and humans, the process of „liver regeneration‟ after partial 
hepatectomy (PH) is actually a process of liver compensatory hyperplasia.  Instead of 
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regenerating new hepatic lobules, the remaining lobules of the liver increase their size 
to restore the total mass of the liver (Bucher and Seaffield, 1964; Michalopoulos and 
Defrances, 1997; Fausto, 2000; Taub, 2004).  During this process, the total mass of the 
liver is tightly regulated by pro-mitotic and apoptotic mechanisms (Saetren, 1956; 
Leong et al., 1964; Scaife, 1970; Fisher et al., 1971).  A two-animal combination 
experiment indicated that the size of the liver may be controlled by the animal weight. 
In the experiment, parabiotic animals (A and B) have a surgically-generated shared 
circulation. The removal of 85% of the liver from animal (A) caused compensatory 
growth of both the remnant (A) and the partner (B) liver (Moolten and Bucher, 1967; 
Verly et al., 1971).  Furthermore, when the animal, which 85% of the liver was 
removed before, was removed from the shared circulation, it resulted in the remainder‟s 
(B) liver shrinking to a size required by the animal before which was about 4.5% of the 
body mass (Moolten and Bucher, 1967).  The work also shows the signal for growth 
come from the circulation.  This means it is a hormone or analogue of hormones.  
 
1.2.2 The importance of liver regeneration 
Since the liver is an essential organ in the body, the lack of liver regeneration after 
injury or resection leads to death.  In all animal studies including human, failure of the 
liver to recover its mass invariably causes death.  For instance, the impairment of liver 
regeneration is observed in non-alcoholic fatty liver disease, cirrhosis, chronic hepatic 
infection, and malnutrition.  These diseases increase cell death, delay mitosis and slow 
the regeneration of normal hepatic mass and in turn result in the failure the regeneration 
ability of the liver.  Therefore, understanding the mechanism of liver regeneration such 
as the nature of signals and pathways involved is important to treat patients who are 
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suffering from such liver diseases.  In addition, understanding of liver regeneration can 
increase patient survival rate following PH, which is used extensively in treatment of 
liver diseases.  Last but not least, the advance in the understanding of liver regeneration 
may lead to new treatments of liver diseases such as liver transplantation.  
 
1.2.3 Review of liver regeneration study 
The development of the understanding of the mechanisms of liver regeneration can be 
simply categorized into three phases. The traditional idea was that a single or several 
humoral factors played a key role in the response to all of the processes involved in 
liver regeneration (Fausto, 2000).  This was first published in the 1960s by Bucher and 
colleague who demonstrated that existing „humoral factors‟ can induce liver 
regeneration following PH (Bucher and Seaffield, 1964). In the 1970s, another group 
identified several humoral factors that played essential roles in liver regeneration 
including islet cell-derived insulin and some other gut-derived agents (Starzl et al., 
1973; Starzl et al., 1977; Francavilla et al., 1978).  Also there was the thought that all 
events required for liver regeneration relied on the activation of one signalling pathway 
(Michalopoulos and Defrances, 1997).  The more recent idea was that liver 
regeneration was dependent on the activity of multiple signalling pathways (Taub, 
2004).  The latest model of liver regeneration was much more complicated than any 
others.  Liver regeneration does require the activity of multiple signalling pathways.  
However, they do not act independently of each other, and there is extensive 
communication between each signalling pathway.  Moreover, the models of interaction 
between these pathways are particularly complicated since they may occur differently 
in each liver cell type, some of them may only happen at certain periods of liver 
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regeneration, and these interactions may involve simultaneous and/or sequential 
operation (Fausto et al., 2006). 
 
1.2.4 Factors involved in liver regeneration 
Dependent on their function, the factors involved in the response to liver regeneration 
can generally be classified into five groups:  priming factors, growth factors, co-
mitogent, tonic growth inhibitors and suppressors of growth inhibitors.  
 
1.2.4.1 Priming factors 
As its name implies, priming factor is the first factor required for liver regeneration 
following PH.  Hepatocytes, which have a very slow turnover (only divide once every 
year or two), normally cannot respond to hepatic mitogens such as hepatocyte growth 
factor (HGF) and transforming growth factors-α (TGF-α).  Therefore, primary factors 
are essential to liver regeneration due to their ability to enable hepatocytes to respond to 
these growth factors.  For instance, tumour necrosis factor-α (TNF-α), which is one of 
the key priming factors, induces transcription of nuclear factors-kB (NF-kB), signal 
transducer and activator of transcription-3 (STAT-3) in stellate cells and interleukin-6 
(IL-6) in Kupffer cells.  These activated factors are then translocated to the nucleus, this 
activates transcription of some immediate early genes, and thereby make hepatocytes 
competent to respond to various hepatic growth factors (Webber et al., 1994a; Webber 
et al., 1998). 
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1.2.4.2 Growth factors 
Growth factors stimulate cells, which have gained replicative competence by priming 
factors, to progress through the cell cycle from gap phase 1 (G1) to S.  The common 
factors which are involved in liver regeneration include HGF, epidermal growth factor 
(EGF) and TGF-α.   
 
HGF was first isolated due to its ability to induce hepatocyte deoxyribonucleic acid 
(DNA) synthesis and was identified as a blood-derived mitogen in culture 
(Michalopoulos et al., 1984; Nakamura et al., 1984).  HGF activates by binding to its 
receptor, hepatocyte growth factor recepto (c-Met), and plays the key roles in liver 
growth and function (Michalopoulos et al., 1984).  The deletion of either protein‟s gene 
expression leads to the incomplete development of liver in mice embryo‟s and causes 
death (Schimidt et al., 1995).  HGF also is important for liver regeneration following 
PH since its concentration in plasma significantly increases after reduction of the liver 
mass (Tomiya et al., 1992).  For instance, in the rat, HGF concentration in plasma 
rapidly increased to more than 20-fold than normal within 1h after PH and then slowly 
declined in the following 72h before it was back to normal level (Lindroos et al., 1991).  
Moreover, more recently researches demonstrated that the HGF/c-Met signalling 
pathway was critical for cell cycle progress after PH by activation of extracellular 
signal-regulated kinase 1/2 (ERK 1/2) pathway and PI3K/Akt pathway (Burr et al., 
1998; Pediaditakis et al., 2001; Okano et al., 2003; Huh et al., 2004).  
 
EGF, which is mainly produced in the salivary glands, stimulates the growth of various 
epidermal and epithelial tissues including liver in vivo and in vitro (Schlessinger, 2000).  
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EGF plays an essential role in liver regeneration since inhibiting its secretion by 
removing salivary glands in rat result in a complete block of liver regeneration after PH 
(Noguchi et al., 1991).   
 
TGF-α, which is a member of EGF family of growth factors, is released by hepatocytes 
and activated on the cell itself (Mead and Fausto, 1989; Koniaris et al., 2003).  TGF-α 
activates the EGFR and induces hepatocyte proliferation.  The overexpression of TGF-
α gene in mice induced hepatocyte proliferation and led to cancer (Webber et al., 
1994b).  However, TGF-α is not necessary for liver regeneration as inhibition of its 
gene expression did not effect normal mouse liver regeneration.  It indicated that EGF 
may replace the loss of TGF-α function in the mechanism (Mann et al., 1993).  On the 
contrary, TGF-α is suggested as an up-regulation factor to HGF since anti-TGF-α 
antibodies partially block the regeneration response in the liver (Matsumoto and 
Nakamura, 1992; Scheving et al., 2002).  
 
1.2.4.3 Co-mitogens 
Co-mitogens such as insulin promote the activity of the growth factors and allow the 
progression of the cell cycle.   
 
Insulin is produced by pancreatic islets and is transferred into the liver through the 
portal vein.  There is no direct evidence to show that insulin induces hepatocyte mitosis 
in normal animals; however the absence of insulin results in the delay of liver 
regeneration (Starzl et al., 1978).  Moreover, insulin accelerates liver regeneration after 
PH (Bucher and Swaffield, 1975; Starzl et al., 1977; Hwang and Chen, 1993).  
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1.2.4.4 Tonic growth inhibitors 
Tonic growth inhibitors such as transforming growth factor-β (TGF-β) are known as 
inhibitors of hepatocyte proliferation (Carr et al., 1986).  TGF-β is normally secreted 
from non-parenchymal cells such as sinusoidal endothelial cells and Kupffer cells 
(Fausto et al., 1991). It is down-regulated by priming factors and controls liver 
regeneration by causing cell apoptosis. The concentration of TGF-β in the plasma 
increases within 3-4h after PH and then slowly rises until reaching a peak at 48-72h 
(Braun et al., 1988). Since hepatocyte DNA synthesis stops between 48-72h after PH, it 
suggested that liver regeneration is stopped by TGF-β.  Hepatocytes are resistant to 
TGF-β effects from 12h to 48h after PH (Houck and Michalopoulos, 1989). Also 
although the injection of TGF-β into the liver after PH caused suppression of  peak 
DNA synthesis at 24h, the whole DNA synthesis response lasts 72h as usual (Russell et 
al., 1988). Recently studies have shown that nitric oxide (NO) may play an important 
role in the cell resistance to TGF-β (Ronco et al., 2004).  This ability of hepatocytes to 
resist TGF-β allows the proliferation of hepatocytes during the time of increasing TGF-
β concentration in plasma.   
 
1.2.4.5 Suppressors of growth inhibitors 
Suppressors of growth inhibitors inhibit the biological activity of the tonic growth 
inhibitors. They reversibly bind to the receptors of tonic growth inhibitors with high 
affinity preventing the tonic growth inhibitors from binding to their cellular receptors. 
They include TGF-β inhibitor, latency activated peptide (LAP), Activin inhibitor and 
follistatin. 
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1.3 Higher eukaryote cell cycle 
The cell cycle is the process by which two daughter cells are produced from the parent.  
In mammals, some cells continuously divide during a life time e.g. bone marrow cells, 
hair cells, skin cells and blood cells, whereas other cells almost never divide in adults 
such as neurons and liver cells.  The key factors that control cell cycle are cyclins and 
cyclin-dependent kinases (CDKs).  From the present evidence, CDK4 and CDK6 
associate with the cyclin D family forming a complex mainly involved in the regulation 
of the G1 phase.  CDK1 associates with cyclin A and cyclin B whose main function 
relates to the gap phase 2 (G2)/ mitosis (M) phase transition and mitosis.  CDK2 is 
involved in the regulation of G1/S phase transition and DNA synthesis by association 
with cyclin E and cyclin A respectively (Figure 1.5).  There are some other CDKs for 
which the function is not well understood.  For instance, CDK3 may trigger G1/S 
transition while CDK7 is important for the activation of other CDKs.  The cell cycle is 
also regulated by negative regulation of CDK activity.  The major factors involved in 
the negative regulation of the cell cycle are called cyclin-dependent kinase inhibitors 
(CKIs).  There are two families of CKIs based on their structure and CDK targets.   The 
Cip/Kip (CDK interacting protein/Kinase inhibitory protein) family including 
p21
Cip1/Waf1
, p27
Kip1
 and p57
Kip2
, which inhibit most cyclin/Cdk complex activation 
(Figure 1.5); while the inhibitors of CDK4 (INK4) family including p15
Ink4b
, p16
Ink4a
, 
p18
Ink4c
 and p19
Ink4d 
which inhibit the activation of CDK4 and CDK6 (Figure 1.5) 
(reviewed in (Pollard et al., 2007). 
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1.3.1 G1 phase 
The G1 phase is the gap between the end of M phase and beginning of DNA synthesis 
phase (S) phase.  In most cells, G1 phase is the longest and most variable period of the 
cell cycle.  During G1 phase, various ribonucleic acid (RNA), enzymes and structural 
proteins, which are required in DNA synthesis and mitosis, are synthesised.  For 
instance, in hepatocytes, growth factors such as EGF trigger the cell cycle at early G1 
phase initially inducing the expression of early response genes including v-fos FBJ 
murine osteosarcoma viral oncogene homolog (c-fos), v-myc myelocytomatosis viral 
oncogene homolog (c-myc) and ras.  These then increase the expression of specific cell 
cycle regulatory genes which result in the sequential synthesis of D type cyclins (D1, 
D2 and D3) and cyclin E (Sherr, 1995).  At this stage, cyclins are then associated with 
cyclin-dependent kinases (CDKs) forming active holoenzymes such as cyclin D1/Cdk4 
which plays a central role during cell progression through G1 phase.  The activated 
cyclin D1/Cdk4 associates with proliferating cell nuclear antigen (PCNA) in turn 
stimulating the processing ability of DNA-polymerase-δ (Sherr, 1994).  Meanwhile, the 
cyclin D1/Cdk4 complex inhibits the activation of p21 and p27, which are members of 
Cip/Kip family that inhibits numerous CDKs (Albrecht et al., 1998).  Also the cylin 
D/Cdk4 complex phosphorylates retinoblastoma protein (pRb), a tumor suppressor that 
is a key repressor of G1 progression that inhibits the expression of cyclin E (Welsh, 
2004) (Figure 1.5).  The cylin D/Cdk4 induces the phosphorylation of pRb and in turn 
activates E2 transcription Factor (E2F).  The activated E2F results in transcription of 
various genes such as cyclin E, cyclinA and thymidine kinase etc.  Cells may delay 
progression through G1 phase and enter gap phase 0 (G0) phase when shortage of 
nutrient or induction of anti-proliferative signal.  Finally, progression through G1 phase 
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is regulated by two checkpoints, the restriction point and the G1 DNA damage 
checkpoint (Pollard et al., 2007).  Cyclin E/Cdk2 complex has been reported to play an 
essential role in driving the cell through restriction point (Pines, 1995; Aleem et al., 
2005). 
 
1.3.2 S phase 
In 1951, DNA replication during one period of the interphase was discovered and 
named as the synthesis phase (S phase) (Howard and Pelc, 1951).  During the S phase, 
the replication of a chromosome, which is composed of one chromatid, is initiated at 
many different sites which are referred to as origins of replication.  Then the S phase 
ends with forming two sister chromatids.  Also, during DNA replication, actively 
transcribed regions of the genome replicate in early S phase while inactive regions 
replicate later.  Furthermore, centrosomes and most histones are replicated during S 
phase (reviewed in (Pollard et al., 2007).  The S phase is tightly regulated by the 
association of CDK2 with cyclin E and A.  Cyclin E/Cdk2 complex exists during late 
G1 phase to early S phase and stimulates replication of a pre-assembled initiation 
complex.  After that cyclin E is degraded and CDK2 associates with cyclin A, which 
activates DNA synthesis from a preassembled replication complex.  Furthermore, the 
cyclin A/Cdk2 complex inhibits the assembly of new replication initiation complexes to 
ensure that the DNA is only replicated once (Coverley et al., 2002) (Figure 1.5).   
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1.3.3 G2 phase 
From the end of S phase until M phase is referred to as G2 phase.  During this period, 
the DNA structure is checked and some RNA and proteins required for M phase such 
as mircotube proteins are synthesised.  There are two checkpoints regulating the 
progression of G2 phase including the G2 DNA damage checkpoint and the G2 
centrosome damage checkpoint (reviewed in (Pollard et al., 2007)).   The transition of 
G2/M phase is controlled by the activation of the cyclin A/Cdk2 complex (Malumbres 
and Barbacid, 2005) (Figure 1.5).   
 
1.3.4 M phase 
In 1882, Flemming firstly named the process of nuclear division as mitosis (M phase) 
which starts after the appearance of the condensed chromosomes, the rest of the cell 
cycle was referred to as interphase (resting stage).  M phase can normally divide into 
five discretephases.  Cell firstly enters prophase, which is characterised by the 
chromosome condensation and the disappearance of nucleolus.  This is controlled by 
the activation of the cyclin B/Cdk1 complex (Figure 1.5).  The protein level of cyclin B 
increases during G2 to M phase and associates with CDK1 to form the mitosis-
promoting factor (MPF).  The MPF is activated in M phase by phosphorylation on a 
threonine residue (Thr161) and dephosphorylation of a tyrosine residue (Tyr15), the 
activated MPF in turn inititates prophase by stimulating downstream proteins which 
stimulate chromosome condensation and assembly of the mitotic spindle (King et al., 
1996).  During prophase, chromatin becomes highly organised and condenses to form 
chromosomes, each of which has two kinetochores, one attached at each sister 
chromatid, to connect between DNA and microtubes (Chan et al., 2005).  Also two 
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centrosomes, which are duplicated during interphase, move to the opposite side of the 
nucleus.  Prometaphase is defined as the formation of the mitotic spindle and the 
breakdown of the nuclear envelope.  It starts with nuclear envelope disassembly and 
formation of fragments and alveolus in the cytoplasms.  The breakdown of the nuclear 
envelope is also regulated by the cyclin B/Cdk1 complex (Malumbres and Barbacid, 
2005).  Chromosomes become more highly condensed and both kinetochores on one 
chromosome are attached to the opposite centrosome by microtubes, forming the 
mitotic spindle.  The chromosome is fully condensed and all chromosomes move to the 
point midway between two poles in metaphase.  Cells then enter anaphase, in which the 
sister chromatids are separated by the degradation of the proteins that bind sister 
chromatids together.  In this stage, a critical complex involved is the anaphase 
promoting complex (AP), which is an ubiquitin ligase that promoting degradation of 
structural proteins associated with the chromosomal kinetochores (Castro et al., 2005).  
The separated sister chromatids then move toward the centrosome to which they are 
attached, followed by the centrosomes moving apart to opposite ends of the cell.  AP 
also ubiquitinates mitotic cyclins including cyclin A and B and in turn drives cells into 
telophase (Castro et al., 2005) (Figure 1.5).  During telophase, the nuclear envelope is 
reformed around each set of separated sister chromosomes and chromosomes then 
unfold back into chromatin.  Finally, a contractile ring contains actin and myosin 
develops in the midway between spindle poles and separates the two daughter cells 
(reviewed in (Pollard et al., 2007). 
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1.3.5 G0 phase 
G0 phase is considered as a special compartment of the G1 phase where cell exist in a 
quiescent state.  Cells entry into the G0 is usually due to a lack of growth factor or 
nutrients and during the G0 phase, cyclins and cyclin-dependent kinases disappear.  
Cells can re-enter in the cell cycle under certain circumstances such as growth factor 
stimulation (Pollard et al., 2007) (Figure 1.5). 
 
   
Figure 1.5 cell cycle regulations  
(Adapted from Cell Signalling Technology, Schwartz & Shah, 2005 and Rang et al, 
2007) 
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1.4 EGF receptor  
The EGF receptor family is a member of the large family of receptor tyrosine kinases 
(RTKs), which activates a wide range of biological responses including mitogenesis, 
migration, differentiation, apoptosis and dedifferentiation (review of (Wells et al., 
1998)).  In mammals, there are four members of the EGF receptor family: ErbB1 (also 
called EGFR), ErbB2 (also called c-Neu), ErbB3 and ErbB4.  EGFR, the prototype 
member of this family, is a 170 kiloDalton transmembrane glycoprotein receptor and is 
widely expressed on many cell types such as epithelial and mesenchymal lineages 
(Thompson and Gill, 1985).  They are involved in multiple biological processes 
including proliferation, survival, differentiation and metabolism (Schlessinger and 
Ullrich, 1992).  This family is also found to be highly expressed in various cancer cells.  
For instance, over-expressed ErbB2 causes approximately 30% of invasive breast 
cancers (Ross and Fletcher, 1998).  The over-expression of this family is also found in 
ovarian and stomach cancers (Salomon et al., 1995).  The receptor has been reported to 
be stimulated by at least five genetically distinct ligands including EGF, TGF-α, 
betacellulin (BTC), epiregulin and heparin-binding EGF-like growth factor (HB-EGF) 
(Reise and Stern, 1998).   
 
1.4.1 Extracellular domain 
As shown in Figure 1.6, the EGF receptor can be divided into three parts: an amino-
terminal 622 amino acids extracellular domain, a single alpha-helical transmembrane 
pass and a 542 amino acids intracellular carboxy-terminal.  The extracellular domain 
consists of four domains which are referred to ligand-binding domains 1 and 2 (L1 and 
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L2) and two cysteine-rich domains (CR1 and CR2).  In them, L1 and L2 are reported to 
consist of β-helix-folds and form the ligand-binding pocket between them (Garrett et al., 
1998; Garrett et al., 2002; Ogiso et al., 2002).  Lemmon and his colleagues presented a 
model in 2003 of which ligand initially binds only L1 in a low affinity state and then 
leads to a conformational change of the receptor extracellular domain, thereby allowing 
ligand association with L2 that results in a high affinity binding (Ferguson et al., 2003).  
CR1 and CR2 domains are reported to consist of a number of small modules each of 
which is held together by one or two disulfide bonds.  A conformational change which 
is due to ligand binding results in the exposure of a loop from the back of CR1, which 
is proposed to interact with another ligand-bound EGF receptor family member (Garrett 
et al., 2002; Ogiso et al., 2002).  Additionally CR2 is also considered to play a role in 
dimer formation and stabilisation (Saxon and Lee, 1999; Berezov et al., 2002).  
Furthermore, it is reported that CR2 is involved in the regulation of binding EGFR to 
caveolae/raft component of cell membrane which suggests this may regulate the 
receptor internalisation (Yamabhai and Anderson, 2002).  Deletion of CR2 increases 
the overall activity of EGFR suggesting that it acts as a negative regulatory factor in 
EGFR activation (Elleman et al., 2001). 
 
1.4.2 Transmembrane domain 
The EGFR passes the cell membrane through a single alpha-helical domain consisting 
of 23 amino acids (Figure 1.6).  Other than spanning the membrane, additional effects 
of this small domain have been reported, especially the role of its regulation of receptor 
dimerisation (Schlessinger, 2002).  For instance, it appears to enhance receptor 
dimerisation after ligand binding in murine B82 cell line (expressing a recombinant 
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form of EGFR which is missing its cytoplasmic domain) (Tanner and Kyte, 1999).  
However, mutation in ErbB2 transmembrane domain caused an increase of receptor 
dimerisation (Bargmann et al., 1986).  Also exposure of cells to transmembrane domain 
peptides blocked the receptor auto-phosphorylation and downstream signalling 
indicating that the transmembrane domain regulating EGFR activity (Bennasroune et 
al., 2004).  Furthermore, other groups also have shown that the transmembrane domain 
regulates the intracellular kinase domain through the rotational twisting dimers (Bell et 
al., 2000; Moriki et al., 2001).   
 
1.4.3 Intracellular domain 
The intracellular domain comprises three domains: a juxtamembrane region (JM), a 
tyrosine kinase domain (kinase) and a carboxy-terminal regulatory region (CT) (Figure 
1.6).  The JM region has been reported to have a number of regulatory functions 
including regulation of downstream proteins (Castagnino et al., 1995) and ligand-
dependent receptor internalisation (Kil and Carlin, 2000).  There is evidence that the 
EGFR kinase domain activation loop adopts a conformation similar to the activated 
insulin receptor kinase domain (Stamos et al., 2002).  However, distinguishable with 
other RTKs, EGF receptor family members do not phosphorylate their downstream 
kinases within kinase domain but in the carboxy-terminal domain.  The CT region 
contains numerous auto-phosphorylation tyrosine residues where there are binding sites 
to proteins containing src homology 2 (SH2) such as phospholipase Cγ (Nishibe and 
Carpenter, 1990; Schlessinger, 2000).  There are also several tyrosine residues, as well 
as serine/threonine residues that are phosphorylated by downstream kinases which are 
part of the EGFR activation cascade (Schlessinger, 2000).  For instance, Thr645 is 
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phosphorylated by protein kinase C (PKC) (Hunter et al., 1984), and Tyr845 is a target 
for tyrosine kinase src (src) (Sato et al., 1995).  Furthermore, protein kinase A (PKA), a 
downregulation protein of EGF receptor can phosphorylate several serine residues 
(Barbier et al., 1999).  Among these phosphorylated residues, the phospho-tyrosines 
serve as binding sites for various proteins that contain SH2 or phospho-tyrosine binding 
domains (PTBs) and recruit proteins to the receptors which in turn regulate various cell 
signalling cascades (Schlessinger, 2000).   
 
 
 
 
Figure 1.6 Structure of the EGF receptor  
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1.5 Mitogen-activated protein kinases signalling pathway 
Mitogen-activated protein kinases (MAPKs), which are members of a large family of 
serine/threonine kinases, play a key role in surface receptor regulation of the cell 
proliferation signalling pathway (Dong et al., 2002).  Growth factors such as EGF-
activated epidermal growth factor receptor (EGFR) recruits the adaptor molecule 
Growth factor receptor-bound protein 2 (Grb2) directly via a high affinity binding site 
for molecules with SH2 domains (Madhani, 2001) or indirectly via other components 
such as src homologous and collagen (Shc) (Plyte et al., 2000).  The remaining two src 
homology 3 (SH3) domains of Grb2 regulate the binding of son of sevenless (Sos), a 
guanine-nucleotide-exchange factor (GEF), which results in GDP/GTP exchange and 
activates Ras activation (Plyte et al., 2000).  Activated Ras recruits the cytosolic protein 
Raf to the membrane and activates it by phosphorylation (Kerkhoff and Rapp, 2001).  
The activated Raf then phosphorylates specific isoforms of mitogen activated 
extracellular regulated kinases (MEKs), which in turn activates MAPKs including 
extracellular signal-regulated kinase (ERK1/2), p38 MAPKs (also termed p38-RK or 
p38 stress activated protein kinases (SAPKs)) and c-jun-NH2-terminal kinases (JNK1 
and JNK2, also known as p46/p54 SAPKs) (Graves et al., 1995; Inglese et al., 1995; 
Seger and Krebs, 1995; Fanger, 1999).   
 
1.5.1 ERK  
The ERK1/2, which were first identified in 1990 (Boulton et al., 1990), have been well 
documented and are typically activated by growth-related signals and linked with 
proliferation and differentiation.  Since then, ERK 3, 4, 5, 6, 7 and 8 have been also 
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identified but are less understood (review in (Bogoyevitch and Court, 2004)).  The 
expression of mutant non-phosphorylatable ERK1/2 abolished CC139 Chinese hamster 
fibroblasts cell proliferation demonstrating the important role of ERK in cell 
proliferation (Pages et al., 1993).  Moreover, inhibition of the activation of ERK by 
blocking its upstream protein MEK activity by 2-amino-3methoxyflavone (PD098059) 
completely inhibits rat kidney cell growth (Dudley et al., 1995).  Not only the 
activation of ERK but also the translocation into the nucleus is required for growth 
factor-induced cell cycle progression and gene expression.  Pouyssegur and colleague 
presented the result that the expression of a catalytically inactive form of cytoplasmic 
MAP kinase phosphoatase was sufficient to sequester ERK in the cytoplasm.  Instead 
of phosphorylation of cytoplasmic substrates, the cytoplasmic ERK inhibited Elk1-
dependent gene transcription and growth factor-induced DNA replication (Brunet et al., 
1999).  This observation indicates that ERK translocation into nucleus is required for 
quiescent cells to response to growth factor and re-enter the cell cycle.  Furthermore, 
ERK nuclear localisation has been demonstrated to be important in the regulation of 
cell proliferation in the natural environment.  For instance, increase of phosphoprotein 
enriched in astrocytes 15 (PEA15), which regulates export of ERK out of the nucleus, 
inhibited ERK-dependent transcription regulation and cell (NIH 3T3 cell line) 
proliferation (Formstecher et al., 2001).  Also it has been reported that Akt 
overactivation prevented ERK translocation into the nucleus by stabilising PEA15 and 
in turn resulted in the inhibition of angiotensin II (AngII) type 1 receptor (AT1) 
mediated cell (Chinese hamster ovary (CHO) cells) proliferation (Gervais et al., 2006). 
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The activated-ERK is reported to regulate the synthesis of cyclin D1.  Inhibition of 
ERK activity by either expressing a dominant negative MEK (Lavoie et al., 1996) or 
MEK inhibitor PD098059 (Brown et al., 1998) was sufficient to block cyclin D1 
expression.  Furthermore, ERK also regulates cyclin D1 transcription via myc activity 
(Daksis et al., 1994).  ERK regulates the formation of the cyclinE/CDK2 complex 
during G1/S transition. ERK regulates the CDK2 translocating into the nucleus, where 
it is activated by the phosphorylation of Thr160 by CDK activating kinase (CAK) and 
dephosphorylation of Thr14 and Tyr16 by the cell division cycle 25 (CDC25) 
phosphatase (Keenan et al., 2001).  There is evidence that ERK is also important to 
cyclinB/CDK1 complex activation.  It has been shown that ERK can phosphorylate two 
of the four phosphorylation sites, all four sites must be phosphorylated for cyclin B1 
translocated into the nucleus where cyclinB is activated by phosphorylation on Thr161 
and dephosphorylation on Thr14 and Tyr15 (Walsh et al., 2003).  It appears that ERK 
also regulates the synthesis of pyrimidine nucleotides in order to synthesise more DNA 
and rRNA.  Evans and colleague reported that ERK increases the activity of the 
multifunctional enzyme known as carbamoyl-phosphate synthetase 2, aspartate 
transcarbamylase, and dihydroorotase (CAD), which controls the synthesis of 
pyrimidine nucleotides (Graves et al., 2000).  Furthermore, nuclear ERK appears to 
play an important role since CAD is more phosphorylated in the nucleus than when it is 
in the cytoplasm.  ERK is also shown to regulate protein translation.  For instance, 
MAP kinase-interacting kinase 1 (MNK1), which is a downstream target of ERK, 
induces the phosphorylation of the translation initiation factor 4E (eIF4E) leading to 
increased translation (Stefanovsky et al., 2006).   
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1.5.2 c-jun-NH2-terminal kinase (JNK) and p38 MAPKs 
Three genes including MAPK8, MAPK9 and MAPK10 together form the JNK isoforms.  
Compared with ERK1/2, JNK appears to be activated by environmental stress and 
cytokines stimulation and is essential for phosphorylation of activating protein 1 (AP1) 
(Ip and Davis, 1998).  It has been demonstrated that JNK also regulates many normal 
physiological processes such as cellular proliferation, apoptosis and tissue 
morphogenesis.  For instance, treatment with exisulind (sulindac sulfone) and related 
compounds induce NIH3T3 cell apoptosis via the protein kinase G (PKG)/ MAP kinase 
kinase kinase (MEKK)/JNK signalling pathway (Soh et al., 2001).  Also, p38 MAPK 
show a crucial role in the regulation of cellular proliferation and differentiation (review 
in (Fang and Richardson, 2005).  However, recent evidence shows that p38 MAPKs 
may be also important in the regulation of cell apoptosis.  It has been reported that the 
adenoviral early region 1A (E1A)-mediated sensitisation to apoptosis is through 
inactivation of Akt and activation of p38 MAPKs (Liao and Hung, 2003).   
 
1.6 PI3K/Akt/mTOR signalling pathway 
Recent studies demonstrated that the PI3K/Akt/mTOR signalling pathway plays a 
crucial role in many biological effects including proliferation, differentiation, anti-
apoptosis, tumorigenesis and angiogenesis (Review in (Fresno Vara et al., 2004).  
Furthermore, this pathway has been shown to be involved in the regulation of a variety 
of cancers including breast cancer (Fry, 2001), lung cancer (Lin et al., 2001b), 
melanomas (Krasilnikov et al., 1999) and leukaemia (Martinez-Lorenzo et al., 2000) 
etc.   
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1.6.1 Phosphatidylinositol-3 kinase (PI3K) 
PI3K isoforms are divided into three classes: Class I, II and III on the basis of their 
structure and function (Rameh and Cantley, 1999).  Class I PI3K are cytoplasmic 
heterodimers composed of a catalytic subunit (p110) and an adaptor protein (p85), 
which contains two SH2 and one SH3 binding domain.  The Class I PI3K can be 
further divided into the Class IA isoforms, which is activated by RTKs, and the Class 
IB, which is activated by Gβγ subunits of GPCRs.  The Class I PI3K are the only ones 
that are able to convert phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2) to the second 
messenger phosphatidylinositol-3,4,5-triphosphate (PI-3,4,5-P3) (review in (Fresno 
Vara et al., 2004)).  Class II PI3Ks, which comprise three catalytic isoforms including 
C2α, C2β and C2γ, are mainly associated with the phospholipid membranes.  They are 
concentrated in the trans-Golgi network and are present in clathrin-coated vesicles.  
This class of PI3K produces PI-3,4,5-P3 from phosphatidylinositol and may also 
produce PI-3,4-P2 from phosphatidylinositol-4-phosphate (PI-4-P) (Domin et al., 2000).  
The structure of Class III PI3Ks are similar as Class I, as they are heterodimers 
composed of a catalytic subunit (Vps34) and a regulatory subunit (p150).  They 
produce PI-3,4,5-P3 through the conversion of phosphatidylinositol (Volinia et al., 
1995).   
 
1.6.2 Protein kinase B  
Akt is a serine/threonine protein kinase which belongs to the cyclic adenosine 
monophosphate (cAMP)-dependent protein kinase A/protein kinase G/PKC super 
family.  In mammals, three members of Akt have been identified, Akt1 (Jones et al., 
1991), Akt2 (Cheng et al., 1992) and Akt3 (Brodbeck et al., 1999).  Akt has been 
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demonstrated to play a central role in PI3K/Akt/mTOR signalling pathway which is 
involved in the regulation of growth factor induced cell growth, transcription and cell 
survival (review in (Brazil and Hemmings, 2001).  Akt isoforms consist of three 
domains: an amino terminal pleckstrin homology domain, a central kinase domain and 
a carboxyl-terminal regulatory domain.     
 
Akt is activated by Class IA and Class IB PI3Ks, which are activated by RTKs and 
GPCR respectively (Wymann et al., 2003).  PI3K produces PI-3,4,5-P3 which recruits 
Akt to the plasma membrane to allow subsequent phosphorylation (Andjelkovic et al., 
1997).  A phosphorylation of a conserved threonine residue (Thr308) at the kinase 
catalytic domain of Akt by the phosphoinositol-dependent kinase-1 (PDK1) is 
necessary for Akt activation (Stephens et al., 1998).  Furthermore phosphorylation 
alone at this residue can partially activate Akt (Alessi et al., 1996).  An additional 
phosphorylation at a serine residue (Ser473) in the carborxyl-terminal domain can fully 
activate Akt.  Moreover, the phosphorylation at Ser473 alone has little effect on Akt 
activation (Alessi et al., 1996).  However, the mechanism of how Akt phosphorylation 
at Ser473 is not clear.  One theory is that another phosphoinositol-dependent kinase, 
PDK2 which has been now widely believed is mTOR Complex 2 (mTORC2) 
(Sarbassov et al., 2005) regulates the phosphorylation at Ser473 (Hill et al., 2001).  
Also the intergrin-linked kinase (ILK) was shown to phosphorylate Akt at Ser473 
(Delcommenne et al., 1998).  Dedhar and colleague provided evidence that inhibition 
of ILK activity by a novel specific inhibitor blocks Ser473 phosphorylation of Akt 
(Persad et al., 2001).  Furthermore, recent evidence has shown that tyrosine 
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phosphorylation may be involved in the regulation of Akt activation (Conus et al., 2002; 
Jiang and Qiu, 2003). 
 
Akt acts as a survival signal by regulation of its downstream targets such as B-cell 
CLL/lymphoma 2 (Bcl-2)/Basal cell lymphoma-extra large (Bcl-xL)-associated death 
promoter (BAD) and forkhead box class o (Foxo).  Akt induces BAD phosphorylation 
which is then released from a complex with Bcl-2/Bcl-xL on the mitochondrial 
membrane.  Subsequently, the free BAD associates with 14-3-3 protein in the cytosol 
and in turn inactivate its pro-apoptotic function (Datta et al., 1999).  Also, Akt induces 
Foxo phosphorylation which promotes nuclear export and preventes transcription of 
growth arrest and pro-apoptotic genes (Skurk et al., 2005).  Akt also regulates cell 
metabolism through the activation of glycogen synthase kinase-3 (GSK-3).  Akt 
inhibits the activation of GSK-3 by the phosphorylation of GSK-3 which results in the 
storage of glucose (Cross et al., 1995).  Furthermore, Akt may also regulate cell cycle 
progression and anti-apoptosis via regulation of GSK-3 activity (Review in (Song et al., 
2005).   
 
1.6.3 Glycogen synthase kinase-3 
GSK-3 is a constitutively active serine/threonine kinase which has two isoforms GSK-
3α and GSK-3β in mammals.  GSK is a downstream target of Akt and can be 
phosphorylated by Akt on Ser21 of GSK-3α and Ser9 of GSK-3β which results in the 
inhibition of GSK-3 enzyme activation (Cross et al., 1995).  GSK is involved in a 
variety of cell functions including transcription, translocation and cell survival by 
controlling a number of substrates (review in (Doble and Woodgett, 2003).  One of the 
Chapter 1 Introduction 
De Montfort University                                                                                                                       Yi Luo 33 
most important functions of GSK-3 is the regulation of cell metabolism.  GSK-3 
inhibits the activity of glycogen synthase (GS).  Akt-induced phosphorylation of GSK-
3 results in inhibition of GSK-3 activation and in turn activates GS which converts 
glucose to glycogen.  GSK also regulates cell proliferation and survival (Hughes et al., 
1993).  Furthermore, it has been shown that GSK-3 phosphorylates transcription factors 
such as c-myc, jun oncogene (c-jun) and v-myb myeloblastosis viral oncogene homolog 
(c-myb) (Plyte et al., 1992) and the translation factor eukaryotic translation initiation 
factor 2B (eIF2B) (Welsh et al., 1996).  GSK-3 also phosphorylates cyclin D, which 
stimulates its proteolytic degradation.  Therefore, stimulating Akt will inhibit GSK-3 
and inhibit cyclin D breakdown, which would contribute to cell cycle progression 
(Diehl et al., 1998).   
 
1.6.4 Mammalian target of rapamycin (mTOR) 
mTOR is a serine/threonine kinase that regulates various biological effects including 
cell proliferation, survival, motility, protein synthesis and transcription (review of (Hay 
and Sonenberg, 2004)).  As the downstream target of Akt, mTOR is activated by Akt-
induced phosphorylation of tuberous sclerosis complex2 (TSC2), which in the 
unphosphorylated form inhibits mTOR activity (Hay and Sonenberg, 2004).  However, 
mTOR involvement in the regulation of Akt phosphorylation on Ser473 also has been 
reported.  mTORC2, which consists of mTOR, rapamycin-insensitive companion of 
mTOR (Rictor), G protein β-subunit-like (GβL) and mammalian stress-activated 
protein kinase interacting protein 1 (mSIN1), is probably PDK2 and phosphorylates 
Akt at Ser473 (Sarbassov et al., 2005).   
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The major function of mTOR is the regulation of translation, especially the recruitment 
of ribosomes to mRNA.  mTOR directly or indirectly regulates the activation of several 
components of the ribosomes recruitment mechanism including eIF4E which 
recognises the cap structure at the 5‟ end of nuclear-transcribed mRNAs; eIF4B and 
eukaryotic translation initiation factor 4G (eIF4G) which unwind the mRNA 5‟-
proximal secondary structure to facilitate for the 40S ribosomal subunit binding; 
ribosomal protein S6 kinase (S6K) and its targets, the ribosomal protein S6 (S6) and 
elongation factor 2 (eEF2) (review in (Hay and Sonenberg, 2004)).  Furthermore, 
mTOR downstream targets eIF4E and S6K appear to control cell (rat fibroblasts) size 
and promote cell cycle progression (Fingar et al., 2002; Fingar et al., 2004). 
 
1.7 Purinergic Receptors 
Purinergic receptors were first defined (Burnstock, 1976) and were classified into two 
major groups: P1 for receptors activated by adenosine and P2 for those activated by 
nucleotides such as adenosine triphosphate (ATP), as shown in Table 1.1 (Burnstock et 
al., 1978).  Based on pharmacology, P2 receptors were divided into two subtypes: P2X 
and P2Y (Burnstock and Kennedy, 1985).  Other P2 receptor subtypes were 
subsequently named including the P2T receptor which was selective for adenosine 
diphosphate (ADP) on platelets, the P2Z receptor on macrophages which was activated 
by ATP (Gordon, 1986) and the P2U receptor which was activated by both uridine 
dinucleotides (UTP) and ATP (O'Connor et al., 1991).  In the early 1990s, based on 
signal transduction mechanisms and cloning studies, two major families were 
confirmed - the P2X family of ligand-gated ion channel receptors and the P2Y family 
of metabotropic GPCRs (Abbracchio and Burnstock, 1994).  Currently seven subtypes 
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of P2X and eight subtypes of P2Y receptor (Table 1.2) are recognised (review in 
(Abbracchio et al., 2006).   
 
 P1 receptors P2 receptors 
Agonist Adenosine ATP, UTP, ADP, UDP, 
UDP-glucose etc 
Subtypes A1, A2A, A2B, A3 P2X1-P2X7 P2Y1-P2Y14 
 
Table 1.1 Classification of P1 and P2 receptors 
 
Receptor subtype Endogenous agonist 
(human) 
Antagonist Coupling 
P2Y1 ADP MRS 2179 Gq/11 
P2Y2 ATP, UTP  AR-C1 26313 Gq/11 
P2Y4 UTP Reactive Blue 2 Gi , Gq/11 
P2Y6 UDP MRS 2578 Gq/11 
P2Y11 ATP, NAD
+
, 
NAADP
-
 
Reactive Blue 2, 
NF 157 
Gs, Gq/11 
 
P2Y12 ADP CT 50547 Gi 
P2Y13 ADP MRS 2211 Gi 
P2Y14 UDP glucose, UDP 
galactose 
No antagonists Gq/11 
 
Table 1.2 Agonist profile of P2 receptors  
(Adapted from Abbracchio et al, 2009) 
 
Chapter 1 Introduction 
De Montfort University                                                                                                                       Yi Luo 36 
1.7.1 The P2Y1 receptor  
The P2Y1 receptor was first cloned and characterised from chick brain (Webb et al., 
1993) and subsequently from human (Janssens et al., 1996), cow (Henderson et al., 
1995), turkey (Filtz et al., 1994), Xenopus (Cheng et al., 2003), rat and mouse 
(Tokuyama et al., 1995).  The P2Y1 receptor is widely distributed and receptor mRNA 
is highly expressed in most human  tissues including brain, heart, placenta, lungs, liver, 
skeletal muscle, kidneys, pancreas and various blood cells (Janssens et al., 1996; Leon 
et al., 1996; Jin et al., 1998).  Northern blotting shows a similar result of P2Y1 mRNA 
distribution in rat (Tokuyama et al., 1995; Nakamura and Strittmatter, 1996).  In most 
species, ADP is a more potent agonist than ATP while UTP, uridine 5-diphosphate 
(UDP) and GTP do not activate the receptor (Waldo and Harden, 2004).  When 
expressed in 1321N1 astrocytoma cells, the rank order of potency is: 2-methylthio-ADP 
(2MesADP) > ADP = 2-methylthio-ATP (2MesATP) > ATP (Waldo et al., 2002).  In 
fact, it has been shown that ATP is a partial agonist at the P2Y1 receptor (Palmer et al., 
1998) and therefore ATP can act as an antagonist when the receptor expression is at a 
low level (Leon et al., 1997).  Recently, by using the purified and reconstituted human 
P2Y1, it was showen that the receptor couples to Gαq and Gα11 but not Gαi1, Gαi2, Gαi3 
or Gαo (Waldo and Harden, 2004).   
 
There is a large body of evidence shows that activated-P2Y1 receptor increase the level 
of intracellular inositol 1,4,5-trisphosphate (IP3) and releases Ca
2+
 from intracellular 
stores (reviewed in (Abbracchio et al., 2006).  Along with P2X1 and P2Y12, the P2Y1 
receptor plays a major role in platelet physiology (Hollopeter et al., 2001).  In P2Y1 
receptor knockout mice, platelet shape change and aggregation are completely 
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abolished.  Furthermore, the knockout of P2Y1 receptor did not apparently affect the 
mouse development, survival and reproduction (Fabre et al., 1999; Leon et al., 1999).   
 
1.7.2 The P2Y2 receptor 
The P2Y2 receptor, which previously named as P2U receptor, was first cloned from 
mouse neuroblastoma cells (Lustig et al., 1993).  Subsequently, it has been cloned and 
pharmacologically characterised from human (Parr et al., 1994) and rat (Chen et al., 
1996) cells or tissues.  Equivalent concentrations of ATP and UTP fully activate P2Y2 
receptors while ADP and UDP are less effective agonists (Lustig et al., 1993; Parr et al., 
1994; Lazarowski et al., 1995).  It has been shown that UTP induced fast 
desensitisation of P2Y2 receptors (within 5min) after exposure of cells to agonist.  
Furthermore, the desensitisation recovered within 5-10min following removal of 
agonist (Otero et al., 2000).  Using haemagglutinin A-tagged P2Y2 to track the receptor, 
it was shown that agonist-induced desensitisation of inositol phosphate responses 
occurred rapidly following agonist binding to the receptor.  Moreover, the receptors 
were internalised at a slower rate which suggesting that receptor internalisation is not 
required for agonist-mediated desensitisation (Sromek and Harden, 1998).   
 
The agonist-induced P2Y2 receptor directly couples to phospholipase C (PLC) via 
Gαq/11 protein to produce IP3 and diacylglycerol (DAG) and mediate release of calcium 
from intracellular stores and PKC activation (reviewed in (Abbracchio et al., 2006).  
P2Y2  receptor activation increases the synthesis and/or release of arachidonic acid 
(AA), prostaglandins and NO (Lustig et al., 1992; Welch et al., 2003; Xu et al., 2003).  
The P2Y2 receptor knockout mice demonstrated that the receptors are responsible for 
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the nucleotide-mediated chloride secretion in airways (Cressman et al., 1999; Homolya 
et al., 1999).  Furthermore, stimulation of P2Y2 receptor can activate alternative 
chloride channels and improve mucus clearance in the bronchi (Kellerman et al., 2002).  
Also activated-P2Y2 receptor has been shown to stimulate chloride secretion and 
increase tear production in the eye (Mundasad et al., 2001).  There is evidence that 
P2Y2 induced ERK activation in rat-1 fibroblasts and  rat adrenal pheochromocytoma 
(PC12) cells via a src-dependent transactivation of EGFR (Soltoff, 1998; Soltoff et al., 
1998).  It also has been shown that human P2Y2 receptor may transactivate EGFR or 
platelet-derived growth factor (PDGF) receptor through two SH3-binding domains in 
the intracellular carboxyl-terminal tail of the receptor (Liu et al., 2004).  In addition to 
induction of ERK activity, the P2Y2 receptor induces the phosphorylation of the stress-
activated kinase JNK and p38 (Gendron et al., 2003).  Activation of P2Y2 causes 
proliferation of smooth muscle cells (Wilden et al., 1998), glioma cells (Tu et al., 2000), 
human lung epithelial tumour cells (Schafer et al., 2003) and human epidermal 
keratinocytes (Greig et al., 2003).  P2Y2 receptor activation also can induce cell cycle 
progression in smooth muscle cells from G1 to S and M phases (Malam-Souley et al., 
1996; Miyagi et al., 1996). 
 
1.7.3 The P2Y3 receptor  
The P2Y3 receptor, which is mainly expressed in the brain, spleen and spinal cord, was 
first cloned and characterised from an embryonic chick brain (Webb et al., 1993).  It 
shares 60% sequence homology with P2Y6 receptor and has the same rank order of 
potency of agonists (Li et al., 1998).    
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1.7.4 The P2Y4 receptor  
The P2Y4 receptor was first cloned and characterised from human (Communi et al., 
1995; Nguyen et al., 1995) and subsequently from rat (Bogdanov et al., 1998; Webb et 
al., 1998) and mouse (Suarez-Huerta et al., 2001).  UTP is the most potent agonist at 
the human P2Y4 receptor (Nicholas et al., 1996) while ATP acts as a competitive 
antagonist (Kennedy et al., 2000).  However, ATP and UTP equipotently activate the 
recombinant rat and mouse P2Y4 receptors (Bogdanov et al., 1998; Webb et al., 1998).  
In rat, extracellular acidification treatment increases the potency of ATP and UTP at 
P2Y4 while Zn
2+
 inhibited the ATP induction of P2Y4 receptor activation; furthermore 
neither treatment affects agonist stimulation of the P2Y2 receptor (Wildman et al., 
2003).  Activation of the P2Y4 receptor stimulate PLC and inhibit adenylyl cyclase, 
which indicates that the receptor is coupling to Gq/11 and Gi (Abbracchio et al., 2006). 
 
The P2Y4-null mice demonstrated that the knockout of the P2Y4 receptor did not affect 
the behaviour, growth and reproduction (Robaye et al., 2003).  The most important 
function of P2Y4 receptor is mediated via the epithelial response in the intestine 
(Cressman et al., 1999).  It has been shown that UTP-mediated epithelial secretion of 
chloride is mainly regulated by the P2Y4 receptor in mouse colon (Ghanem et al., 2005), 
while both P2Y2 and P2Y4 receptor are involved in the UTP induction secretion of 
potassium (Matos et al., 2005). 
 
1.7.5 The P2Y5 receptor  
The orphaned G protein-coupled receptor  was originally cloned from activated chicken 
T cells (Kaplan et al., 1993) and subsequently named as P2Y5 receptor (Webb et al., 
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1996).  However, its agonist dATPαS appears not a general ligand for P2Y receptors 
and further studies showed that the receptor can not be activated by over 40 nucleotides 
and nucleosides which indicated that P2Y5 may not be a nucleotide receptor (Janssens 
et al., 1997; Li et al., 1997). 
 
1.7.6 The P2Y6 receptor  
The P2Y6 receptor, which is activated by UDP, was cloned and characterised from 
mouse (Lazarowski et al., 2001), rat (Chang et al., 1995) and human (Communi et al., 
1996).  In addition to UDP, uridine 5-O-2- thio-diphosphate (UDPβS) and the uracil 
dinucleotide are also potent P2Y6 agonists.  Furthermore these two agonists do not 
active P2Y1, P2Y2 or P2Y4 receptors, which show 38%, 44% and 40% sequence 
identity to the P2Y6 receptor (reviewed in (Abbracchio et al., 2006).   The P2Y6 
receptor-induced IP3 response is insensitive to pertussis toxin (PTX) inhibition which 
suggests that the receptor is coupled to Gq/11 (Chang et al., 1995).  Unlike the P2Y2 
receptor, ligand induced P2Y6 receptor desensitisation and internalisation is slower 
(30min following exposure to agonist) and the response does not recover following 
agonist removal.  Furthermore, it has been demonstrated that neither PKC nor other 
Ca
2+
 activated kinases are involved in agonist-induced the P2Y6 receptor 
desensitisation (Robaye et al., 1997; Brinson and Harden, 2001).  It has been shown 
that the P2Y6 receptor widely express in many tissues and/or cells including human 
splenn, thymus, placenta, intestine and blood leukocytes (Communi et al., 1996) and in 
rat lung, spleen, stomach, intestine and aorta (Chang et al., 1995).   
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P2Y6 receptor message is present in rat smooth muscle cells for which UDP acts as a 
growth factor (Hou et al., 2002).  This finding suggests that the P2Y6 receptor may be 
involved in the regulation of cell proliferation.  The P2Y6 receptor regulates contractile 
effect since UDP and UDPβS inducing the contraction of rat (Malmsjo et al., 2003b) 
and human (Malmsjo et al., 2003a) cerebral arteries.  Also activation of P2Y6 is 
involved in the UTP-mediated chloride secretion in rat colonic epithelial cells (Kottgen 
et al., 2003) and human nasal epithelial cells (Kim et al., 2004).   
 
1.7.7 The P2Y7 receptor 
The P2Y7, which has been shown to be a leukotriene B4 (LTB4) receptor (Yokomizo et 
al., 1997), was first identified by low-stringency screening of a human erthroleukemia 
cell line cDNA library using a P2Y3 receptor encoding probe (Akbar et al., 1996). 
 
1.7.8 The P2Y8 receptor  
The P2Y8 receptor was cloned from frog embryo (Xenopus laevis) (Bogdanov et al., 
1997) and may represent an early evolutionary ancestor of P2Y2 and P2Y4 receptors. 
However, it is not a mammalian receptor. 
 
1.7.9 The P2Y9 receptor  
Although the P2Y9 receptor cloning was by homology to other P2Y receptor genes, it 
has been recently identified as the fourth lysophosphatidic acid receptor (LPA4) 
(Noguchi et al., 2003). 
 
Chapter 1 Introduction 
De Montfort University                                                                                                                       Yi Luo 42 
1.7.10 The P2Y10 receptor 
There is no data which can prove that the P2Y10 sequence is a true nucleotide-activated 
receptor (Ralevic and Burnstock, 1998).  The P2Y10 receptors only express in lymphoid 
tissue and it may play a role in B cell development (Rao et al., 1997).   
 
1.7.11 The P2Y11 receptor 
The P2Y11 receptor was first cloned and characterised from human placenta cDNA and 
genomic DNA libraries (Communi et al., 1997).  The human P2Y11 receptor has a 
unique profile which it is dually coupled to PLC, leading to the release of DAG, IP3 and 
intrcellular Ca
2+
, and also to adenylyl cyclase (AC) to increase cAMP production 
(Communi et al., 1997).  The P2Y11 receptor is activated by adenine nucleotides such 
as ATP, which is its natural agonist.  However, the potency of ATP activating P2Y11 is 
relatively low since the EC50 is in the 5 to 100μM range whereas in the same 
expression systems (1321N1 or CHO cells), the EC50 of ATP activation of other P2Y 
subtypes is in the 10 to 500nM range (Abbracchio et al., 2006).  The rank order of 
potency is ARC67085MX ≥ ATPγS ≈ BzATP > dATP > ATP > ADP (Communi et al., 
1997; Qi et al., 2001).  There is no evidence that functional P2Y11 is expressed in rat or 
mouse.   
1.7.12 The P2Y12 receptor  
The human (Hollopeter et al., 2001; Savi et al., 2001), rat (Hollopeter et al., 2001) and 
mouse (Foster et al., 2001) P2Y12 receptor have been identified and characterised.  
ADP is the natural agonist of the P2Y12 receptor and the rank order of agonist potency 
is 2MesADP >> ADP > ADPβS in all cases (Abbracchio et al., 2006).  ATP and its 
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triphosphate analogs appear to be agonists of the P2Y12 receptor in either native P2Y12 
expressing cells (Simon et al., 2001) and heterologously transfected cells (Zhang et al., 
2001); however, they are antagonists of the P2Y12 receptor in platelets (Kauffenstein et 
al., 2004).  The P2Y12 receptor is mostly expressed in platelets (Hollopeter et al., 2001) 
and also in brain capillary endothelial cells (Simon et al., 2001), glial cells (Fumagalli 
et al., 2003), smooth muscle cells (Wihlborg et al., 2004) and chromaffin cells (Ennion 
et al., 2004).  The P2Y12 receptor knockout mice demonstrated that it is important to 
arrest bleeding and ADP-induced platelet aggregation (Conley and Delaney, 2003). 
 
1.7.13 The P2Y13 receptor  
Human P2Y13 receptor was first cloned (Communi et al., 2001) and later characterised 
(Zhang et al., 2002).  Subsequently it has been identified and characterised from mouse 
(Zhang et al., 2002) and rat (Fumagalli et al., 2004).  ADP and AP3A are natural 
agonists of the P2Y13 receptor while ATP behaves as a weak partial agonist (Marteau et 
al., 2003).  2MesADP is more potent than ADP at human P2Y13 receptor whereas ADP 
is more potent than 2MesADP on the rat P2Y13 receptor (Fumagalli et al., 2004).  The 
activation of the P2Y13 receptor regulates the inhibition of cAMP formation. The P2Y13 
receptor induced ERK1/2 phosphorylation, accumulation of IP3 and all the other 
responses are inhibited by PTX (Communi et al., 2001; Marteau et al., 2003).  This 
suggests that the P2Y13 receptor is coupled to a Gi/o protein.  P2Y13 mRNA was mostly 
expressed in spleen, followed by placenta, liver, bone marrow, lung and brain (Zhang et 
al., 2002).  The role of the P2Y13 receptor is still unclear, however, P2Y13-null mice 
have been recently generated (A. Ben Addi and B. Robaye, unpublished data) and no 
phenotype has been characterised (review in (Abbracchio et al., 2006). 
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1.7.14 The P2Y14 receptor 
The P2Y14 receptor, which was previously known as GPR105 or UDP-glucose 
receptor), has been cloned from human myeloid cells, mouse and rat tissue (Chambers 
et al., 2000).  The P2Y14 can be activated by UDP-glucose, UDP-galactose, UDP-
glucuronic acid and UDP-N-acetylglucosamine whereas uridine or adenine nucleotides 
are inactivate (Chambers et al., 2000).  In common with the P2Y12 and P2Y13, it is 
coupled to Gi protein to inhibit cAMP production (Moore et al., 2003).  P2Y14 mRNA 
is widely distributed in the human body including placenta, adipose tissue, stomach, 
intestine, brain, spleen, lung, heart, bone marrow and thymus (Abbracchio et al., 2006).  
In the rat, P2Y14 is expressed in the brain and has been reported to be regulated by 
immunological challenge (Moore et al., 2003).  This finding suggests that the receptor 
may be involved the humoral and nervous system response to infection and 
inflammation.   
 
1.8 Endocytic signalling  
Ligand-mediated receptor internalisation has been considered as a mechanism which 
terminates the activation of the receptor in the past.  In the classical model of 
transmembrane receptor signalling mechanism, association with extracellular ligand 
results in the receptor at cell surface activating cascades which lead to the cytoplasm 
and nucleus.  The activated receptor is then internalised and degraded.  However, new 
evidence demonstrates that internalisation and formation of signalling endosomes may 
be important to the full activation of receptor (review in (McPherson et al., 2001a). 
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1.8.1 Growth factor endocytic signalling 
The study in liver parenchyma provided clear evidence that the internalised EGFR may 
be continuing signal from endosomes.  Bergeron and colleagues showed that ligand 
binding to the receptor induced a rapid translocation of the EGFR from the plasma 
membrane to early endosomes, where the receptor associated with its downstream 
targets including Shc, Grb2 and Sos (Di Guglielmo et al., 1994).  Also, it has been 
reported that nerve growth factor (NGF) associated with its receptor neurotrophic 
tyrosine kinase receptor type 1 (NTRK1) in endocytic organells (Grimes et al., 1996).  
Furthermore, recent data showed that ligand-bound activated EGFR stimulate the 
receptor internalisation via activation of Rab5, which is largely associated with early 
endosomes (Rink et al., 2005).  Moreover, the same group showed that treatment of 
EGF also reduced the rate of endosomes disassociation of Rab5 and association of 
Rab7, which may be the key process that regulates early-to-late endosomes 
conversation.  All these finding suggest a possibility that growth factor receptors such 
as EGFR may signal from early endosomes after ligand association.  Furthermore, 
internalisation of growth factor may be necessary for the receptor activation.  When the 
EGFR internalisation was inhibited by expression of Dynamin
K44A 
to prolong residence 
of activated EGF on the plasma membrane, it reduced the receptor activation of its 
downstream signalling components such as ERK1/2 and the p85 subunit of PI3K 
(Vieira et al., 1996).  Further evidences have been provided by using specific reversible 
inhibitor of EGFR and platelet-derived growth factor receptor (PDGFR) tyrosine 
kinases to create internalised inactivated non-phosphorylated ligand bound receptors.  
Then removal of the inhibitor resulted in the recovery of the activation of the 
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internalised receptor which was able to stimulate further signals and biological effects 
from endosomes (Wang et al., 2002; Pennock and Wang, 2003; Wang et al., 2005).  
These studies are of great important because they show that signalling from endosomes 
in the absence of signalling from cell surface is sufficient to form certain responses.  
Moreover, it has been reported that some downstream signalling molecules of growth 
factor such as epidermal growth factor receptor pathway substrate 8 (Eps8) preferred to 
association with the EGFR in endosomes rather than on cell plasma membrane (Burke 
et al., 2001).  Although the same group also showed that some other downstream 
signals such as Grb2 were like to associate with the EGFR on the plasma membrane.  
This finding suggests that EGFR stimulation downstream signals may be from both cell 
surface and endosomes depending on the targets.   
 
There is considerable evidence that growth factor receptor internalisation is regulated 
by the activation of clathrin-coated vesicles - the clathrin-mediated internalisation 
pathway.  In the beginning of this process, the adaptor protein 2 (AP2) recruits clathrin 
to the plasma membrane to allow the conversion of a flat membrane into a bud of high 
curvature named as clathrin-coated pits (McPherson et al., 2001a).  The AP2 also 
recruits ligand-bound receptor such as EGFR to the clathrin-coated pits (Sorkin and 
Carpenter, 1993).  Furthermore, in mutant AP2 overexpressed Hela cell, the number of 
clathrin-coated pits was significantly reduced and transferrin induced internalisation 
(clathrin-dependent internalisation) was abolished (Johannessen et al., 2006).  However, 
the treatment of EGF resulted in the formation of new clathrin-coated pits and then 
induced internalisation of the EGFR along with AP2, clathrin and Grb2.  There are 
many evidences show that the clathrin and AP2 directly or indirectly associate with 
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other endocytic proteins such as amphiphysin I and II (Ramjaun and McPherson, 1998), 
epidermal growth factor receptor pathway substrate 15 (Eps15) (Owen et al., 2000), 
dynamin (Sever et al., 2000) and synaptojanin (Slepnev and De Camilli, 2000) etc, 
which together regulates the clathrin-mediated internalisation.  Recently, other 
endocytic pathways which are not dependent on the activation of clathrin have been 
discovered such as caveolae-mediated endocytosis which may be the best studied 
clathrin-independent internalisation pathway (review in (Mayor and Pagano, 2007).  
Caveolae are small flask-shaped pits which formatted in the plasma membrane.  They 
are enriched in caveolin, sphingolipids and cholesterol (Simons and Ikonen, 1997).  It 
has been reported that the EGFR may be internalised via caveolae-mediated pathway 
when stimulation with high concentration of EGF.  Sigismund and colleague showed 
that the high concentration of EGF induced the EGFR internalisation and ubiquitylation 
via a cholesterol-sensitive (may be caveolae-mediated) pathway; while low 
concentration of EGF resulted in the EGFR internalisation via clathrin-dependent 
pathway and did not lead to the receptor degradation (Sigismund et al., 2005).  They 
showed that when the EGFR internalised via caveolae-mediated pathway, the EGFR 
was interacted with the proteins such as eps15 and epsin, which contains ubiquitin-
interacting motif.  Therefore, caveolae-mediated internalisation pathway leads to the 
EGFR degradation.   
 
The internalisation of the growth factor may provide a way to allow the receptors to 
directly activate their target site (Verhey et al., 2001).  For instance, signals from axon 
terminals must travel along the axon to the cell body where it activates further 
processes.  Ye and colleagues showed that NGF-induced neurotrophic tyrosine kinase 
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receptor type 1 (TrkA) internalises and maintains activity in endosomes as it travel 
along the axon, a processes necessary for neuronal survival (Ye et al., 2003).  
Furthermore, the internalisation may be depending on the proportion of receptors.  For 
example, the EGFR (ErbB1) rapidly internalised in Human epithelial carcinoma cell 
line (A431) cells after ligand induction, and continue signalled before degradation.  
Other member of the EGFR family, for instance ErbB2 is preferred to signal from the 
plasma membrane for a longer period (Sorkin et al., 1991; Wiley, 2003).   
 
1.8.2 GPCR endocytic signalling 
It has been shown that inhibition of β2-adrenergic receptor internalisation reduced 
GPCR-mediated MAPKs (ERK1/2) activation (Daaka et al., 1998).  This suggested that 
the receptor internalisation plays an important role in the GPCR activation.  
Furthermore, that receptor internalisation is required for GPCR-regulated ERK1/2 
activation has been found in several other GPCRs including 5-HT1A, μ and δ opioid 
receptors (McPherson et al., 2001a).  It appears that β-arrestin, an adapter protein, 
along with src together regulate the GPCR internalisation and activation, such as 
induction of ras activation (Luttrell et al., 1999).   
 
1.9 Nuclear localisation of EGFR 
The EGFR was first claimed to be detected in the nucleus of regenerating hepatocytes 
in 1991 (Marti et al., 1991).  Also Raper and colleague reported that EGF translocated 
to the nucleus during the pre-S phase of liver regeneration (Raper, 1987).  There are 
considerable evidences showed that the EGFR also located in the inner nuclear 
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membrane of mice liver cells (Klein et al., 2004).  Furthermore, many groups showed 
that the nuclear EGFR appears to be as a full-length receptor and can be in the 
phosphorylated form in many cells and tissues such as Human placental 
choriocarcinoma cell line (JEG-3) cells (Cao et al., 1995), A431 cells (Lin et al., 2001a) 
and breast carcinomas (Lo et al., 2005b).  Recently evidences suggested that the 
nuclear translocation may begin with the EGF/EGFR coupled complexes internalisation 
and inhibition of the receptor internalisation with mutant dynamin blocked the nuclear 
import of the EGFR (review in (Lo and Hung, 2006).  It appears that association with 
nuclear transport receptors including importin β1 and importin α may be the key for the 
EGFR translocation from cell surface into the nucleus (DIttmann et al., 2005; Lo et al., 
2005a).  Lo and colleague suggested that the nuclear localisation signals (NLSs) within 
JM of the EGFR interacts to the nuclear transport receptor such as importin β1, which 
then regulating the receptor translocation into the nucleus (Lo et al., 2005a).  
 
The nuclear ErbBs may act as a transcriptional activator was first suggested by Xie and 
colleagues (Xie 1994).  Furthermore, recently findings showed that the nuclear EGFR 
associated with signal transducers and activators of transcription 3 (STAT3) and then 
enhanced gene transcription such as cyclin D and inducible NO synthase (iNOS) (Lo et 
al., 2005a).   
1.10 Aims and objectives 
The main objectives of this study are as following: 
* To study the signalling pathway of how cell surface receptor regulates rat hepatocytes 
proliferation related responses 
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* To understand how G protein-coupled receptors (P2Y2) and tyrosine kinase receptors 
(EGFR) signal through PI3K/Akt and MEK/MAPK pathways which leading to 
different biological response in rat hepatocytes 
* To investigate the role of endocytic signal in the full EGFR activation 
* To further study the role of internalised EGFR or nuclear EGFR signal to biological 
response of rat hepatocytes 
           
 
 
 
Chapter2  
Materials and Methods 
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2.1 Materials 
Male Wistar Rats were purchased from Charles River.  All the medium was obtained 
from Invitrogen. FCS (fetal calf serum) was supplied by Biosera, BSA, insulin-
transferrin-sodium selenite media supplement (ITS) and collagen type 1 (in solutions 
from rat rail) were supplied by Sigma.  Collagenase A was from Roche.  Penicillin and 
gentamicin was ordered from GIBCO.  LY294002, 1, 4-diamino-2, 3-dicyano-1, 4-bis 
(2-aminophenylthio) butadiene (UO126), nystatin, were obtained from Calbiochem.  4-
(3-Chloroanilino)-6,7-dimethoxyquinazoline (AG1478), 4-hydroxy-3-methoxy-5-
(benzothiazolylthiomethyl) benzylidene cyanoacetamide (AG825), concanovalin A, 
and filipin were supplied by Sigma.  Gefitinib was purchased from AstraZeneca 
Pharmaceuticals.  (S)-1-(1H-indol-3-ylmethyl)-2-[5-(3-methyl-1H-indazol-5-yl)-
pyridin-3-yloxy]-ethylamine (A443654 or A443) was a kind gift of Dr Yan Luo, 
Abbott, Illinois, U.S.A.. The phospho-Akt (Ser473) antibody, Akt antibody, phospho-
GSK-3α/β (Ser21/9) antibody and EGFR antibody were obtained from Cell Signalling 
Technology via New England Biolabs.  Rabbit anti-active MAPK pAB, donkey anti-
rabbit lgG (H+L) HRP, Anti-Mouse lgG (H+L), HRP conjugate were purchased from 
Promega.  Purified mouse anti-ERK (Pan ERK) mAb was from BD Transduction 
LaboratoriesTM.  Anti-GSK3α/β was produced by Millipore.  Phospho-EGFR (tyr1173) 
antibody was obtained from Santa Cruz Biotechnology.  Cy5-affinipure donkey anti-
rabbit IgG (H+L) was purchased from Jackson ImmunoResearch Laboratories via 
Stratech.  Transferrin from human serum, Alexa Fluor® 546 conjugate, epidermal 
growth factor (EGF), biotinylated, complexed to Alexa Fluor® 488 streptavidin 
conjugated EGF (488-EGF) and   SYTOX® green nucleic acid stain were purchased 
from Invitrogen.  All the nucleotides such as ATP, UTP were provided by Sigma.  The 
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adenovirus constructs were a kind gift from Dr Richard Rippe and cultured by Dr John 
Hall and PhD student Zhong Cheng.  All other chemicals were from Sigma and Fisher.   
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2.2 Methods 
2.2.1 Hepatocyte preparation and culture 
2.2.1.1 Buffer preparation 
Calcium-free buffer was prepared by the addition of 6.77g of NaCl, 0.42g KCl, 0.197g 
MgSO4, 0.15g NaH2PO4, 015g KH2PO4, 2.10g NaHCO3, 2.00g Glucose and 0.076g 
ethyleneglycol-bis(aminoethylether)-tetraacetic acid (EGTA) to 900ml of deionised 
water.  1M NaOH or 1M HCl was used to adjust the pH to 7.4.  The buffer volume was 
then adjusted to 1L, and the pH was re-checked and re-adjusted, if necessary.  Buffer 
was stored in an autoclaved bottle at 4˚C for up to 1 month. 
 
Calcium-Hepes buffer was prepared by the addition of 6.77g of NaCl, 0.42g KCl, 
0.197g MgSO4, 0.15g NaH2PO4, 015g KH2PO4, 0.35g NaHCO3, 2.00g glucose, 1.8ml 
of 1M CaCl2 solution and 4.76g 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(Hepes) to 900ml of deionised water.  The buffer was then perfused with the gas 
(O2:CO2, 95%/5% v/v) for 10-15min.  1M NaOH or 1M HCl was subsequently used to 
adjust the pH to 7.4 before filling the buffer volume to 1L.  The solution was stored in 
an autoclaved bottle at 4˚C for up to 1 month. 
2.2.1.2 Cell preparation 
Hepatocytes were isolated from male, fed, 200-300g Wistar strain rats following the 
technique introduced by Berry and Fried (1969) and developed by Seglen (1976). 
Firstly, the rat was stunned by a blow to the head and killed by cervical dislocation.  
Immediately following death, a two stage of perfusion was performed at 37˚C by the 
injection into the hepatic portal using an 18 gauge Monoject needle (Sherwood 
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Medical).  Oxygen was provided into the perfusate by continuous gassing (O2:CO2, 
95%/5% v/v) of the buffers which also maintained the optimal pH for enzymatic 
dispersion by collagenase A (pH 7.4).  An initial calcium-free perfusion was performed 
with 150ml of calcium-free buffer during which the liver was dissected out of the rat 
and suspended above a beaker in a temperature-controlled water-bath.  This calcium-
free pre-perfusion aids cell dispersion (Seglen, 1972).  During the second stage, the 
liver was perfused on a recirculating basis for 15min with 100ml of the same buffer 
with calcium (3.8mM), collagenase A (0.04% w/v) and BSA (0.05% w/v).  The cells 
were teased apart from the connective and vascular tissue of the liver by using a scalpel 
blade to rupture the capsule and the rounded end of a spatula to gently dissociate them, 
and then filtered through 100μM nylon mesh.  The cells were shaken in a temperature 
controlled water bath at 37˚C to remove dead cells.  Then the cells were washed three 
times in a calcium-Hepes buffer medium by gentle centrifugation at 50g for 2min to 
remove non-parenchymal and damaged parenchymal cells, and subcellular debris.  A 
final centrifugation yielded a pellet of intact hepatocytes.  Cell viability and 
concentration were assessed by trypan blue exclusion.  The cells were diluted at a 
density of 2 x 10
5
 cells/ml in Williams Medium E (WME) containing BSA (0.05% w/v), 
penicillin (100 units/ml), gentamicin (50μg/ml), ITS, 10% FCS and then plated into 
collagen coated plates.  The cells were incubated in a humidified 5% CO2 incubator at 
37˚C for 4h before changing the medium to serum-free (SF) WME.   
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2.2.2 Total [
3
H]-Inositol (Poly) phosphates accumulation assay 
The assay is based on the use of lithium, which is an uncompetitive inhibitor of the 
enzyme-inositol monophosphatase, to block the recycling of inositol in the 
phosphoinositide pathway and in turn cause the accumulation of inositol phosphates 
(Fauroux and Freeman, 1999).  The cells were labelled to equilibrium [
3
H]-inositol, 
which is incorporated into the membrane phospholipids, and total inositol phosphate 
accumulation was measured in the presence of lithium. 
 
2.2.2.1 Labelling cells with myo-[
3
H]-inositol 
Hepatocytes were obtained and plated in 24-well plates as described before and 
incubated 4h in WME supplement with ITS and 10% FCS.  Then the cells were 
incubated in 500μl of serum free WME for 20h.  Subsequently cells were labelled with 
myo-[
3
H]-inositol (0.037Mbq/ml) in serum free medium 199 (M199) (low inositol) 
with additional penicillin (100units/ml) and gentamicin (50μg/ml) for 48h.  
 
2.2.2.2 Agonist challenge 
The plates were transferred to a 37˚C water-bath for all subsequent steps.  To 500μl of 
medium, 50μl of 10mM of Lithium (11X concentration) was firstly added and left for 
15min.  Subsequently 50μl of agonists (12X concentration) was added to the medium 
as indicated in each different experiment.  The medium was aspirated and immediately 
replaced with 500μl ice-cold 1M trichloracetic acid (TCA) to terminate the reaction.  
Plates were then directly transferred onto wet ice for 30min to ensure complete rupture 
of the cellular membranes and release of the water-soluble phospholipids.   
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2.2.2.3 Tri-n-octylamine and 1, 1, 2-trichlorofluoroethane extraction 
From each well of the 24-well plate, 400μl of the supernatant was transferred into a 5ml 
polystyrene tube and 100μl of 10mM ethylenediaminetetraacetic acid (EDTA) was also 
added into the tube to chelate  ions such as Ca
2+
, Na
+
, K
+
, Mg
2+
 from the solution.  To 
the resulting solution, 500μl of a freshly prepared 1:1 v/v tri-n-octylamine and 1, 1, 2-
trichlorofluoroethane mixture was added.  The solution was mixed by vortex, and then 
microfuged at 10,000g for 10min.  Next, 400μl of the upper aqueous phase was 
carefully transferred into a 1.5ml microfuge tube and 25μl of 250mM NaHCO3 was 
finally added to the resulting solution to neutralise the pH.  Samples were stored at 
20˚C or processed further immediately.   
 
2.2.2.4 Separation of total Inositol Phosphates by using the Dowex Columns 
A mixture of 1:1 v/v of Dowex and distilled water (dH2O) was prepared and 2ml of the 
mixture was added to each polypropylene chromatography column and allowed to 
settle.  The Dowex was then stripped of chloride ions using 2M ammonium formate 
and recharged with formate ions by the addition of 1M formic acid.  The columns were 
then washed a further 3 times with 10ml dH2O and then stored at 4˚C covered with 
sufficient dH2O.   
 
The columns were washed once with 10ml dH2O before adding samples.  After each 
sample was added, another 5ml dH2O was also added into the column.  The eluant was 
run to waste and a further 10ml dH2O was applied and steps repeated 3 times until the 
inositol phosphates had attached to the Dowex by exchanging with the formate ions.  
Next, 10ml of a low concentration of ammonium formate (60mM) was added to the 
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column to remove the glycerophosphoinositols.  Finally total 
3
H-inositol phosphate 
fraction was eluted by the addition of a high concentration ammonium formate (4ml, 
2M) and collected into the scintillation vials.  Following the addition of 15ml FLO-
Scintillant to each vial, the samples were vortexed and counted for 3min for each 
sample.  The columns were regenerated by washing with 10ml 1M formic acid after use 
followed with 3 washes with 10ml dH2O, then stored as described before until required.   
 
2.2.3 [
3
H]-thymidine assay 
2.2.3.1 Agonist challenge 
[
3
H]-Thymidine assay is a common technique used to measure DNA synthesis, which 
can be used as an index of cell cycle progression, in cultured cells (Pace et al., 1991).   
 
Hepatocytes were isolated and seeded as described before in the 24-well plates and 
incubated in WME (500μl) with 10% FCS and ITS for 4h.  Then serum was removed 
by changing the medium to SF WME and the cells were further incubated for 24h to 
allow cells to enter the quiescent G0 stage of the cell cycle. (In some experiment 
adenovirus was added and left for 2 or 16h at the beginning of this 24h SF incubation 
(adenovirus was then removed by washing the cells with SF WME)).  Inhibitors such as 
LY294002, A443654 and AG1478 etc were dissolved in dimethyl sulfoxide (DMSO) 
to give 1000X the final concentration (F.C.) and then diluted in WME to give 2X the 
required concentration and mixed well by vortexing.   Next, 250μl of medium was 
gently removed from each well of the 24-well plates and 250μl of 2X inhibitors were 
added to achieve the F.C. of inhibitors and given a F.C. of 0.1% DMSO.  After pre-
incubation with inhibitors, cells were then exposed to agonist such as nucleotides and 
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growth factors which were diluted in calcium-Hepes and WME respectively.  To 500μl 
medium, 100μl 6X agonist (5μl 100X) was added and left 24h.  In some experiments 
(see Chapter 6) inhibitor and agonist (or only agonist) was removed one or several 
hours after the stimulation by washing the cells with SF WME three times, leaving a 
2min gap between second and third wash to allow the cells releasing the inhibitors.  
Cells were further incubated to achieve a total of 24h incubation from the time of 
adding agonist, while sometimes inhibitor and/or agonist was added back to cells as 
described before after an 8h gap from the third wash and further incubated until 24h 
from the first stimulation.  20h following the first exposure of cells to the agonist, 
100μl of WME containing 6μl/ml (7μl/ml) of methyl-3H-thymidine (activity 
=37MBq/ml) was added to the 500μl (600μl) medium in each well to give a F.C. of 
1μCi/ml and incubated for a further 4h to allow incorporation of the radiolabelled 
nucleotide into the newly synthesised DNA.   
 
2.2.3.2 Extraction of the radiolabelled DNA 
Plates were then transferred onto wet ice and the cells were gently washed twice with 
1ml ice-cold balanced salt solution (phosphate buffered saline (PBS): 137mM NaCl, 
10mM Phosphate, 2.7mM KCl, pH 7.4) with 5min intervals between to remove 
residual methyl-
3
H-thymidine.  The cells were then washed twice with 500μl ice-cold 
5% TCA to precipitate acid-insoluble proteins and DNA and then twice with 500μl ice-
cold 100% ethanol.  After aspiration of the ethanol the residue was placed in a hood to 
allow evaporation before the addition of 250μl of 0.5M NaOH which was used as a 
solvent for DNA.  Then the plates were well shaken for 15min and stored at -20˚C if 
necessary.  To this 250μl solution, 200μl was transferred into scintillation vials with 
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4ml of Emulsifier Safe scintillation fluid added and each vial was vortexed for around 
6s until the phases had mixed.  The remaining 50μl of solution was used in the protein 
assay.  The radioactivity was determined in scintillation counter for 3min each vial at 
least 1h after vortex to allow abeyance of background chemiluminescence.         
 
2.2.4 Western blotting 
Western blotting is a standard method to detect proteins by electrophoretic separation 
and electro-transfer of the proteins onto a stable substrate such as nitrocellulose film or 
polyvinylidene fluoride (PVDF).  Subsequently specific antibodies are used to probe 
the interesting proteins which are visualised by application of a secondary antibody 
linked to a chemiluminescent or fluorescent dye (Burnette, 1981). 
 
2.2.4.1 Buffer preparation 
Lysis buffer (20mM Tris-HCl, 250mM NaCl, 3mM EDTA, 3mM EGTA, 0.5% 
TritonX-100, pH 7.6) was prepared by the addition of 2ml of 1M Tris-HCl (pH8.0), 
5ml of 5M NaCl, 600μl of 500μM EDTA, 600μl of 500μM EGTA and 500μl of 
TritonX-100 to 80ml of dH2O.  1M HCl or 1M NaOH was used to adjust the pH of the 
buffer to 7.6.  The buffer volume was then made up to 100ml with dH2O, and the 
buffer pH was re-checked and re-adjusted, if necessary.  The solution was stored in 5ml 
aliquots at -20˚C until use.  Directly before use, the inhibitors including 50µl of 
100mM phenylmethylsulfonylfluoride (PMSF), 50µl of 200mM Na2VO4, 50µl of 
2mg/ml aprotinin, 2.5µl of 10mg/ml leupeptin and 5µl of β-mercaptoethanol (β-ME) 
were added to 5ml of lysis buffer. The solution was stored on ice until use. 
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Running buffer was prepared by the dilution of 10X running buffer at ratio 1:10 in 
dH2O.  10X running buffer (25mM Tris base, 250mM glycine, 0.1% sodium dodecyl 
sulphate (SDS), pH 8.3) was prepared by the addition of 30.3g of Tris base, 187.7g of 
glycine and 10g of SDS to 600ml of dH2O.  It was dissolved completely by using a 
magnetic stirrer at approximate 50˚C for about 2h.  It was then made up to 1L with 
dH2O.  The pH of solution should be approximately 8.3 and it was checked but not 
adjusted.  Solution was stored at room temperature for up to six months.   
 
2X sample buffer (250mM Tris-HCl, 4% SDS, 20% glycerol, 0.008% bromophenol 
blue and 4% β-ME ) was prepared by the addition of 1g SDS, 5ml glycerol, few grains 
of bromophenol blue and 1ml of β-ME into 20ml of 250mM Tris-HCl (pH 6.8). 
 
Blotting buffer (39mM glycine, 48mM Tris base, 0.037% SDS, 20% methanol, and pH 
8.3) was prepared for by the addition of 8.7g of glycine, 17.4g of Tris base, 1.11g of 
SDS and 0.6L of methanol to 2.4L of dH2O.  The pH of solution should be 
approximate 8.3 and it was checked but not adjusted.  This buffer was freshly prepared 
for each experiment and stored at 4˚C and used within 48h.   
 
10X Tris buffered saline (10X TBS) buffer (20mM Tris base, 137mM NaCl, pH7.5) 
was prepared by the addition of 24.2g of Tris base and 80g of NaCl to 600ml of dH2O.  
HCl (37%) or 5M NaOH was used to adjust the pH to 7.5.  The buffer volume was then 
adjusted to 1L with dH2O and the buffer pH was re-checked and re-adjusted, if 
necessary.  Tris buffered saline-tween (TBS-T) buffer was prepared by the dilution of 
10X TBS buffer at ration 1:10 in dH2O and addition of tween 20 to give the F.C. of 
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0.05% v/v e.g. 1ml of tween 20 in 2L TBS.  Solution was stored at room temperature 
for up to six months. 
 
2.2.4.2 Agonist challenge  
Hepatocytes were isolated and seeded onto collagen coated 6-well plates as described 
above.  After 4h incubation, the medium was replaced with 3ml SF WME and the cells 
were incubated for the further 24h or 48h to induce quiescence.  In some experiments, 
adenovirus was added after changing the medium and left for 2h or 16h before removal 
by washed the cells with SF WME.  Prior to stimulation, 1ml of medium was gently 
aspirated from each well (3ml before taken) at least one hour before exposure of the 
cells to agonist.  Inhibitors were dissolved in DMSO to achieve a 1000 folder of 
required concentration and diluted in WME to give 2X F.C. and mixed well by vortex.  
Next, 1ml of medium was gently removed from each well (2ml) of the 6-well plates 
and 1ml of 2X inhibitors was added and left for a suitable period (15-30min).  The cells 
were then treated with agonists (11X or 100X) as described in each experiment.  In 
some experiments a further wash was required.  The cells were washed twice with 3ml 
SF WME and incubated for about 2min followed with a third wash (2ml SF WME).  In 
some experiments, an acid wash was used to remove extracellular EGF. The cells were 
placed on ice and washed with cold SF WME, then cells were incubated on ice with 
cold 0.5M NaCl/0.2M acetic acid for 5min, subsequently cells were washed twice with 
cold SF WME, finally the cells were removed from the ice and washed once with SF 
WME at 37˚C.  In all the experiments the stimulation was stopped by rapid removal of 
the entire medium from the plates and immediately freezing at -80˚C for at least 2h.   
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2.2.4.3 Preparation of cell lysates 
The plates were then transferred onto wet ice and 100μl ice-cold lysis buffer was added 
to each well.  Cells were detached from the plate using a scraper which was washed 
with dH2O and 100% ethanol between using on each well.  The solution was 
transferred to a 1.5ml microcentrifuge tube and sonicated on ice for 5min and then 
microfuged at 13000rpm for 10min at 4˚C.  The supernatant was transferred to an 
Eppendorf and vortexed.  Appropriate (the remaining volume was enough for the 
protein assay) volume was transferred to another Eppendorf and an equal volume of 2X 
sample buffer was added and heated at 105˚C for 5min before storage at -20˚C until 
assay, while the rest was kept for protein assay.  
 
2.2.4.4 SDS-Polyacrylamide gel electrophoresis 
Polyacrylamide gels (0.75mm thick) consisted of a 5% stacking gel (5% 1:30 
acrylamide, 0.125M Tris-HCl pH 6.8, 0.1% SDS, polymerised with 0.1% ammonium 
persulphate (APS) and 0.1% tetramethylethylenediamine (TEMED)) and a 7% or 10% 
running gel (7% or 10% acrylamide, 0.375M Tris-HCl pH 8.8, 0.1% SDS, 0.1% APS 
and 0.0625% TEMED).   
 
Protein-equalised samples (re-heated 5min at 105˚C) were loaded to achieve 10-40μg 
(volume not greater than 25μl) each lane and 5μl Bio-Rad Precision Protein Standards 
(a range of 250, 150, 100, 75, 50, 37, 25, 15 and 10kDa) was loaded into the first lane 
and sample buffer into any unused lanes.  Samples were firstly run through stacking gel 
at 150V for 15min using Bio-Rad Protein II mini-gel system to focus proteins into a 
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narrow band.  Subsequently proteins were electrophoretically separated on the running 
gel at 100V for approximately 1h until the dye front reached the end of the gel.   
 
2.2.4.5 Electro-transfer of proteins 
The running gel was cut away from the mini-gel system and transferred onto a pre-
soaked membrane PVDF soaked in methanol 5s then 30min in water and cold blotting 
buffer 15min). Next, the gel and membrane were sandwiched between 6 sheets of 
blotting paper and 2 fibre pads (soaked in blotting buffer for 15min) and enclosed in the 
blotting cassette.  Wet blotting was performed in a Bio-Rad Trans-blot cell which was 
filled with cold blotting buffer.  The proteins were transferred to membrane (from 
cathode to anode) at 100V for 1h under cooled conditions.   
 
2.2.4.6 Probing with antibodies 
The membrane was washed 5min within TBS-T and transferred to a suitable size 
container and blocked in blocking agent e.g. 2% BSA or 5% milk (dissolved in TBS-T) 
for 1-2h at room temperature with a gentle shaking.  The membrane was washed with 
TBS-T six times for 5min each wash on a rocking platform.  The blot was then soaked 
in primary antibody at a required dilution in suitable diluent (5% milk or 0.1% BSA) 
and gently rocked overnight at 4˚C.  The next day, the blot was washed by two times of 
1min washes, six times of 15min washes with TBS-T on a well-shake rocker at room 
temperature to rinse out the excess antibody.  After that, secondary antibody (diluted in 
5% milk or 0.1% BSA) was incubated with the blot at room temperature for 1h with a 
gentle rock.  The excess secondary antibody was washed out in the same way as 
performed after primary antibody.  The membrane was then drained off to remove 
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excess TBS-T and immediately soaked in enhanced chemiluminescence (ECL) Plus
TM
 
reagent and rocked in dark at room temperature for 5min.  Next, the membrane was 
wrapped in cling film and exposed to the film in an extremity cassette in the dark room 
for an appropriate time (10s to 1h).  Finally, the film was developed and fixed using 
Kodak GBX developer and replenisher.   
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 Blocking agent Primary antibody Secondary antibody 
Phospho-ERK 2% BSA/TBS-T 1:5000 in 0.1% 
BSA /TBS-T  
1:35000 donkey 
anti-rabbit in 0.1% 
BSA /TBS-T 
Pan-ERK 2% BSA/TBS-T 1:1000 in 0.1% 
BSA /TBS-T 
1:35000 donkey 
anti-mouse in 0.1% 
BSA /TBS-T 
Phospho-Akt 2% BSA/TBS-T 1:1000 in 0.1% 
BSA /TBS-T 
1:20000 donkey 
anti-rabbit in 0.1% 
BSA /TBS-T 
Pan-Akt 2% BSA/TBS-T 1:1000 in 0.1% 
BSA /TBS-T 
1:20000 donkey 
anti-rabbit in 0.1% 
BSA /TBS-T 
Phospho-GSK 5% milk/TBS-T 1:1000 in 5% BSA 
/TBS-T 
1:10000 donkey 
anti-rabbit in 5% 
milk/TBS-T 
Pan-GSK 5% milk/TBS-T 1:1000 in 5% BSA 
/TBS-T 
1:10000 donkey 
anti-rabbit in 5% 
milk/TBS-T 
Phospho-EGFR 5% milk/TBS-T 1:1000 in 5% BSA 
/TBS-T 
1:10000 donkey 
anti-rabbit in 5% 
milk/TBS-T 
Pan-EGFR 5% milk/TBS-T 1:1000 in 5% BSA 
/TBS-T 
1:10000 donkey 
anti-rabbit in 5% 
milk/TBS-T 
 
Table 2.1 Concentration, blocking agent and dilution of each antibody 
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2.2.5 Bradford protein assay using 96-well plate 
The Bradford protein assay is used to measure the shift in the absorption maximum 
from 465nm to 595nm caused by the reaction between Coomassie Brilliant Blue G-250 
dye and protein (Bradford, 1976).  The standard concentration series was produced by 
dissolution of suitable volume of 1mg/ml BSA to dH2O to obtain a concentration range 
from 0 to 1mg/ml at each 0.1mg/ml.  Bradford reagent was added to the standard 
protein and unknown sample and the absorbance was measured at 595nm after mixing 
the protein and reagent on a shaker for approximately 30s and further incubating at 
room temperature for about 5min.  The unknown sample was diluted to around 
0.3mg/ml-0.7mg/ml and then the reading was compared to the standard curve to 
achieve the concentration.   
 
2.2.6 MTT assay 
The technique is based on the tetrazolium ring of 3-[4, 5-dimethylthiazol-2-yl]-2, 5-
diphenyltetrazolium (MTT) which is cleaved by mitochondrial dehydrogenases in 
living cells to generate a purple formazan.  The purple formazan is then dissolved in 
solubilization solution, such as DMSO, and quantified by measuring at 540nm.  Since 
the reduction can only be induced by activated mitochondrial reductase enzymes, the 
assay can reflect the number of viable cells (Mosmann, 1983). 
 
Hepatocytes were plated on collagen coated 24-well plates (500μl) as described before.  
If adenovirus was involved, cells were incubated with virus as described in [
3
H]-
thymidine assay.  After 24h SF incubation, the cells were treated with inhibitors and 
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agonists in the same way described in [
3
H]-thymidine assay.  22h after the cells 
exposed to agonist, 125μl of MTT (2mg/ml in PBS) was added to each well (500μl) 
and further incubated for 2h.  All medium was aspirated without disturbing the purple 
solid, and the formazan was solubilised in 350μl DMSO with a 1min shake.  Finally, 
the absorbance was measured at 540nm using a UV microplate reader.   
 
2.2.7 Immunocytochemistry and confocal work 
2.2.7.1 Agonist challenge  
Hepatocytes were produced and seeded in collagen coated 12-well plates (1ml) with 
16mm plastic coverslips as described above.  The cells were then incubated in SF 
WME for 24h to induce quiescence.  When the adenovirus was required, the cells were 
incubated with virus for 2h or 16h of the beginning of the 24h SF incubation and 
removed by washing the cells with SF WME.  Inhibitors were firstly dissolved at 
1000X concentration in DMSO and diluted in WME to obtain 2X concentration.  To 
1ml of medium, 500μl was removed and 500μl of 2X inhibitor solution (or WME) 
added and cells were further incubated for a suitable time (15-30min).  Then 2μl of 
EGF (200μg/ml) or 488-EGF (200μg/ml) was added to the medium (1ml).  In some 
experiments, EGF was firstly diluted to 11X concentration before adding to medium to 
achieve 3nM F.C.  When a wash was required, it was performed as described in the 
[
3
H]-thymidine assay. 
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2.2.7.2 Immunocytochemistry staining 
The cells (on coverslips) were quickly washed with cold PBS before fixing in freshly 
prepared cold 3.7% paraformaldehyde in PBS for 15min at 4˚C.  This was followed 
with a rapid wash in cold PBS.  The cells were then permeabilised in Triton (0.1% 
TritonX-100 in 2% BSA in sterile PBS) at room temperature for 2min.  After that the 
cells were washed three times with cold PBS (two quick washes with 5min between 
each wash) on ice to remove Triton from the cells.  100μl of blocking buffer (10% 
donkey serum in 2% BSA/PBS) was pipetted onto each converslip and incubated for 1h 
at room temperature.  The blocking buffer was removed and replaced with 80μl 
primary antibody (1:100 anti-EGFR or 1:50 anti-P-EGFR in 2% BSA/PBS).  Following 
incubation overnight at 4˚C, primary antibody was washed as performed after 
permeabilisation.  The secondary antibody (Cy5-donkey anti-rabbit, 1:1 diluted in 
Glycerol and then 1:200 in 2% BSA/PBS) was then applied to the cells.  And 
secondary antibody off, washes were applied to the cells as described after 
permeabilisation.  In some experiments, a nuclear stain was applied such as propidium 
iodide (PI) (50μg/ml in PBS), which was incubated with the cells for 30min at 37˚C 
with ribonuclease (RNAse) (10μg/ml) supplement, or SYTOX green (100nM in PBS), 
which was incubated with the cells for 30s at room temperature (Suzuki et al., 1997; 
Monga et al., 2002).  
 
2.2.7.3 Mounting and observation  
The coverslips were fixed on microscope slides around the edge by using nail polish, 
while Citi-fluor was added to protect the fluorescent signal.  In the experiment that did 
not require the application of antibody, coverslips were directly mounted after fixing.  
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The slides were then observed under confocal microscope (Leica) with the same setting 
of offset and gain applied to every slide from one experiment.   
 
2.2.8 Preparation of adenovirus lysis solution 
Human Embryonic Kidney 293 (HEK-293) cells were grown in T175 cm
2 
flasks until 
90% confluent.  Then the HEK-293 cells were infected with adenovirus encoded 
encoding dominant negative Akt (Dn-Akt), constitutively active Akt (myr-Akt) or 
dominant negative dynamin (Dn-dynamin) at 1:1000 dilutions.  Subsequently 
incubation of the cells with adenovirus at 37˚C (O2:CO2, 95%/5% v/v) until cytopathic 
effect was detected, typically 3-5 days.  The cells were then harvested by shaking to 
gently loosen and transferred to centrifuge pots, spin at 2000rpm for 10min.  
Supernatant were removed, followed washing remains with PBS and then resuspend 
the cell pellet in 1ml of PBS.  Cells were lysed by three cycle of freezing/thawing 
(liquid nitrogen/37˚C water bath) treatment.  Finally, cellular debris was removed by 
centrifugation at 2500rpm for 10min and the supernatant was aliquoted and stored at -
80˚C until used.    
 
2.2.9 Data analysis 
Image J (National Institutes of Health, U.S.A.), a Java-based image processing program, 
was performed to quantify the level of signal from western blotting image.  Data 
analysis was performed using GraphPad Prism (GraphPad Software Inc, San Diego, 
CA).  Data was presented in figure and text as mean  standard error of the mean 
(SEM).  For comparison, one-way analysis of variance (one-way analysis of variance 
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(ANOVA)) or two-way analysis of variance (two-way ANOVA) was used for multiple 
comparisons.  In the case of significantly difference, further analysis was performed 
including Dunnet‟s (compares all data sets to the control) and Bonferroni‟s post-test 
(compares selected data sets).  In all cases, data was considered as significant different 
if P values were less than 0.05. 
  
 
 
 
Chapter 3  
The Effect of Growth Factor on Primary Rat 
Hepatocytes 
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3.1 Introduction 
Growth factors such as EGF and HGF are considered to be the primary inducers 
involved in the stimulation of hepatocyte proliferation and liver recovery in vivo 
(Matsumoto and Nakamura, 1992; Huh et al., 2004; Michalopoulos and Khan, 2005; 
Fausto et al., 2006).  In the early 1980s, it has been reported that PH down-regulated 
the phosphorylation of EGF and EGFR activity (Rubin, 1982).  Furthermore, low levels 
of EGF in the plasma following removal of the salivary glands in male mice resulted in 
the failure of liver regeneration after PH (Jones et al., 1995).   The essential role of 
HGF and c-Met during liver regeneration was demonstrated by inducing mutated c-Met 
expression in adult mice (Borowiak et al., 2004).  They showed that in the Mx-cre 
transgene induced c-Met mutant mice the liver regeneration response after PH was 
significantly reduced.  Limited proliferation and retention of function of primary human 
or rat hepatocytes in culture has been achieved on stimulation with growth factors 
(Loyer et al., 1996; Runge et al., 1999; Bell et al., 2000; Runge et al., 2000a; Runge et 
al., 2000b; Paine and Andreakos, 2004; Serandour et al., 2005; Yamasaki et al., 2006).  
For instance, EGF induced hepatocyte cell cycle progression (Loyer et al., 1996); 
moreover it have been reported that a small number of cells divided during culture after 
EGF treatment (Yamasaki et al., 2006).  Also, it has been demonstrated that primary 
hepatocytes could retain their functions including the storage of glycogen, expression 
of plasma proteins and response to growth factor stimulation up to at least 36 days in 
culture (Runge et al., 1999; Runge et al., 2000a; Runge et al., 2000b).   
 
In the work described in this chapter two growth factors, EGF and HGF, both of which 
have been reported to stimulate hepatocyte proliferation in vivo and in vitro 
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(Michalopoulos and Khan, 2005; Fausto et al., 2006), were compared for their ability to 
stimulate primary rat hepatocytes in vitro.  ITS (Insulin-transferrin-sodium selenite 
media supplement from Sigma), which is used as a supplement during cell culture, has 
been shown to improve the survival of isolated cells (Hermann et al., 2000; Lawlor and 
Alessi, 2001), and therefore the effect of ITS on hepatocytes was also investigated.  
EGF was further studied to investigate in more detail of the possible mechanisms 
involved in its stimulation of hepatocytes.  These studies involved determination of the 
time course of EGF induction of DNA synthesis, cell proliferation and the 
phosphorylation of Akt and ERK, since Akt and ERK were demonstrated to play 
essential roles in the stimulation of hepatocyte proliferation and liver regeneration by 
growth factor (Roberts et al., 2000; Coutant et al., 2002).  For instance, it has been 
shown that the inhibition of ERK activity, by which blocking the up-regulation of MEK 
with PD098059, reduced the ability of the EGF to suppress TGF-β1 induced apoptosis 
in primary hepatocytes (Roberts et al., 2000).  This indicated a key role of ERK in 
EGF-mediated survival signalling pathway.  Also when Akt activity was blocked by 
inhibition of PI3K using LY294002, EGF did not significantly reduce the TGF-β1 
induced apoptosis of rat hepatocytes.  Furthermore, when Akt activity was inhibited, 
hepatocytes were more sensitive to TGF-β1 induced apoptosis (Roberts et al., 2000).  
This suggested that PI3K/Akt pathway played a critical role in both normal and EGF-
mediated protection of hepatocytes to apoptosis.  However, Baffet and his group 
presented a slightly different result.  They claimed that the PI3K/mTOR pathway is 
only essential for hepatocyte proliferation while the MEK/ERK response is crucial to 
both proliferation and survival (Coutant et al., 2002).  They showed that blocking of the 
activity of either PI3K with LY294002 or MEK with U0126 completely inhibited EGF 
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induction of DNA synthesis in primary rat hepatocytes.  Furthermore, the inhibition of 
MEK/ERK signalling pathway reduced the ability of EGF to protect hepatocytes from 
apoptosis whilst the inhibition of PI3K activity had no effect (Coutant et al., 2002).  
However, both groups provided strong evidences that the PI3K/Akt and MEK/ERK 
pathways are important for hepatocytes in response to EGF stimulation of proliferation- 
and/or survival-related effect.  Therefore the role of PI3K/Akt and MEK/ERK 
signalling pathways was studied using a number of highly specific inhibitors and 
mutant proteins.  The activity of PI3K was inhibited by LY294002, a highly selective 
inhibitor of PI3K (Vlahos et al., 1994; Semba et al., 2002), and the effect of EGF on its 
downstream protein-Akt and cell cycle progression were investigated.  The role of 
mTOR on EGF stimulation of cell cycle progression was also investigated by using 
rapamycin, a selective inhibitor of mTOR (Gingras et al., 2001), to block the activity of 
the mTOR and DNA synthesis was measured by the  [
3
H]-thymidine assay.  UO126, 
which is a dual MEK1 and MEK 2 inhibitor (Favata et al., 1998), was supplied and the 
effect of EGF on MEK down-regulated protein-ERK and hepatocytes DNA synthesis 
was measured.  In order to study the effect of Akt on the EGF stimulation in 
hepatocytes, A443654 which is a novel inhibitor of Akt (Luo et al., 2005), was used to 
inhibit Akt activity, then the phosphorylation of GSK-3 which is a downstream protein 
of Akt and DNA synthesis were investigated by western blotting and [
3
H]-thymidine 
assay respectively.  Furthermore, cells were transfected by adenovirus to express Dn-
Akt and myr-Akt and the level of [
3
H]-thymidine incorporation and cell viability was 
measured.   
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Since the EGFR is member of the tyrosine kinase superfamily of receptors (Thompson 
and Gill, 1985; Wells, 1999), the effect of tyrosine kinase inhibition was also 
investigated.  It was reported that ligand-binding causes both homo-dimerisation and 
hetero-dimerisation of EGFR (also known as ErbB1) with itself and other family 
members such as ErbB2, which has been reported as a major binding partner for EGFR 
(Tzahar et al., 1996; Graus-Porta et al., 1997), followed with auto-phosphorylation of 
the kinase domain of the receptors.  Furthermore, it have been reported that the 
complex was more stable at the cell surface when it contained ErbB2 (Lenferink et al., 
1998).  Also, Yarden and his colleagues claimed that ErbB2/EGFR were preferentially 
recycled and re-activated on the cell surface after internalisation whereas EGFR homo-
dimers were usually undergone degradation (Levkowitz 1998).  Therefore ErbB2/ErbB1 
signalling was considered as more extensive and potent than EGFR homo-dimers-
regulated signalling.   In this chapter, two tyrosine kinase inhibitors were used, 
AG1478 which inhibits EGFR homo-dimerisation dependent tyrosine kinase activity 
and AG825 which has been reported to inhibit (EGFR/ErbB2) tyrosine kinase activities 
(Osherov et al., 1993; Osherov and Levitzki, 1994).  The effect of the AG1478 or 
AG825 inhibition on the EGF induction of the phosphorylation of EGFR and cell cycle 
progression were measured to investigate which dimer (ErbB1/ErbB1 or ErbB1/ErbB2) 
is responsible for EGF stimulation in primary rat hepatocyte.    
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3.2 Results 
3.2.1 Comparison of EGF and HGF concentration-response curve effect 
on the phosphorylation of Akt and ERK 
In Figure 3.1, cells were exposed to different concentrations of EGF or HGF for 20min 
and Akt and ERK phosphorylations was measured using western blotting.  To study 
only the growth factor effect on the stimulation of the phosphorylation of Akt and ERK, 
cells were not treated with ITS as usually done in other experiments.  The results 
showed that EGF was more potent than HGF at stimulating phosphorylation of Akt and 
ERK.  EGF stimulation of the phosphorylation of ERK was evident at 300pM and 
reached a peak at 3nM, while the HGF induction of ERK phosphorylation was firstly 
detected at 1nM.  Furthermore 3nM EGF also resulted in an increase of the level of Akt 
phosphorylation, whereas 3nM HGF did not clearly stimulate the phosphorylation of 
Akt in primary rat hepatocytes.  Therefore, EGF was further studied due to its greater 
stimulation of ERK and Akt phosphorylation.  A concentration of 3nM EGF was 
chosen as it gave an optimal stimulation of phospho-Akt and phospho-ERK and was 
comparable to accepted physiological concentrations (Jones et al., 1995).   
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A.  
                      -      0.01   0.03   0.1   0.3      1        3      10   EGF nM 
P-ERK       
 
B.  
                     -    0.003  0.01  0.03   0.1    0.3      1        3      HGF nM 
P-ERK      
 
C.  
                    -     0.01   0.03   0.1   0.3       1        3     10    EGF nM 
P-Akt      
 
 
D.  
                   -     0.003  0.01   0.03   0.1   0.3      1       3     HGF nM 
P-Akt      
 
 
Figure 3.1 Effect of EGF induction on (A) ERK phosphorylation, (C) Akt 
phosphorylation and HGF induction on (B) ERK phosphorylation, (D) Akt 
phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with 10% FCS after plating for 4h, 
followed with 24h SF incubation.  Cells were then stimulated by different concentrations of EGF (from 
10pM to 10nM) or HGF (from 3pM to 3nM) for 20min as indicated before western blotting. Western 
blots are representative of 3 independent experiments. 
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3.2.2 The effect of EGF on primary rat hepatocytes 
3.2.2.1 The effect of ITS on the phosphorylation of Akt and ERK 
In order to improve hepatocyte survival after plating, ITS was supplied for the first 4h 
of incubation.  However, ITS contains insulin which has been reported to induce Akt 
and ERK phosphorylation in hepatocytes (Peak et al., 1998; Senn et al., 2002).  
Therefore the effect of ITS on the phosphorylation of Akt and ERK was investigated in 
our cells.  Cells were cultured for 4h in FCS (no ITS), then maintained serum free for 
24h after which they were stimulated with ITS.  The effect on Akt and ERK 
phosphorylation was measured following the stimulation.  
 
Figure 3.2 shows that ITS has a potent effect on the increase of both Akt and ERK 
phosphorylation in primary rat hepatocytes.  ITS stimulation of the phosphorylation of 
Akt rapidly increased and peaked at 5min.  The response was maintained at a high level 
for about 2h before it gradually decreased over the following 22h.  ITS stimulation of 
ERK phosphorylation gradually increased in the first 1h and maintain in a high level 
for over 24h.   
 
Therefore, in future experiments, after incubating cells with ITS for 4h, ITS was 
removed by changing medium to SF WME and incubated for a further 48h to remove 
ITS induced  phosphorylation of Akt and ERK.  
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A. 
                       0       1      5    15    30     60    min 
P-Akt         
P-ERK       
 
B. 
                      0       2       4      6      8     24     h   
P-Akt        
P-ERK      
 
Figure 3.2 ITS stimulation of phospho-Akt and phospho-ERK A. short time course 
and B. long time course 
Primary rat hepatocytes were cultured in WME supplemented with 10% FCS after plating for 4h, 
followed with 24h SF incubation.  Cells were then stimulated with ITS at different time points as 
indicated.  Western blotting for phospho-Akt and phospho-ERK were measured.  Western blots are 
representative of 3 independent experiments. 
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3.2.2.2 EGF stimulation of the phosphorylation of Akt and ERK time course 
The next experiment was designed to examine the extent and duration of the EGF 
stimulation of the phosphorylation of Akt, ERK and EGFR in hepatocytes.  As shown 
in Figure 3.3A, EGF induced a rapid and brief phosphorylation of Akt response in 
hepatocytes.  After exposure of cells to EGF for 1min, an increase in phospho-Akt was 
detected.  The phosphorylation of Akt rapidly rose to peak at 5min, after which the 
response decreased and almost disappeared in the following 1-2h.  There was little 
difference detected with treatment longer than 2h.  EGF stimulation of phospho-ERK 
was slower but more stable than phospho-Akt, as shown in Figure 3.3B.  The response 
peaked around 1h.  Then the level of the phosphorylated ERK gradually decreased and 
almost disappeared after 4h incubation.  Figure 3.3C presents EGF induced EGFR 
auto-phosphorylation of tyrosine kinase over time.  EGF activated its receptor after 
exposure to cells within 1min and peaked at about 30min.  This was rapidly increased 
and maintained for about 2h before it gradually decreased over the following 6h. 
A. 
                      0       1      5      15     30     60   min 
P-Akt        
                     0       2        4       6        8     24   h 
P-Akt        
 
 
B. 
                      0       1      5      15     30      60   min 
P-ERK     
                     0      2        4       6        8      24    h 
P-ERK     
 
 
C. 
                      0       1      5      15     30      60   min 
P-EGFR   
                      0      2        4       6        8      24   h 
P-EGFR        
 
Figure 3.3 Time course of EGF stimulation of A. phospho-Akt, B. phospho-ERK and 
C. phospho-EGFR 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h serum free incubation.  Cells were then stimulated with 3nM EGF at different time 
points as indicated and western blotting for phospho-Akt and phospho-ERK. Western blots are 
representative of 3 independent experiments. 
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3.2.2.3 The effect of EGF on hepatocyte DNA synthesis and cell viability 
It has previously shown that EGF can stimulate the incorporation of [
3
H]-thymidine 
into DNA in the culture of rat hepatocytes (McGowan et al., 1981).  Here we 
investigated the time course and concentration dependence of EGF stimulation of cell 
cycle progression in hepatocytes.  Furthermore, the effect of EGF on cell viability was 
studied.   
 
Figure 3.4 shows the results from an experiment in which hepatocytes were treated with 
3nM EGF for different periods before the agonist was removed and cells were further 
incubated, to give a total of 24h incubation.  The result demonstrated that 4h exposure 
of primary rat hepatocytes to EGF was the minimum time required to give a significant 
increase in [
3
H]-thymidine incorporation.  A treatment of 24h with EGF resulted in the 
largest stimulation of DNA synthesis compared to control cells.  Therefore 24h 
exposure of the cells to EGF was used as a standard time in the rest study of ligand 
induction of hepatocyte DNA synthesis. 
 
Figure 3.5 illustrates the effect of different concentrations of EGF on hepatocyte DNA 
synthesis and cell viability.  This shows that 1nM was the lowest concentration to 
produce a significant stimulation of hepatocyte DNA synthesis (Figure 3.5A).  The 
stimulation reached a maximum at 3nM and no further increase from higher 
concentration of EGF (10nM).  However, 24h stimulation with 3nM or 10nM EGF did 
not result in an increase of the cell viability, as presented in Figure 3.5B.    
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Figure 3.4 EGF stimulation of hepatocyte DNA synthesis time course 
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating. 
Subsequently, cells were changed to SF WME and incubated for 24h.  3nM EGF was added and removed 
at different time points as indicated.  All the cells were incubated 24h from the time of adding EGF.  
DNA synthesis was measured by [
3
H]-thymidine assay (as described in Chapter Two, Section 2.2.2). 
Data represented mean ± SEM (n=4) from a single experiment and were analysed by One-way ANOVA 
and post test was performed with Dunnet‟s to compare all data sets to the control using Graphpad Prism 
(*p<0.05, ***p<0.001). Results are representative of 2 independent experiments.. 
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Figure 3.5 Effect of different concentrations of EGF on hepatocytes A. DNA 
synthesis and B. cell viability 
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating.  
Subsequently cells were changed to SF WME and incubated for 24h. Different concentrations of EGF 
was added to the cells and left for 24h. (A) DNA synthesis was measured by [
3
H]-thymidine assay and 
(B) cell viability was measured by MTT assay (as described in Chapter Two, Section 2.2.2 and 2.2.5).  
Data represented mean ± SEM (n=4) from a single experiment and were analysed by One-way ANOVA 
and post test was performed with Dunnet‟s to compare all data sets to the control using Graphpad Prism 
(*p<0.05, **p<0.1).  Results are representative of 2 independent experiments. 
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3.2.3 The role of PI3K/Akt signalling pathway in the EGF response of 
primary rat hepatocytes  
The previous results have shown that the level of Akt phosphorylation is increased by 
EGF.  Here we set out to test the hypothesis that EGF stimulation of cell cycle 
progression requires activation of the PI3K/Akt pathway.  EGF stimulation of [
3
H]-
thymidine incorporation into DNA was measured while blocking PI3K, Akt or mTOR 
activity.  Also the phosphorylation of Akt and GSK-3 were investigated to monitor the 
extent of the inhibition of their up-regulated protein PI3K and Akt respectively.   
 
3.2.3.1 The effect of PI3K on EGF stimulation  
Different concentrations of LY294002 (from 1 to 20μM) were added before exposure 
of cells to EGF. The phosphorylation responses of Akt and GSK-3, and DNA synthesis 
were investigated by western blotting and [
3
H]-thymidine assay respectively.  Since 
DMSO was the diluent of inhibitors in most experiments, in this preliminary 
experiment the effect DMSO was determined. 
 
Figure 3.6A shows that up to 0.5%, DMSO did not have an effect on hepatocyte cell 
cycle.  Furthermore, DMSO (from 0.05% to 0.5%) did not have a statistically 
significant effect on the EGF stimulation of [
3
H]-thymidine incorporation into DNA as 
shown in Figure 3.6B.  Therefore, 0.05%-0.1% of DMSO was used as the standard 
dilution for inhibitors in all the experiments.   
 
Figure 3.7 illustrates that LY294002 strongly inhibited the EGF stimulation of Akt 
phosphorylation, while LY294002 itself did not induce the phosphorylation of Akt.  
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10μM LY294002 was the lowest concentration that gave a total inhibition of EGF-
induced Akt phosphorylation. 
 
Figure 3.8 demonstrates that neither LY294002 nor its solvent (0.1% DMSO) 
significantly reduced hepatocyte cell viability in 24h incubation.  It also can be seen 
from Figure 3.9 that 10μM LY294002 totally inhibited EGF-induced DNA synthesis 
and significantly reduced [
3
H]-thymidine incorporation into DNA in un-stimulated 
hepatocytes.  This indicates that the decrease of DNA synthesis resulting by LY294002 
was not due to cell death but because of inhibition of Akt activation. 
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Figure 3.6 Effect of increasing concentrations of DMSO on A. un-stimulated and 
B.EGF stimulated hepatocytes 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in SF WME for 24h.  Different concentrations of DMSO were added 15min before 
incubation of cells with/without EGF for 24h.  DNA synthesis was measured by [
3
H]-thymidine assay (as 
described in Chapter Two, Section 2.2.2).  Data represented mean ± SEM (n=4) from a single experiment 
and were analysed by One-way ANOVA and post test was measured with Bonferroni‟s to compare all 
data sets using Graphpad Prism (***p<0.001).  Results are representative of 2 independent experiments. 
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Figure 3.7 Effect of different concentrations of LY294002 on EGF-induced Akt 
phosphorylation 
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating followed 
with 48h SF incubation before stimulation.  Cells were pre-incubated with different concentrations of 
LY294002 for 15min before incubation with/without 3nM EGF for 5min.  Phospho-Akt was measured 
by western blotting.  Western blots are representative of 3 independent experiments. 
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Figure 3.8 Effect of DMSO and LY294002 on hepatocyte viability 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in SF WME for 24h.  DMSO or LY294002 was added 15min before incubation of cells 
with/without EGF for 24h.  Cell viability was measured by MTT assay (as described in Chapter Two, 
Section 2.2.5).  Data represented mean ± SEM (n=4) from a single experiment and were analysed by 
One-way ANOVA using Graphpad Prism (no significant difference).  Results are representative of 3 
independent experiments. 
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Figure 3.9 Effect of different concentrations of LY294002 on A. un-stimulated and B. 
EGF-stimulated hepatocyte DNA synthesis 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in SF WME for 24h.  Different concentrations of LY294002 were added 15min before 
incubation of cells with/without EGF for 24h.  DNA synthesis was measured by [
3
H]-thymidine assay.  
Data represented mean ± SEM (n=4) from a single experiment and were analysed by One-way ANOVA 
and post test was measured with Bonferroni‟s to compare all data sets using Graphpad Prism (**p<0.1, 
***p<0.001). Results are representative of 3 independent experiments. 
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3.2.3.2 The effect of Akt on EGF stimulation  
Luo and colleagues have reported that A443654 is a selective inhibitor of Akt (Luo et 
al., 2005).  Here we investigated whether in hepatocytes, A443654 inhibits EGF 
stimulation of Akt phosphorylation and/or activity of Akt.  The phosphorylation of Akt 
and its substrate (GSK-3) was measured using western blotting.   If A443654 is a 
selective inhibitor of Akt activity, then it should not affect the phosphorylation of Akt 
but it should inhibit GSK-3 phosphorylation. 
 
Figure 3.10A shows that A443654 at concentrations up to 10μM did not inhibit the 
EGF induction of Akt phosphorylation.  However, 3μM A443654 completely abolished 
EGF-stimulated GSK-3 phosphorylation.  Inhibition started at a concentration of 30nM, 
the lowest concentration used (Figure 3.10B).  It was then able to use A443654 to 
investigate the dependence of the EGF stimulation of the cell cycle on Akt.  The 
influence of different concentrations of A443654 on EGF stimulated thymidine 
incorporation is shown in Figure 3.11.  At 3μM, A443654 significantly inhibited 
(p<0.001) the EGF stimulated DNA synthesis.  Consequently, 3μM A443654 was used 
in further experiments to block Akt activity.   
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                       -         +        +         +        +         +       3nM EGF 
                       -         0       0.03     0.3      3         10      A443 μM 
P-Akt      
Pan-Akt   
 
B 
                       -         +        +         +        +         +       3nM EGF 
                       -         0       0.03     0.3      3         10      A443 μM 
P-GSK      
Pan-GSK  
 
Figure 3.10 Effect of different concentrations of A443654 on EGF-induced A. 
phospho-Akt and B.phospho- GSK  
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating followed 
by 48h SF incubation before stimulation.  Cells were pre-incubated with different concentrations of 
A443654 for 30min before incubation with/without 3nM EGF for 5min.  Phospho-Akt and phospho-
GSK were measured by western blotting (as described in Chapter Two, Section 2.2.3).  Western blots are 
representative of 3 independent experiments. 
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Figure 3.11 Effect of different concentrations of A443654 on the EGF stimulation of 
hepatocyte DNA synthesis 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in SF WME for 24h.  Different concentrations of A443654 werr added 30min before 
exposure of cells to EGF for 24h.  DNA synthesis was measured by [
3
H]-thymidine assay.  Data 
represented mean ± SEM (n=4) from a single experiment and were analysed by One-way ANOVA and 
post test was performed with Bonferroni‟s to compare all data sets using Graphpad Prism (***p<0.001). 
Results are representative of 3 independent experiments. 
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3.2.3.3 The effect of Akt on hepatocyte cell cycle progression and cell viability 
The previous work has shown that Akt is necessary for the cell cycle response to EGF 
using PI3K and Akt inhibitors.  The role of Akt was investigated further using 
adenovirus expressing dominant-negative (Dn) Akt and constitutively active (myr) Akt.  
The experimental work was carried out by collaboration with Dr John Hall and Mr 
Zhong Cheng. 
 
The optimal time for exposure of hepatocytes to adenovirus encoding Dn-Akt and myr-
Akt was determined by treating the cells for 2h, 16h and 48h as shown in Figure 3.12.  
In the experiment, HEK-293 cell lysis solution containing Dn-Akt (4μl) or myr-Akt 
(1μl) encoded adnovirous was added to 3ml of 1x105 hepatocytes.  The results show 
that, following exposure of cells to 1:4 (volume/volume) of HEK-293 cell lysis solution 
contacting myr-Akt and Dn-Akt encoded adenovirus, hepatocytes presented with a 
similar level of Akt expression.  The 16h exposure gave the strangest level of the 
expression of Akt (Dn and myr) in hepatocytes.  Furthermore, long exposure (48h) of 
hepatocytes to adenovirus caused the formation of groups of cells see under mircoscope 
(data not shown).  Therefore, cells were exposed to adenovirus for 2h/16h in the 
beginning of 24h/48h incubation before stimulating cells with ligand such as EGF in 
following experiments.  Threrfore, in further experiments, cells were cultured with 10% 
FCS and ITS for 4h as usual following 2h/16h exposure of the cells to adenovirus 
encoding Dn-Akt and myr-Akt (4/1 v/v).  Adenovirus was removed by changing to SF 
medium and cells were further incubated 22h/32h to allow the expression of mutant 
Akt before stimulation.  
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In order to investigate the role of Akt in the EGF stimulation of cell cycle progression, 
Dn-Akt and myr-Akt were incorporated into hepatocytes by adenovirus infection.  
Adenovirus was incubated with cells for 2h to allow the RNA replication and cells were 
further incubated for 22h without adenovirus to produce target proteins.  Cells were 
exposed to EGF for 24h and DNA synthesis and cell viability were measured to 
investigate the role of Akt in the un-stimulated cell cycle, and EGF-stimulated cell 
cycle progression.  
 
The results in Figure 3.13A show that Dn-Akt significantly inhibited the EGF 
stimulation of hepatocyte DNA synthesis and myr-Akt increased the level of [
3
H]-
thymidine incorporation into DNA.  Furthermore EGF significantly increased the level 
of [
3
H]-thymidine incorporation into DNA in myr-Akt expressing hepatocytes.  Dn-Akt 
reduced EGF stimulation of DNA synthesis to the control level.  Interestingly, as 
shown in Figure 3.13B, myr-Akt caused a statistically significant increase in the MTT 
measure of cell viability.  However, addition of EGF did not increase cell viability in 
either normal hepatocytes or in the myr-expressing cells.  Importantly, there was no 
change in cell viability with the Dn-Akt treated cells.  This indicated that the inhibition 
of Akt activity did not directly cause a decrease of the cell viability.   
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Figure 3.12 Dn-Akt and myr-Akt expression time course in primary rat hepatocyte 
Hepatocytes were cultured for 4h in WME supplemented with ITS and 10% FCS, which were then 
replaced with SF WME containing encoding kinase-dead Dn-Akt or constitutively active myr-Akt.  At 
different time points as described adenovirus were removed by changing the medium and cells were 
further incubated for a total of 24h incubation before Pan-Akt was measured by western blotting (at 48h, 
adenovirus was left for all 48h period).  Western blots are representative of 3 independent experiments.  
Blots are provided by Mr Zhong Cheng. 
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Figure 3.13 Effect of Akt on hepatocyte A. DNA synthesis and B. cell viability 
Hepatocytes were cultured for 4h in WME supplemented with ITS and 10% FCS, which were then 
replaced with SF WME containing encoding kinase-dead Dn-Akt or constitutively active myr-Akt for 2h 
and further incubated for 22h before supplement with/without 3nM EGF for another 24h. [
3
H]-thymidine 
incorporation and cell viability were measured by thymidine assay and MTT assay, respectively.  Data 
represented mean ± SEM (n=4) from a single experiment and were analysed by One-way ANOVA and 
post test was performed with Bonferroni‟s to compare all data sets (A) and Dunnet‟s to compare all data 
sets to the control (B) using Graphpad Prism(*p<0.05, **p<0.1, ***p<0.001).  Results are representative 
of 3 independent experiments.  Data are provided by Dr John Hall. 
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3.2.3.4 The effect of mTOR on hepatocyte cell cycle progression  
The activity of mTOR has been reported to be regulated by Akt (Nave et al., 1999).  
Furthermore, Coutant et al (2002) reported that mTOR was critical for the EGF 
stimulation of cell proliferation in hepatocytes.  Therefore, here the role of mTOR in 
EGF stimulation of cell cycle progression in our cells was investigated using its 
inhibitor-rapamycin (Rap).   
 
Figure 3.14 shows that 3nM rapamycin completely abolished EGF stimulation of [
3
H]-
thymidine incorporation into DNA in our cells.   
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Figure 3.14 Effect of mTOR on hepatocyte DNA synthesis 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in SF WME for 24h. 3nM Rap was added 30min before stimulation of cell with 3nM 
EGF for 24h.  DNA synthesis was measured by [
3
H]-thymidine assay.  Data represented mean ± SEM 
(n=4) from a single experiment and were analysed by One-way ANOVA and post test was performed 
with Bonferroni‟s to compare all data sets using Graphpad Prism (***p<0.001).  Results are 
representative of 3 independent experiments. 
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3.2.4 The role of MEK/ERK signalling pathway in EGF stimulation of 
primary rat hepatocytes 
The previous results demonstrated that the level of the phosphorylation of ERK was 
increased after the exposure of cells to EGF.  This indicated that ERK may play a 
crucial role in the cell response to EGF stimulation.  To investigate the role of ERK in 
EGF stimulation, the activity of ERK was inhibited by blocking its upstream protein 
kinase-MEK activity with UO126.  The EGF stimulation of cell cycle progression was 
then measured by [
3
H]-thymidine assay.  A UO126 concentration-response experiment 
was firstly performed to find a suitable concentration which totally inhibited the EGF 
stimulation of ERK phosphorylation. 
 
It can be seen from Figure 3.15 that 10μM UO126 was the lowest concentration tested 
that completely abolished the EGF triggered phosphorylation of ERK.  However, as 
shown in Figure 3.16, the inhibition of the phosphorylation of ERK did not result in a 
complete inhibition of the EGF stimulation of hepatocyte DNA synthesis.  Although 
10μM UO126 significantly reduced the EGF stimulation of hepatocyte DNA synthesis, 
the level of [
3
H]-thymidine incorporation was still significantly greater than in un-
stimulated control cells.   
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Figure 3.15 Inhibition of the EGF induced phospho-ERK in hepatocytes by different 
concentrations of UO126 
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating followed 
with 48h S.F incubation before stimulation.  Cells were pre-incubated with different concentrations of 
UO126 for 15min before incubated with/without 3nM EGF for 20min. Phospho-ERK was measured by 
western blotting.  Western blots are representative of 3 independent experiments. 
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Figure 3.16 Effect of 10μM UO126 on the EGF stimulation of hepatocyte DNA 
synthesis 
Hepatocytes were cultured with 10% FCS and ITS for 4h after plating and then further incubated in SF 
WME for 24h.  10μM UO126 was added 15min before incubation of cells with/without EGF for 24h, as 
indicated.  DNA synthesis was measured by [
3
H]-thymidine assay.  Data represented mean ± SEM (n=4) 
from a single experiment and were analysed by One-way ANOVA and post test was performed with 
Bonferroni‟s to compare all data sets using Graphpad Prism (***p<0.001).  Results are representative of 
3 independent experiments. 
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3.2.5 The role of tyrosine kinase in EGF stimulation of primary rat 
hepatocytes  
In order to investigate whether EGF stimulating the auto-phosphorylation of its 
receptor and hepatocyte DNA synthesis were due to EGF inducing EGFR/EGFR homo-
dimerisation or EGFR/ErbB2 hetero-dimerisation, AG1478 and AG825 were used to 
inhibit the homo- and hetero- dimerisation dependent tyrosine kinase phosphorylation 
of the receptor respectively.  The EGF induction of the EGFR phosphorylation and 
[
3
H]-thymidine incorporation into DNA were measured.   
 
3.2.5.1 The effect of AG1478 on EGF stimulation  
The results presented in Figure 3.17 show that increasing concentrations of AG1478 
inhibited the EGF stimulation of EGFR phosphorylation.  300nM was the lowest 
concentration at which AG1478 almost completely abolished the EGF-induced EGFR 
phosphorylation.  Also as shown in Figure 3.18, this concentration of AG1478 also 
succeeded in a significant inhibition of EGF stimulation of [
3
H]-thymidine 
incorporation into DNA.   
 
3.2.5.2 The effect of AG825 on EGF stimulation  
The results (Figure 3.19) show that AG825 had no effect on the phosphorylation of 
EGFR in either EGF-stimulated or un-stimulated cells.  There was also a minimal or 
insignificant effect of AG825 on the EGF stimulation of hepatocyte DNA synthesis 
(Figure 3.20).   
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Figure 3.17 Effect of AG1478 on EGF stimulation of phosphorylation of EGFR  
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating followed 
with 48h SF incubation before stimulation.  Cells were pre-incubated with different concentrations of 
AG1478 for 15min before incubated with/without 3nM EGF for 20min. Phospho-EGFR was measured 
by western blotting (as described in Chapter Two, Section 2.2.3).  Western blots are representative of 3 
independent experiments. 
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Figure 3.18 Effect of different concentrations of AG1478 on EGF stimulation of 
hepatocyte DNA synthesis 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in S.F WME for 24h.  Different concentrations of AG1478 were added 15min before 
incubation of cells with/without EGF for 24h as indicated.  DNA synthesis was measured by thymidine 
assay (as described in Chapter Two). Data represented mean ± SEM (n=4) from a single experiment and 
were analysed by One-way ANOVA and post test was performed with Dunnet‟s to compare all data sets 
to the control using Graphpad Prism (***p<0.001).   Results are representative of 3 independent 
experiments. 
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Figure 3.19 Effect of AG825 on EGF stimulation of EGFR phosphorylation 
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating followed 
with 48h SF incubation before stimulation.  Cells were pre-incubated with different concentrations of 
AG825 for 15min before incubated with/without 3nM EGF for 20min. Phospho-EGFR was measured by 
western blotting.  Western blots are representative of 3 independent experiments. 
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Figure 3.20 Effect of different concentrations of AG1478 on EGF stimulation of 
hepatocyte DNA synthesis 
Hepatocytes were cultured in WME supplemented with ITS and 10% FCS for 4h after plating and then 
further incubated in SF WME for 24h.  Different concentrations of AG825 were added 15min before 
incubation of cells with/without EGF for 24h, as indicated.  DNA synthesis was measured by [
3
H]-
thymidine assay.  Data represented mean ± SEM (n=4) from a single experiment and were analysed by 
One-way ANOVA and post test was performed with Dunnet‟s to compare all data sets to the control 
using Graphpad Prism (***p<0.001).  Results are representative of 3 independent experiments. 
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3.3 Discussion   
HGF has been reported to play a central role in liver regeneration and hepatocyte 
proliferation. Evidence from c-Met mutant mice (non-activated c-Met) proved that 
when c-Met activation was inhibited, the liver regeneration was significantly reduced 
after PH (Borowiak et al., 2004).  EGF also has been reported to be important for liver 
regeneration and hepatocyte proliferation via the PI3K/Akt and MEK/ERKs pathway 
(Jones et al., 1995; Roberts et al., 2000; Coutant et al., 2002).  The results presented 
here suggested that in primary rat hepatocytes, EGF produced a stronger stimulation of 
both the phosphorylation of Akt and ERK than the response induced by the same 
concentration of HGF.  EGF also induced [
3
H]-thymidine incorporation into DNA 
which demonstrated that EGF driving quiescent hepatocytes from G0 into S phase.  
This finding agreed with the work of others (Loyer et al., 1996).  EGF did not increase 
the cell viability, which indicated that under the conditions of our experiment, EGF did 
not induce hepatocyte proliferation.  However, Yoshizato and colleagues claimed that 
they have achieved limited hepatocyte proliferation in culture (Yamasaki et al., 2006).  
This could be due to the medium (hepatocyte clonal growth medium; HCGM) used to 
support a longer period of the growth of hepatocytes and/or human serum which 
stimulated cell proliferation in their experiments.  In order to minimise cell cycle 
progression ([
3
H]-thymidine response) in the control (unstimulated) cells in our 
experiments, cells were routinely cultured in SF WME to achieve most cells entering 
G0 phase before stimulation.  Also, it could be because small amount of the cell 
proliferation could not produce a measurable effect on cell viability.   
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In rat hepatocytes, the PI3K/Akt/mTOR pathway has a crucial role in the cell response 
to EGF.  This signalling pathway was vital for EGF effect since EGF stimulation of 
DNA synthesis was completely abolished by the inhibition of PI3K activity by the 
selective inhibitor LY294002.   Moreover, when Akt or mTOR activity was inhibited 
by A443654 or rapamycin respectively, EGF-induced hepatocyte DNA synthesis was 
abolished.  This was in partial agreement with the work of another group who showed 
that the PI3K/mTOR pathway was necessary for the EGF stimulation of hepatocyte 
proliferation (Coutant et al., 2002).  However, the same group has also shown that 
blocking Akt activity by the expression of Dn-Akt did not affect EGF stimulation of 
cell cycle progression and in turn concluded that the activation of Akt may not be 
necessary in this pathway.  In fact, this could be because of the low transfection 
efficiency (35% to 40%) in their experiment.   The results presented in this chapter 
showed that EGF stimulation of the phosphorylation of Akt happened in the very early 
stage after exposure of hepatocytes to EGF (the response was detected 1min after 
stimulation). This indicated the crucial role that Akt may play in EGF stimulation of 
hepatocytes.  Furthermore, only a small amount of total Akt activity was sufficient to 
give a complete [
3
H]-thymidine response. It has been shown that 300nM A443654 
inhibits most of the Akt activity (ie stimulation of GSK-3 phosphorylation) (Figure 
3.10); however, it did not affect the level of EGF-induced [
3
H]-thymidine incorporation 
into DNA (Figure 3.11).  The importance of Akt in hepatocyte response to EGF 
stimulation was also supported by using Akt selective inhibitor.  The inhibition of the 
activity of Akt with A443654 (3μM) leaded to a complete abolishment of EGF 
stimulation of [
3
H]-thymidine incorporation into DNA (Figure 3.11).  Further strong 
evidence that Akt is necessary for EGF stimulation of cell cycle progression came from 
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Dn-Akt work.  When hepatocytes expressed Dn-Akt following infection of cells with 
encoded adenovirus, EGF failed to induce cell cycle progression.  This strongly 
suggested that Akt plays an essential role in the cell response to EGF stimulation.  
Furthermore, when the cell expressed myr-Akt, there was a significant increase of the 
level of [
3
H]-thymidine incorporation into DNA comparing to un-stimulated control 
cells.  Also myr-Akt expressing cells presented a higher viability than the control cells.  
These suggested that the continued activation of Akt may result in DNA synthesis.  
 
Furthermore, the expression of myr-Akt might also induce hepatocyte proliferation 
(cell viability response).  However, the increase of cell viability in myr-Akt expressed 
cells might be also due to the increase of the cell survival rate, because long-term 
incubation of un-stimulated hepatocytes showed a decreasing curve of cell viability.  
Treatment of EGF further increased the level of [
3
H]-thymidine incorporation into 
DNA in myr-Akt expressed hepatocytes; however, the response was not greater than in 
EGF-induced control hepatocyte (no myr-Akt expressed) (Figure 3.13A).  It can be due 
to 3nM EGF induced maximum [
3
H]-thymidine incorporation response and therefore 
myr-Akt expression did not increase the response.  EGF did not further increase cell 
viability in myr-Akt expressed cells (Figure 3.13B).  This suggested that continual 
activation of Akt may increase the cell survival which in turn results in a higher DNA 
synthesis rate and cell viability than in control hepatocytes (no myr-Akt expression).  
However, Akt did not induce cell proliferation.  The results also demonstrated that EGF 
stimulation hepatocyte cell cycle progression was Akt dependent.  Finally, inhibition of 
Akt activity with Dn-Akt did not reduce cell viability in EGF-stimulated or un-
stimulated cells indicating that the inhibition of Akt activity does not directly lead to 
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apoptosis.  It has been shown that EGF suppression of TGF-β mediated hepatocyte 
apoptosis is PI3K/Akt pathway dependent (Roberts et al., 2000).  The result suggested 
that Akt may have an anti-apoptic effect.   
 
ERK also plays an important role in the EGF stimulation of hepatocyte cell cycle 
progression.  It was phosphorylated in the early stages after exposure of cells to EGF.  
Inhibition of the activity of ERK by blocking its upstream protein MEK activation led 
to a significant reduction in EGF stimulation of [
3
H]-thymidine incorporation into 
hepatocyte DNA.  However, complete inhibition of the phosphorylation of ERK did not 
result in abolishment of EGF induction of DNA synthesis.  This result did not 
correspond to the work of Baffet and colleagues, who showed that MEK/ERK was 
necessary for EGF stimulation of hepatocyte cell cycle progression (Coutant et al., 
2002).  This might be due to the higher concentration of MEK inhibitor-UO126 (50μM) 
they used in their experiment.  The results in this chapter showed that 10μM UO126 
completely inhibited EGF-stimulated ERK phosphorylation but only partially inhibited 
EGF-stimulated cell cycle progression to S phase.  This suggested that other pathways, 
insensitive to UO126, lead to EGF stimulation of the cell cycle.  For instance, JNK has 
been reported to be involved in the regulation of hepatocytes response to growth factor 
inducing cell cycle progression (Auer et al., 1998).  Alternatively, it could be that 
10μM UO126 did not actually completely inhibit ERK activity but reduced the 
phosphorylation of ERK to levels below the detection limit of western blotting.  In 
conclusion, the results presented in this chapter suggested that ERK was important but 
may be not necessary for all EGF-stimulated cell cycle progression in hepatocytes.  
Furthermore, the inhibition of ERK activity did not lead to a significant decrease of 
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DNA synthesis in un-stimulated hepatocytes, which indicated that ERK may be more 
important to hepatocyte proliferation rather than survival.   
 
Since the  EGFR is a member of the superfamily-RTKs, tyrosine kinase plays a crucial 
role in EGF stimulation pathway (Thompson and Gill, 1985; Wells, 1999).  Inhibition 
of the ligand-induced auto-phosphorylation of tyrosine kinase on the EGFR CT domain 
caused the abolishment of EGF stimulating the phosphorylation of any downstream 
proteins on its signalling pathway and cell cycle progression.  Furthermore, in primary 
rat hepatocytes, binding with EGF leaded to a homo-dimerisation of EGF-receptor 
rather than hetero-dimerisation, since AG825 did not inhibit EGF-induced auto-
phosphorylation of EGFR.  It has been reported that the stimulation of EGFR/ErbB2 
hetero-dimerisation may be more stable and stronger than EGFR homo-dimerisation 
because the hetero-dimer complexes are more stable at the cell surface and prefer 
recycling back to the cell surface and re-activating after internalisation, whereas the 
homo-dimers are usually undergoing degradation after internalisation (Levkowitz et al., 
1998).  The results in this chapter showed that EGF mainly inducing EGFR homo-
dimerisation rather than hetero-dimerisation in cultured hepatocytes.  This could be one 
of the possibilities explaining why EGF failed to induce cultured hepatocyte 
proliferation.   
 
  
 
 
 
 
 
Chapter 4 
The Effect of Nucleotides on Proliferation-
Related Response in Primary Rat Hepatocytes 
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4.1 Introduction 
It has been shown that exposure of primary rat hepatocytes to extracellular ATPγS, a 
nonhydrolysable ATP analog, activated early response genes such as c-jun and c-fos 
expression of which is essential for the cell to enter S phase (Thevananther et al., 2004).  
Also, it has been reported that in hepatocytes, excellular ATP and UTP stimulated cell 
proliferation-associated responses such as increased cytosolic free Ca
2+
 concentration 
and the phosphorylation of ERK and JNK (Dixon et al., 2005).  Furthermore, 
extracellular ATP initiated JNK signalling in regenerating liver and significantly 
increased the rate of liver regeneration after PH in vivo (Thevananther et al., 2004; 
Kerem et al., 2006).  These reports suggested that extracellular nucleotides may play an 
important role in liver regeneration and hepatocyte proliferation.  Therefore, the effect 
of a range of nucleotides including ATP, UTP, UDP, 2MesADP and ADPβS on some 
proliferation-related responses of rat hepatocytes were studied.  Moreover, these 
nucleotides were chosen to cover the majority of rat hepatocyte subtypes of P2Y 
receptors.  Functional P2Y1, which has been identified in rat hepatocytes, can be 
activated by 2MesADP (Dixon et al., 2000).  ATP and UTP are the agonists of the 
P2Y2 receptor, which has been shown to express functional subtype in rat hepatocytes 
(Dixon et al., 2000).  Furthermore, it has been shown that the transcripts for P2Y4, 
P2Y6, P2Y12 and P2Y13 were expressed in freshly isolated rat hepatocytes (Dixon et al., 
2000; Dixon et al., 2004).  Therefore, UTP and ATP which are potent activators for 
P2Y4 (Bogdanov 1998), P2Y6 receptor agonist UDP (Chang et al., 1995), 2MesADP 
the most potent agonist for P2Y12 (Unterberger et al., 2002) and P2Y13 receptor agonist 
ADPβS and 2MesADP (Marteau et al., 2003) have been chosen.  In order to determine 
the effect of each nucleotide on the proliferation-related response in rat hepatocytes, the 
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phosphorylation of Akt and ERK, [
3
H]-thymidine incorporation into DNA and cell 
viability were investigated.  
Chapter 4 The Effect of Nucleotides on Proliferation-Related Response in Primary Rat Hepatocytes 
De Montfort University                                                                                                                       Yi Luo 111 
4.2 Results 
4.2.1 Comparison of different types of nucleotides on the proliferation-
related response 
4.2.1.1 The effect of nucleotides on the induction of the phosphorylation of Akt 
and ERK in hepatocytes 
In order to compare the ability of each nucleotide/P2Y receptor effect on rat hepatocyte 
proliferation, nucleotide stimulation of the phosphorylation of Akt and ERK was 
investigated by western blotting.  Cells were exposed to the same concentration of 
nucleotides (100μM) for 5min and 20min before western blotting.   
 
In cultured rat hepatocytes, it has found that ATP and UTP stimulated Akt and ERK 
phosphorylation with the ATP stimulation being greater than UTP, as shown in Figure 
4.1.  ADPβS also induced the phosphorylation of Akt and ERK while 2MesADP 
appeared to stimulate ERK phosphorylation.  The other nucleotides tested did not 
produce a considerable response.   
 
4.2.1.2 Nucleotide effects on the regulation of cell cycle and proliferation in 
hepatocytes 
Figure 4.2A shows ATP slightly increased the level of [
3
H]-thymidine incorporation 
into DNA, while treatment with 2MesADP inhibited DNA synthesis in primary rat 
hepatocytes.  Moreover, although it was not statistically significant, ADPβS also 
increased the DNA synthesis response.  All the treatments of nucleotides appeared to 
reduce hepatocytes viability, although UTP did not statistically significantly decrease 
the response (Figure 4.2B).   
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Figure 4.1 Comparison the effect of each nucleotide on the induction of A. phospho-
Akt and B. phospho-ERK 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were then stimulated with 100μM nucleotides for 5min or 20min 
and western blotting for phospho-Akt and phospho-ERK.  Data represented mean ± SEM (n=3) and were 
analysed by One-way ANOVA and post test was performed with Dunnet‟s to compare all data sets to the 
control using Graphpad Prism (**p<0.01, *p<0.05).  Blots are representative of 3 independent 
experiments and data are from 3 independent experiments. 
Chapter 4 The Effect of Nucleotides on Proliferation-Related Response in Primary Rat Hepatocytes 
De Montfort University                                                                                                                       Yi Luo 113 
  
C
on
tr
ol
A
TP
U
TP
U
D
P S
A
D
P
2M
es
A
D
P
0
2500
5000
7500
10000
*
**
A
[3
H
]-
th
y
m
id
in
e
 (
d
p
m
)
co
nt
ro
l
A
TP
 +
 C
PK
U
TP
 +
 C
PK
U
D
P 
+ 
H
K S
A
D
P
2M
es
A
D
P
0.0
0.2
0.4
0.6
0.8
B
* * * **
A
b
s
o
rb
5
9
5
 
Figure 4.2 Comparison the effect of each nucleotide on the A. regulation of cell cycle 
and B. cell viability  
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating cell, 
subsequently cells were changed to SF WME and incubated for 24h.  100μM nucleotides were added and 
left for 24h as indicated. (A) DNA synthesis was measured by [
3
H]-thymidine assay and (B) cell viability 
was measured by MTT assay.  Data represented mean ± SEM (n=16) and were analysed by One-way 
ANOVA and post test was performed with Dunnet‟s to compare all data sets to the control using 
Graphpad Prism (**p<0.01, *p<0.05).  Data are from 4 representatively independent experiments.   
Chapter 4 The Effect of Nucleotides on Proliferation-Related Response in Primary Rat Hepatocytes 
De Montfort University                                                                                                                       Yi Luo 114 
4.2.2 UTP stimulation of primary rat hepatocytes 
4.2.2.1 UTP stimulation of phosphorylation of Akt and ERK 
UTP induced an increase in the level of Akt and ERK phosphorylation has been shown 
in Figure 4.1.  In the following experiments, UTP concentration-response curve and 
time course of the phosphorylation of Akt and ERK were investigated to establish the 
dose-response, extent and duration of the response to UTP. 
 
Figure 4.3A shows a relatively rapid stimulation of either ERK or Akt phosphorylation 
by UTP.  After exposure to UTP for 1min, both the phosphorylation of Akt and ERK 
was detected.  The level of UTP-induced the phosphorylation of Akt and ERK peaked 
at 5min after which the stimulation of both decreased.  The stimulation of Akt 
phosphorylation response lasted for about 1h before returning to the control level.  The 
induction of the phosphorylation of ERK was still detectable at 1h, although it was not 
significantly higher than control level.   
 
Figure 4.3B shows the dose-response curve of UTP stimulation of Akt and ERK 
phosphorylation.  UTP-induced Akt and ERK phosphorylation was evident at 30μM 
and the response peaked at 100μM (Figure 4.3).  The level of the phosphorylation of 
ERK and Akt increased as the concentration of UTP increased.  There was no 
significant difference in the response to 100μM and 300μM UTP, the two highest 
concentrations used. 
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Figure 4.3 A. UTP time course and B. Different concentrations of UTP stimulation 
of the phosphorylation of Akt and ERK 
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating followed 
with 48h SF incubation before stimulation.  Cells were treated with A. different concentrations of UTP 
for 5min or B exposed to 100μM UTP for different durations.  Phospho-Akt and phospho-ERK response 
were measured by western blotting.  Data represented mean ± SEM (n=3) and were analysed by One-
way ANOVA and post test was performed with Dunnet‟s to compare all data sets to the control using 
Graphpad Prism (**p<0.01, *p<0.05).  Blots are representative of 3 independent experiments and data 
are from 3 independent experiments. 
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4.2.2.2 UTP stimulation of hepatocyte DNA synthesis  
The effect of different concentrations of UTP on DNA synthesis was determined by 
measuring [
3
H]-thymidine incorporation.  Hepatocytes were exposed to different 
concentrations of UTP for 24h before [
3
H]-thymidine assay. 
 
On exposure of cells to UTP for 24h, every concentration tested failed to induce the 
hepatocyte cell cycle progression, as shown in Figure 4.4.  Furthermore, 300μM UTP 
inhibited [
3
H]-thymidine incorporation into DNA, although this concentration of UTP 
gave the most potent response of induction of Akt and ERK phosphorylation.  This 
could be because the high concentration of UTP induced cell apoptosis (Coutinho-Silva 
et al., 2005).  Therefore, 100μM of UTP was chosen to use in further experiment, since 
this concentration gave a strong stimulation of phospho-Akt and phospho-ERK in 
hepatocyte and did not cause the inhibition of DNA synthesis. 
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Figure 4.4 UTP concentration-response curve of stimulation hepatocyte DNA 
synthesis  
Hepatocytes were incubated in WME supplemented with ITS and 10% FCS for 4h after plating cell, 
subsequently cells were changed to SF WME and incubated for 24h.  Different concentrations of EGF 
was added to the cells and left for 24h.  (A) DNA synthesis was measured by [
3
H]-thymidine assay and 
(B) cell viability was measured by MTT assay.  Data represented mean ± SEM (n=8) and were analysed 
by One-way ANOVA and post test was performed with Dunnet‟s to compare all data sets to the control 
using Graphpad Prism (*p<0.05).  Data are from two independent experiments. 
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4.3 Discussion 
ATP and UTP produced the largest response of induction of Akt and ERK 
phosphorylation which suggested that P2Y2 and P2Y4, the receptors for these two 
agonists (Dixon et al., 2000), were the main receptors inducing the phosphorylation of 
Akt and ERK.  Although the function of the P2Y13 is still not clear, the slight 
stimulation of the phosphorylation of Akt and ERK caused by ADPβS (Figure 4.1) 
indicated that P2Y13 may be also involved in the nucleotides inducing the 
phosphorylation of Akt and ERK in rat hepatocytes.  2MesADP, which is the agonist of 
P2Y1 (Dixon et al., 2000) and P2Y13 (Marteau et al., 2003), also produced a slight 
stimulation of ERK phosphorylation.  UDP, which stimulates P2Y6 (Chang et al., 1995), 
did not stimulate Akt and ERK phosphorylation, suggesting that P2Y6 may be not 
involved.  
 
P2Y2 regulates cell cycle progression and proliferation, while P2Y4 is mainly involved 
in the regulation of epithelial response have been demonstrated by several groups 
(Greig et al., 2003; Robaye et al., 2003; Schafer et al., 2003).  The phosphorylation of 
MAPK including ERK1/2, JNK and p38 following activation of the P2Y2 has been 
reported by many groups (Soltoff, 1998; Soltoff et al., 1998; Gendron et al., 2003).  
This resulted in cell proliferation and/or migration in many cell types such as human 
epidermal keratinocytes, lung epithelial tumour cells, glioma cells and smooth muscle 
cells (Wilden et al., 1998; Tu et al., 2000; Seye et al., 2002; Greig et al., 2003; Schafer 
et al., 2003).  Furthermore, ATP/UTP induced HeLa cell proliferation via activation of 
the P2Y2 receptor through the regulation of PI3K/Akt and MEK/ERK signalling 
pathways (Muscella et al., 2003).  All these data suggested that the P2Y2 receptor plays 
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an essential role in nucleotides-induced proliferation-related response.  On the other 
hand, P2Y4 is mainly thought to involve in the regulation of the epithelial response.  
For example, UTP mediated epithelial secretion of chloride in the colon was reported 
via the activation of the P2Y4 (Ghanem et al., 2005).  In the liver, P2Y4 has also been 
proved to play a major role in the mediation of ion secretion with the addition of other 
P2Y subtypes such as P2Y1, P2Y2 and P2Y6 (Robaye et al., 2003).  The use of the 
P2Y4 receptor knockout mice model provided strong evidence that P2Y4 is not involved 
in the regulation cell proliferation.  The result showed that P2Y4-null mice have 
apparently normal behaviour, growth and reproduction.  This indicated that P2Y4 may 
be not involved in the regulation of hepatocyte proliferation and/or DNA synthesis.  
Therefore, in hepatocytes, it was possible that the P2Y2 receptor is the major receptor, 
which regulates the proliferation-related signals such as Akt and ERK. 
 
Figure 4.1 also shows that ATP produced a greater stimulation of Akt and ERK 
phosphorylation than UTP.  This could be due to various reasons.   For example, ATP 
resulted in a greater stimulation of the activation of P2Y2 and/or P2Y4 receptor than 
UTP.  However, in the experiment, ATP and UTP were used at 100μM, which has been 
demonstrated as a supra-optimal concentration inducing the strongest response in 
human hepatocytes (Schofl et al., 1999).  Therefore, the stronger Akt and ERK 
phosphorylation stimulated by ATP might not be because ATP induced stronger 
activation of P2Y2 and/or P2Y4 receptors.  Another possibility was that ATP activated 
other P2Y subtypes, which may stimulate the phosphorylation of Akt and ERK in rat 
hepatocytes.  The results show that P2Y13 and/or P2Y1 (ADPβS, 2MesADP) produced a 
slight stimulation of the phosphorylation of Akt and ERK (Figure 4.1).  ATP is a weak 
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partial agonist at P2Y1 and P2Y13, the ability of ATP to activate P2Y1 and P2Y13 may 
depend on the level of expression of the receptor, has been reported (Marteau et al., 
2003; Dixon et al., 2000).  Therefore, ATP might stimulate the phosphorylation of Akt 
and ERK through the activation of P2Y1 and/or P2Y13 and hence produce a stronger 
stimulation response.  Moreover, although ATP gave a small increase in DNA synthesis 
(Figure 4.2A) in hepatocytes, it also reduced cell viability (Figure 4.2B).  This might be 
because ATP induced DNA synthesis in some cells, however, it also arrested most cells 
at S and/or G1 phase and may induce apoptosis after that.  It indicated the multiple 
functions of ATP and makes it difficult to understand.  In order to avoid the 
interference of P2Y1 and/or P2Y13 activation and the multiple biological effects may be 
resulted by ATP; UTP was choosed to further study the possible role for P2Y2 in 
hepatocyte proliferation.  
 
The results presented here show that, in primary rat hepatocytes, UTP did not induce 
DNA synthesis and/or proliferation; although it caused the phosphorylation of both Akt 
and ERK, which have been shown to increase cell survival and control cell proliferation 
(Woodgett, 2005; Charmbard et al., 2007).  Moreover it has been recently reported that, 
in human endometrial stromal cells, activation of the P2Y2 receptor leaded to the 
inhibition of cell viability (Chang et al., 2008).  They reported that ATP activated the 
PLC/PKC/ERK signalling pathway leading to a reduction of cell viability.  Furthermore, 
the high concentration (100μM) of nucleotides used in our experiments also could be 
the reason for the decrease of hepatocyte cell viability.  For instance, Burnstock and 
colleagues showed that a high concentration of ATP (>10μM) induced cell apoptosis 
through P2X7 and maybe P2Y2 in HCT8 and Caco-2 cell lines (Coutinho-Silva et al., 
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2005).  The effect of P2Y2 receptor induction of apoptosis and anti-proliferation have 
also been found in other cells such as human epithelial carcinoma cells, colorectal and 
esophageal cancer cells (Hopfner et al., 1998; Hopfner et al., 2001; Maaser et al., 2002).  
As shown in Figure 4.4, a high concentration of UTP (300μM) decreased the level of 
[
3
H]-thymidine incorporation into DNA, which indicated that, at high concentration, 
nucleotides may have anti-proliferative and/or apoptotic effects in rat hepatocytes.  
However, the different pathways may cause different effects of P2Y2 activation on cell 
proliferation and DNA synthesis.  For example, the activation of MAPK signalling 
pathway through the P2Y2 induced src-mediated transactivation of growth factor 
receptors has been reported to stimulate COS-7 cell proliferation (Luttrell et al., 1997).  
From our results, 100μM UTP had no effect on hepatocyte DNA synthesis and cell 
viability although UTP clearly stimulated Akt and ERK phosphorylation at this 
concentration.  Therefore, in further experiments, this concentration of UTP was used 
as a sample, which stimulates the phosphorylation of proliferation-related proteins such 
as Akt and ERK without inducing cell cycle progression.   
 
 
  
 
 
 
 
Chapter 5  
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5.1 Introduction  
Previous results have shown that EGF, a growth factor (Chapter 3) or UTP, a 
nucleotide (Chapter 4), can stimulate the phosphorylation of Akt and ERK.  Both Akt 
and ERK cascades have been shown to play a central role in the regulation of the 
hepatocyte cell cycle progression.  However, UTP did not induce hepatocyte cell cycle 
progression, while EGF triggered cell entry into S phase.  These results suggest that 
EGF and UTP may stimulate Akt and ERK phosphorylation to a different extent or via 
different signalling pathways, which then lead to the different biological effects.  
Therefore, the EGF and UTP stimulation in primary hepatocytes were further studied.   
 
It has been shown that ATP stimulated Muller glial cell mitosis via PI3K/Akt and 
ERK1/2 pathways by trans-activation of the EGFR (Milenkovic et al., 2003).  They 
claimed that ATP activated the P2Y receptor to releasing HB-EGF from the Muller cell 
matrix, which then activated the EGFR mitogenic signalling.  Also, another group 
reported that the P2Y receptor induced MAPK activation in rat-1 fibroblasts and PC12 
cells was dependent on the trans-activation of the EGFR (Soltoff, 1998; Soltoff et al., 
1998).  Furthermore, Schlessinger and colleagues concluded that the src family of 
tyrosine kinases played an essential role in the GPCR trans-activation of the EGFR 
(Andreev et al., 2001).  Therefore, the effects of src and EGFR-mediated tyrosine 
kinase on UTP and EGF stimulation of hepatocytes were investigated.  The activation 
of src was inhibited using PP2, a potent and selective inhibitor of the src family of 
tyrosine kinases (Hanke et al., 1996), while EGFR-mediated tyrosine kinase activity 
was blocked using AG1478, which inhibits EGFR homo-dimerisation dependent 
tyrosine kinase activity (Osherov and Levitzki, 1994).   
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Previously we have provided strong evidence that the PI3K/Akt pathway is crucial for 
EGF induction of rat hepatocyte cell cycle progression (Chapter 3).  The inhibition of 
the activation of Akt prevented growth factor inducing cell enter S phase.  Also either 
EGF or UTP induced the phosphorylation of Akt in freshly isolated rat hepatocytes.  It 
has been suggested in certain cells that the activation of Akt may be PI3K independent.  
For instance, it has been reported that the inhibition of PI3K by wortmannin did not 
affect dopamine induction of the phosphorylation of Akt at Thr308 in striatal neurons 
(Brami-Cherrier et al., 2002).  It also has been shown that the activation of Akt may 
depend on cyclic AMP protein kinase in HEK-293 cells (Filippa et al., 1999).  
Moreover, in NG108 neuroblastoma cells, N-methyl-D-aspartate (NMDA) activated 
Akt directly via Ca
2+
/calmodulin-dependent protein kinase kinase (CaM-KK) (Yano et 
al., 1998).  Therefore, it is possible that the different effects of EGF and UTP on the rat 
hepatocyte cell cycle may be due to EGF and UTP inducing Akt phosphorylation 
through different signalling pathways.  Therefore, the activation of PI3K and Akt were 
blocked by LY294002 and A443654 respectively, EGF and UTP stimulation of Akt 
and GSK-3 phosphorylation were then investigated.   
 
Traditionally, ligand binding to RTKs or GPCRs activates signal transduction and 
induces receptor internalisation, which is an effective mechanism to terminate receptor 
activation.  However, more recent studies demonstrated that receptors may continue 
signal from endosomes.  In fact, certain signalling events such as ERK phosphorylation 
appeared to require receptor internalisation (reviewed by (McPherson et al., 2001b; 
Tobin et al., 2008).  Therefore, whether the different of EGF and UTP effects were due 
to these two receptors signal from different intracellular locations was investigated.  
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Con A, a non-selective endocytosis inhibitor (Xiang et al., 2002), was used to inhibit 
ligand induced EGFR and P2Y2 receptor internalisation.   
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5.2 Results  
5.2.1 Comparison of EGF and UTP stimulation time course 
In order to investigate whether EGF induced hepatocyte cell cycle progression was due 
to a more prolonged EGF stimulation of the PI3K/Akt and MEK/ERK signalling 
pathways than UTP, the time courses of EGF and UTP induction of Akt, ERK and 
GSK-3 phosphorylation were measured by western blotting. 
 
5.2.1.1 EGF and UTP time course of phospho-Akt  
Figure 5.1 shows the extent and duration of EGF and UTP stimulation of Akt 
phosphorylation.  EGF and UTP rapidly stimulated the phosphorylation of Akt and the 
response rose to peak at approximately 5min.  The stimulation gradually decreased and 
at 1h either EGF or UTP stimulation of the phosphorylation of Akt declined to control 
levels, which was 1.4 ± 0.3 and 1.3 ± 0.2 fold of unstimulated cells respectively.  
Furthermore, 3nM EGF and 100μM UTP produced a very similar level of stimulation 
of Akt phosphorylation, the maximum response being 3.2 ± 0.5 and 4.2 ± 0.7 fold over 
control respectively.  
 
5.2.1.2 EGF and UTP time course of phospho-GSK-3 
UTP increased the level of GSK-3 phosphorylation and peaked at 10min (1.6 ± 0.2 
fold), while the maximum EGF stimulation was measured around 10 to 15min (2.5 ± 1 
to 2.7 ± 0.7 fold), as shown in Figure 5.2.  After that UTP stimulation of GSK-3 
phosphorylation decreased, returning to control levels after 40min.  However, EGF 
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stimulation of GSK-3 phosphorylation decreased gradually.  At 1h, the level of GSK-3 
phosphorylation was still 1.3 ± 0.6 fold higher than unstimulated cells. 
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Figure 5.1 EGF stimulation of Akt phosphorylation A. short time course C. long time 
course and UTP stimulation of Akt phosphorylation B. short time course D. long 
time course. 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h serum free incubation.  Cells were then stimulated with 3nM EGF or 100μM UTP at 
different time points as indicated and western blotting for phospho-Akt. Data represented mean ± SEM 
(n=3) and were analysed by two-way ANOVA using Graphpad Prism (not significant different between 
EGF and UTP stimulation).  Western blots are representative of 3 independent experiments and statistic 
data are from 3 independent experiments. 
 
Chapter 5 Comparison of Growth Factor and Nucleotide Stimulation in Primary Rat Hepatocytes 
De Montfort University                                                                                                                       Yi Luo 128 
 
                     EGF                                                                            UTP 
A                  0     1      2     5    10    15   min                 B              0     1     2      5     10    15    min 
P-GSK                              P-GSK      
Pan-GSK                          Pan-GSK  
 
C                 0     5     10   20   40    60    min                 D               0     5     10   20   40    60    min 
P-GSK                              P-GSK     
Pan-GSK                          Pan-GSK  
0 5 10 15 20
0
100
200
300
400
EGF
UTP
Time (min)
P
e
rc
e
n
ta
g
e
 (
%
)
0 10 20 30 40 50 60 70
0
100
200
300
400
500
EGF
UTP
Time (min)
P
e
rc
e
n
ta
g
e
 (
%
)
 
Figure 5.2 EGF stimulation of GSK phosphorylation A. short time course C. long 
time course and UTP stimulation of Akt phosphorylation B. short time course D. 
long time course. 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h serum free incubation.  Cells were then stimulated with 3nM EGF or 100μM UTP at 
different time points as indicated and western blotting for phospho-GSK-3. Data represented mean ± 
SEM (n=3) and were analysed by two-way ANOVA using Graphpad Prism (not significant different 
between EGF and UTP stimulation). Western blots are representative of 3 independent experiments and 
statistic data are from 3 independent experiments. 
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5.2.1.3 EGF and UTP time course of P-ERK 
Figure 5.3 shows a significant difference between EGF and UTP stimulation of ERK 
phosphorylation in hepatocytes.  UTP induced a rapid increase of the level of the 
phosphorylation of ERK.  The response was measured after exposure of cells to UTP 
for 1min and the level of UTP induction of the phosphorylation of ERK peaked at 5min.  
The stimulation quickly decreased after that, and almost reduced to control level after 
1h.  However, EGF stimulation of ERK phosphorylation was firstly detected at 5min.  
Then the response gradually rose and reached the maximum at 1h, which was about 20 
fold higher than control levels.  It shows a significant difference between the EGF and 
UTP stimulation of ERK phosphorylation time course. 
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Figure 5.3 A. EGF and B. UTP stimulation of ERK phosphorylation time course 
Blot A is from Figure 3.3 and B is from Figure 4.3.  
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5.2.2 Comparison of EGF and UTP stimulation signalling pathways  
5.2.2.1 Cross-talking between the P2Y2 receptor (GPCR) and the EGFR (Growth 
Factor Receptor) 
5.2.2.1.1 Src-mediated cross-talking between the GPCR and growth factor receptor 
The src family of tyrosine kinases have been reported as one of the major factors 
mediating the GPCR trans-activated growth factor receptor (Andreev et al., 2001).  The 
possibility of src-dependent cross-talk between the EGFR and the P2Y2 receptor was 
investigated by treatment with PP2, an inhibitor of the src tyrosine kinase family; EGF 
and UTP stimulation of Akt and ERK phosphorylation were measured by western 
blotting.   
 
The results show that the inhibition of the src kinase family activity did not 
significantly affect EGF or UTP stimulation of Akt or ERK phosphorylation in primary 
rat hepatocytes (Figure 5.4). 
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Figure 5.4 Effect of PP2 on EGF and UTP induction of A. Akt phosphorylation and 
B. ERK phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h serum free incubation.  Cells were pre-incubated with 100μM PP2 for 15min and then 
stimulated with 3nM EGF or 100μM UTP for 5min or 20min. Western blotting of phospho-ERK (20min) 
and phospho-Akt (5min) were measured.   Blots are representative of 3 independent experiments. 
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5.2.2.1.2 The role of tyrosine kinase in the GPCR trans-activated growth factor 
receptor 
In rat-1 fibroblasts and PC12 cells, the P2Y receptor induced MAPK activation was 
dependent on cross-talk with the EGFR (Soltoff, 1998; Soltoff et al., 1998).  This 
suggested that the EGFR is downstream target of the P2Y receptor, and inhibition of 
the EGFR tyrosine kinase would block response from both receptors.  Here we used 
AG1478 to inhibit EGFR-activated tyrosine kinase activity, EGF and UTP simulation 
of the phosphorylation of Akt and ERK and [
3
H]-thymidine incorporation into DNA 
were measured. 
 
Figure 5.5 shows that pre-incubation with 300nM AG1478 effectively abolished EGF 
stimulation of Akt and ERK phosphorylation.  However, the inhibition of tyrosine 
kinase activity had no significantly effect on UTP induction of Akt and ERK 
phosphorylation in hepatocytes.   
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Figure 5.5 Effect of AG1478 on EGF and UTP induction of A. Akt phosphorylation 
and B. ERK phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 300nM AG1478 for 15min and then 
stimulated with 3nM EGF or 100μM UTP for 5min or 20min. Western blotting of phospho-ERK (20min) 
and phospho-Akt (5min) were measured. Data represented mean ± SEM (n=3) and were analysed by 
One-way ANOVA and post test was measured with Bonferroni‟s to compare all data sets using 
Graphpad Prism (***p<0.001).  Western blots are representative of 3 independent experiments and 
statistic data are from 3 independent experiments. 
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5.2.2.2 Comparison of EGF and UTP stimulation of PI3K/Akt signalling pathway 
5.2.2.2.1 The role of PI3K on EGF and UTP stimulation signalling pathway 
In order to investigate whether EGF and UTP stimulation of Akt phosphorylation is 
PI3K activity dependent, LY294002 was used to block PI3K activation and EGF and 
UTP induction of Akt phosphorylation was measured by western blotting.  Furthermore, 
EGF and UTP induction of the phosphorylation of GSK-3, Akt downstream protein, 
was also measured with LY294002 present.  
 
The inhibition of PI3K activity completely blocked EGF and UTP stimulation of Akt 
phosphorylation (Figure 5.6A).   Furthermore, LY294002 significantly reduced EGF 
and UTP induction of the phosphorylation of GSK, a downstream protein of Akt, to 
21% and 53% respectively.   
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Figure 5.6 Effect of LY294002 on EGF and UTP induction of A. Akt 
phosphorylation and B. GSK phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 10μM LY294002 for 15min and then 
stimulated with 3nM EGF or 100μM UTP for 5min. Western blotting of phospho-GSK and phospho-Akt 
were measured.  Data represented mean ± SEM (n=3) and were analysed by One-way ANOVA and post 
test was measured with Bonferroni‟s to compare all data sets using Graphpad Prism (***p<0.001).  
Western blots are representative of 3 independent experiments and statistic data are from 3 independent 
experiments. 
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5.2.2.2.2 The role of Akt in EGF and UTP stimulation signalling pathway 
To detect whether EGF and UTP stimulation of the phosphorylation of GSK-3 was 
directly through Akt activation, Akt activity was inhibited using A443654. 
 
Figure 5.7 shows that the inhibition of Akt activation completely blocked EGF 
induction of GSK-3 phosphorylation in rat hepatocytes.  A443654 greatly reduced 
UTP-mediated the phosphorylation of GSK-3 to 6.9% ± 1.5%.  However, the level of 
EGF and UTP stimulation of GSK-3 phosphorylation was significantly different. 
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Figure 5.7 Effect of A443654 on EGF and UTP stimulation of GSK phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 3μM A443654 for 30min and then 
stimulated with 3nM EGF or 100μM UTP for 5min. Western blotting of phospho-GSK were measured. 
Data represented mean ± SEM (n=3) and were analysed by One-way ANOVA and post test was 
measured with Bonferroni‟s to compare all data sets using Graphpad Prism (*p<0.05, ***p<0.001).  
Western blots are representative of 3 independent experiments and statistic data are from 3 independent 
experiments. 
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5.2.2.3 Effect of the internalisation on EGF and UTP stimulation  
5.2.2.3.1 Effect of concanovalin A (con A) on EGF and UTP stimulation  
The role of internalisation of EGF/EGFR and UTP/P2Y2 was studied using con A, a 
non-selective internalisation inhibitor.  EGF and UTP stimulation of Akt and ERK 
phosphorylation were measured.   
 
As shown in Figure 5.8, the inhibition of ligand/receptor internalisation in primary rat 
hepatocytes with con A strongly reduced EGF induction of the increase of Akt and 
ERK phosphorylation.  However, con A did not inhibit UTP stimulation in hepatocytes.  
In fact, the inhibition of internalisation significantly increased UTP stimulation of Akt 
and ERK phosphorylation to 153% ± 35% and 170% ± 36% respectively in hepatocytes.   
 
The effect of con A on UTP stimulation of Akt and ERK phosphorylation may be a 
result of prolonged UTP stimulation at the cell surface, which would maintain the 
receptor on a longer period of time.  Also, it could be due to con A increased the size of 
the response without changing the time course.  In order to distinguish between these 
possibilities, a time course of UTP stimulation was measured, while cells were treated 
with/without con A.   
 
Figure 5.9 shows that the con A-mediated inhibition of UTP/P2Y2 did not affect the 
duration of UTP stimulation of Akt and ERK phosphorylation in hepatocytes.  
However, blocking internalisation increased the extent of UTP stimulation.  As shown 
in Figure 5.9A, UTP stimulation of Akt phosphorylation was significantly increased in 
con A treated cells.  The data (Figure 5.9B) indicates that UTP induced ERK 
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phosphorylation was also increased by con A, although the effect was not statistically 
significant.   
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Figure 5.8 Effect of con A on EGF and UTP stimulation of A. Akt and B. ERK 
phosphorylation  
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 250μg/ml con A for 15min and then 
stimulated with 3nM EGF or 100μM UTP for 5min and 20min. Western blotting of phospho-ERK/Pan-
ERK (20min) and phospho-Akt/Pan-Akt (5min) were measured.  Data represented mean ± SEM (n=3) 
and were analysed by One-way ANOVA and post test was measured with Bonferroni‟s to compare 
selected pairs of columns using Graphpad Prism (*p<0.05, **p<0.01, ***p<0.001).  Western blots are 
representative of 3 independent experiments and statistic data are from 3 independent experiments.                          
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Figure 5.9 Effect of con A on UTP stimulation of A. Akt and B. ERK 
phosphorylation at different time points 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 250μg/ml con A for 15min and then 
stimulated with 100μM UTP as indicated. Western blotting of phospho-ERK/Pan-ERK and phospho-
Akt/Pan-Akt were measured. Data represented mean ± SEM (n=3) and were analysed by Two-way 
ANOVA (related values are spread across a row) (*P<0.05).  Western blots are representative of 3 
independent experiments and statistic data are from 3 independent experiments. 
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5.3 Discussion   
Nucleotides such as ATP could induce cell cycle progression and cell proliferation via 
PI3K/Akt and ERK1/2 pathways (Milenkovic et al., 2003).  Furthermore, in many cells, 
nucleotide/P2Y receptor-induced Akt and ERK phosphorylation were mediated through 
the trans-activation of growth factor receptors such as the EGFR (Soltoff, 1998; Soltoff 
et al., 1998; Milenkovic et al., 2003).  However, in primary hepatocytes, the results 
show that UTP/P2Y2 (GPCR) stimulation of the phosphorylation of Akt and ERK did 
not depend on the trans-activation of EGFR (growth factor receptor).  Either inhibition 
of the src family tyrosine kinase activity, which plays an essential role in the GPCR 
tranactivation of the EGFR (Andreev et al., 2001), or directly block of the EGFR 
tyrosine kinase activity did not affect the UTP/P2Y2 stimulation.   
 
From other works, Akt could be induced via either PI3K dependent or independent 
signalling pathways  (Yano et al., 1998; Filippa et al., 1999; Brami-Cherrier et al., 
2002; Woodgett, 2005).  The inhibition of PI3K activity by LY294002 abolished EGF 
or UTP induction of the phosphorylation of Akt (Figure 5.6A) suggesting that the 
activation of Akt is PI3K dependent in hepatocytes.  This indicated that the different 
effect of EGF and UTP on stimulation of hepatocyte cell cycle progression may be not 
due to EGF and UTP inducing Akt activation via different signalling pathways.   
However, the inhibition of PI3K-dependent Akt activity did not completely block EGF 
or UTP stimulation of the phosphorylation of GSK-3, a down-stream regulation target 
of Akt (Figure 5.6B).  Compared to control cells, EGF and UTP stimulation of GSK-3 
phosphorylation was reduced to about 20% and 50% respectively in LY294002 pre-
treated cells.  This suggested that EGF and UTP may stimulate GSK-3 phosphorylation 
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in an Akt-independent pathway.  However, in all experiments, the phospho-Akt was 
detected using the antibody specific for the Ser473 phosphorylation site.  Recent 
evidence showed that when Akt was phosphorylated at Thr308, it was partially 
activated; additional phosphorylation at Ser473 fully activated the receptor.  
Furthermore, the phosphorylation of Akt at Thr308 alone was able to stimulate Akt 
down-stream regulated proteins such as GSK-3 (Jacinto et al., 2006).  Therefore, EGF 
and UTP stimulation of GSK-3 phosphorlyation could still be Akt-dependent, which 
means the phosphorylation of Akt at Thr308 alone contributed a part of the stimulation 
of GSK-3 phosphorylation, while phosphorylated Akt at both Ser473 and Thr408 
induced full response.  It indicated that PI3K activation is necessary for the 
phosphorylation on Ser473 but may be not on Thr308.  Therefore, although exposure of 
the cells to LY294002 abolished EGF or UTP stimulation of Akt phosphorylation at 
Ser473 site, it did not completely inhibit the EGF or UTP inducing Akt phosphorylation 
at Thr308 site and in turn stimulated the phosphorylation of GSK-3.  Also it could be 
because 10μM LY294002 inhibited PI3K-mediated Akt phosphorylation on Ser473 but 
not Thr308, and higher concentration is required to abolish the phosphorylation on 
Thr308.  Furthermore, when Akt activation was directly inhibited by A443654, EGF-
induced Akt phosphorylation was abolished, while UTP-induced response decreased to 
approximately 10% of the level in control cells (no A443654 present) (Figure 5.7).  
Therefore, it suggested that EGF stimulation of GSK-3 phosphorylation was Akt-
dependent, while UTP stimulation was mainly Akt-regulated.   
 
Differences in the duration and extent of agonist induction of the phosphorylation of 
one target can result in different biological effects.  For instance, in CCL39 cells, α-
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thrombin induced a biphasic phosphorylation of ERK, which has a 30min to 1h first 
stimulation phase and another late phase lasting for several hours.  The inhibition of the 
late phase alone completely abolished α-thrombin stimulated cell cycle progression, 
while only inhibiting the first phase did not affect the ligand-induced cell cycle 
progression (Meloche et al., 1992).  This suggests that one agonist stimulation of the 
same protein activity at different time or different duration may result in different 
biological responses.  In primary rat hepatocytes, EGF and UTP produced a very 
similar stimulation of Akt phosphorylation.  The response reached a maximum at 
around 5min and then declined to control level after 1h.  GSK-3, which is an Akt 
downstream protein (Brazil et al., 2004), was phosphorylated by either EGF or UTP.  
UTP and EGF stimulation of GSK-3 phosphorylation peaked at about 10min, which 
was approximately 5min after the maximum response of EGF and UTP inducing Akt 
phosphorylation.  After that UTP-induced response rapidly decreased to control level, 
with exposure of cells to UTP for 40min the response was similar to unstimulated cells.  
EGF stimulation gradually dropped, at 1h EGF stimulation of the increase of the level 
of GSK-3 phosphorylation was still 1.3 ± 0.6 higher control (unstimulated cells) but not 
significantly different.  However, EGF and UTP induction of ERK phosphorylation 
was very different in hepatocytes.  The time course of UTP stimulation of the 
phosphorylation of ERK was very similar to the time course of Akt phosphorylation.  
The response peaked at about 5min and quickly decreased to control level within 1h.  
EGF stimulation of the phosphorylation of ERK rose much slower than UTP 
stimulation.  The response gradually increased and peaked after exposure of cells to 
EGF for 1h.  There are a lot of evidences that the MEK/ERK signalling cascade is one 
of the key signalling pathways in response to extracellular signals, which leads to cell 
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cycle progression and cell proliferation.  ERK is a central and key player in this 
signalling cascade and the activation of ERK is indispensable for cell proliferation in 
mature differentiated eukaryotic cells (reviewed by (Charmbard et al., 2007).  
Therefore, the more prolonged EGF stimulation of MEK/ERK signalling pathways than 
UTP may cause the difference between the EGF and UTP stimulation of hepatocyte 
cell cycle progression.   
 
Figure 5.8 suggests that in primary rat hepatocytes, the internalisation of EGF/EGFR 
was necessary for EGF stimulation of Akt and ERK phosphorylation, while the 
internalisation of UTP/P2Y receptor leaded to the reduction of the stimulation.   This 
finding corresponded to Bergeron and colleagues early work, which showed that 
internalised EGFR maintained phosphorylation of its tyrosine kinase domain and still 
was activated (in vivo) (Lai et al., 1989).  Furthermore, the same group claimed that in 
liver the EGF receptor and its down-stream regulated proteins such as Shc, Grb2 and 
Sos were found in early endosomes, but not in plasma membrane which indicates that 
EGFR signalling stimulating from intracellular compartment.  In other cells, for 
example BT20, a breast cancer cell line (in vitro), the internalised EGFR could activate 
further signalling cascades such as Akt and ERK from early endosomes (Wang et al., 
2002).  However, in the experiment, the internalisation was inhibited by con A, which 
has been shown that inhibits EGFR activation by inducing proteolytic cleavage of the 
EGFR at carboxyl terminus  (Tang et al., 2000).  Therefore, the inhibition of EGF 
stimulation of Akt and ERK phosphorylation by con A might be due to the con A-
mediated inhibition of EGFR internalisation or proteolysis of the receptor.  In primary 
rat hepatocyte, the level of UTP stimulation of ERK and Akt phosphorylation was 
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increased, when cells were exposed to con A (Figure 5.9).  This suggested that 
UTP/P2Y receptor stimulated signalling on the cell surface and that internalisation of 
the receptor leaded to the reduction of the stimulation.  This was in agreement with the 
classical model: after binding to an extracellular agonist, the receptor recruits and 
activates secondary messengers on cell membrane, and the stimulation is then 
terminated by the internalisation of receptor into lysosomes where the receptor is 
degradated following ubiquitination.  However, recent evidences showed that GPCRs 
may continue stimulating signalling in endosomes before the degradation.  For instance, 
isoprotereno-induced β2-adrenergic receptor (β2AR) phosphorylation and association 
with β-arrestins resulted in receptor internalisation and stimulation of ERK and JNK 
activation (Luttrell et al., 1999; McDonald et al., 2000).  However, inhibition of 
receptor internalisation increased the size of UTP stimulation of Akt and ERK 
phosphorylation but did not prolong the time course.  This suggested that inhibition of 
the receptor internalisation into lysosomes, where the receptor is then degradated, did 
not affect the termination of the receptor activity.  It indicated that there may be another 
factor involved in the regulation of the receptor activation or the receptor can be 
desensitivated on the cell surface.   
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6.1 Introduction 
A possible interpretation of previous results is that EGF stimulation might be regulated 
by the receptor internalisation, while UTP stimulation might be terminated by the 
internalisation in primary rat hepatocyte (Chapter 5).  In the early 1980s, Hubbard and 
colleagues demonstrated that the the EGFR binding to its ligand (EGF) resulted in the 
internalisation of the receptor in rat hepatocyte (Dunn and Hubbard, 1984; Dunn et al., 
1986).  Furthermore, internalised EGFR maintained auto-phosphorylation of its 
tyrosine kinase domain in both endosomes isolated from rat liver homogenates (in vivo) 
and in BT20, a breast cancer cell line (in vitro) (Lai et al., 1989; Wang et al., 2002).  
However, con A, which was used to inhibit receptor internalisation in previous 
experiments, also induces EGFR proteolysis in vascular smooth muscle cells and in 
turn inhibits the signalling (Tang et al., 2000).  It is not known whether this occurs in 
other cell types.  Therefore, inhibition of EGF stimulation by con A may be due to 
either the EGFR breakdown or inhibition of the receptor internalisation.  In order to 
further study the role of internalisation in EGF/EGFR and UTP/P2Y receptor signalling, 
specific inhibitors were used to block ligand-mediated receptor internalisation.  
Activated receptor can be internalised via several pathways in which clathrin-dependent 
and caveolin-dependent endocytosis are the best studied.  Therefore, the role of these 
two endocytotic pathways in EGF and UTP stimulation of ERK and Akt 
phosphorylation were measured.  Caveolin-dependent internalisation was inhibited by 
nystatin, which is a specific caveolin-regulated internalisation inhibitor (Schnitzer et al., 
1994; Okamoto et al., 2000), and clathrin-dependent internalisation was inhibited by 
sucrose, which inhibits of clathrin-mediated endocytosis (Hansen et al., 1993).  
Furthermore, since it has been demonstrated that dynamin is essential for the formation 
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and activation of clathrin-coated pits (Schmid, 1997; McNiven, 1998), the clathrin-
dependent internalisation was also blocked by transfection of hepatocytes to express 
Dn-dynamin.   
 
EGFR (also known as ErbB1) appears to signal from endosomes during most of its 
activated time whereas other members of this family (ErbB2, ErbB3 and ErbB4) prefer 
to signal from the plasma membrane after EGF induction.  For instance, in A431 cells, 
EGF binding results in the rapidly internalisation of the EGFR into endosomes, and it 
remains active until degradation.  Moreover, approximate 30% of the receptor is 
recycled to the membrane (Sorkin et al., 1991; Wiley, 2003).  Therefore, the location of 
receptor and ligand after stimulation was investigated.  For example, EGF was 
visualised using Alexa-488 conjugated EGF and the EGFR was visualised by 
application of EGFR antibody, which was then labelled by a cy5 conjugated secondary 
antibody.  The image of the location of EGF and EGFR was then captured at different 
time points after stimulation.   
 
Recently, Wang and colleagues showed that the internalisation of EGFR is not 
dependent on its activation, which means that even with inhibition of the EGFR 
activation, EGF can still result in the receptor internalisation (Wang et al., 2002; Wang 
et al., 2005).  This finding provides a model to study the possibility of signalling 
exclusively from internalised EGFR.  Therefore, in experiment here, EGF stimulation 
was inhibited by AG1478, followed by removal of both inhibitor and cell surface 
binding EGF at which point signalling can only come from internalised receptor.  The 
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effect of internalised EGFR on signalling cascades and cell cycle progression were then 
investigated.   
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6.2 Results 
6.2.1 The internalisation pathways 
6.2.1.1 Effect of the Caveolin-dependent internalisation on the EGF and UTP 
stimulation 
The previous result (Figure 5.8) suggested the importance of receptor internalisation to 
EGF and UTP stimulation.  Here, we further investigated the detail of the EGF/EGFR 
and UTP/P2Y2 receptor internalisation after stimulation.  Firstly we investigated 
whether the internalisation of the EGFR and P2Y2 receptor are caveolin-dependent 
using nystatin, a specific caveolin-mediated internalisation inhibitor. 
 
As shown in Figure 6.1, nystatin did not have a significant effect on EGF stimulation of 
Akt and ERK phosphorylation, which suggested that the EGF/EGFR internalisation is 
caveolin-independent.  However, nystatin increased the UTP stimulation of Akt and 
ERK phosphorylation to 1.2 ± 0.1 and 2.0 ± 0.2 fold over control levels (only UTP 
stimulation), respectively, which indicated that caveolin-mediated receptor 
internalisation played an important role in the regulation of P2Y2 receptor degradation 
in hepatocytes.   
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Figure 6.1 Effect of nystatin on EGF and UTP stimulation of A. Akt and B. ERK 
phosphorylation  
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 50mg/ml nystatin for 15min and then 
stimulated with 3nM EGF or 100μM UTP for 5min and 20min. Western blotting for phospho-ERK 
(20min) and phospho-Akt (5min) were measured. Data represented mean ± SEM (n=3) and were 
analysed by One-way ANOVA and post test was measured with Bonferroni‟s to compare all data sets 
using Graphpad Prism (*p<0.05, ***p<0.001).  Western blots are representative of 3 experiments and 
statistic data are from 3 independent experiments. 
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6.2.1.2 Effect of the Clathrin-dependent internalisation on the EGF and UTP 
stimulation   
The role of clathrin-coated vesicles in EGF/EGFR and UTP/P2Y2 receptor 
internalisation was studied.  In an attempt to investigate this, sucrose, an inhibitor of 
clathrin-coated vesicle-mediated endocytosis, was used.  Since sucrose is a heavy 
compound and may deposit to form a high concentration solution at the bottom of the 
plate, in order to achieve the right concentration, two ways of adding sucrose were used.  
In one way, 0.9M sucrose was dissolved in WME and 1ml of resulting solution was 
added into cells which were in 1ml medium, to achieve a final 0.45M sucrose.  The 
disadvantage of this method is that, without vigorous mixing (which itself stimulates 
the cell) the loading sucrose might results in cell being covered with 0.9M sucrose, 
twice the target concentration.  Therefore, in the other way, 1ml of 0.45M sucrose was 
prepared and carefully layered into cells (in 1ml medium).  Because the sucrose 
solution was heavier than medium (WME) it might form two levels of solution which at 
the bottom, near the cells, was 0.45M sucrose solution.   
 
As shown in Figure 6.2, sucrose alone induced the phosphorylation of Akt and ERK 
and could not be used as an inhibitor.  Moreover, either way of adding sucrose to 
hepatocytes provided very similar results. 
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Figure 6.2 Effect of Sucrose on EGF and UTP stimulation of A. Akt and B. ERK 
phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation.  Cells were pre-incubated with 0.45M sucrose for 30min and then 
stimulated with 3nM EGF or 100μM UTP for 5min and 20min. Western blotting for phospho-ERK 
(20min) and phospho-Akt (5min) were measured.  Data are representative of 3 independent experiments. 
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Dynamin is essential for the formation and activation of clathrin-coated pits (Schmid, 
1997; McNiven, 1998), therefore, clathrin-dependent internalisation was blocked by 
expressing Dn-dynamin.  The Dn-dynamin encoded adenovirus was incubated with the 
cells for 16h, and the cells were further incubated for at least 8h without adenovirus to 
allow expression of Dn-dynamin before stimulation.   
 
Figure 6.3 shows that the inhibition of the clathrin-dependent internalisation 
significantly reduced EGF stimulation of ERK phosphorylation.  This was, however, 
only a partial effect.  In the Dn-dynamin expressing hepatocytes, EGF stimulation of 
Akt phosphorylation was also reduced, although the response was not statistically 
significant.  Furthermore, UTP stimulation of Akt phosphorylation was not affected by 
the Dn-dynamin treatment, while ERK response was reduced, although it was not 
significant. 
   
The effect of inhibition of clathrin-dependent internalisation by Dn-dynamin on the 
EGF stimulation in hepatocytes was further studied.  As shown in Figure 6.4A, EGF 
induced EGFR phosphorylation was significantly increased, when clathrin-dependent 
internalisation was inhibited.  EGF stimulation of Akt phosphorylation was not affected 
by inhibition of clathrin-dependent internalisation after 5min, however, the response 
decreased to 60% ± 14% after 30min (Figure 6.4B).  In Dn-dynamin expressing rat 
hepatocytes, EGF stimulation of ERK phosphorylation was decreased to 81% ± 6% and 
77% ± 1% at 5min and 30min exposure of the cells to agonist respectively (Figure 
6.4C).   
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Figure 6.3 Effect of Dn-dynamin on the EGF and UTP stimulation of A. Akt and B. 
ERK phosphorylation 
Hepatocytes were cultured for 4h in WME supplemented with ITS and 10% FCS, which were then 
replaced with SF WME containing encoding kinase-dead Dn-dynamin adenovirus for 16h and further 
incubated for 32h without adenovirus to allow the protein expression before stimulation with 3nM EGF 
or 100μM UTP for 5min or 20min.  Western blotting of phospho-ERK (20min) and phospho-Akt (5min) 
were measured.  Data represented mean ± SEM (n=3) and were analysed by One-way ANOVA and post 
test was measured with Bonferroni‟s to compare all data sets using Graphpad Prism (*p<0.05).  Western 
blots are representative of 3 independent experiments and statistic data are from 3 independent 
experiments. 
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Figure 6.4 Effect of Dn-dynamin on the EGF stimulation of A. EGFR, B. Akt and C. 
ERK phosphorylation  
Hepatocytes were cultured for 4h in WME supplemented with ITS and 10% FCS, which were then 
replaced with SF WME containing encoding kinase-dead Dn-dynamin adenovirus for 16h and further 
incubated for 32h without adenovirus to allow the protein expression before stimulation with 3nM EGF 
for 5min and 30min.  Western blotting of phospho-EGFR, phospho-ERK and phospho-Akt were 
measured.  Data represented mean ± SEM (n=3) and were analysed by One-way ANOVA and post test 
was measured with Bonferroni‟s to compare all data sets using Graphpad Prism (*p<0.05, **p<0.01).  
Western blots are representative of 3 independent experiments and statistic data are from 3 independent 
experiments. 
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Since EGF stimulation is at least partially clathrin-dependent, as suggested in Figure 
6.3 and Figure 6.4, the location of EGF and EGFR after ligand stimulation were further 
studied.  Cells were incubated with 488-EGF and Alexa-546 fluorescence conjugated 
transferrin (transferrin-546), a marker for clathrin-dependent internalisation, for 30min 
to visualise whether the internalisation of EGF is clathrin-dependent in hepatocytes.  
Furthermore, Dn-dynamin expressing cells were incubated with 488-EGF and 
transferrin-546 to examine the effect of Dn-dynamin on the EGF and transferrin 
internalisation.  The green fluorescence was from 488-EGF, red signal was from 
transferrin-546 and the yellow signal was the combined green and red fluorescence. 
 
Figure 6.5A shows that both EGF (green) and transferrin (red) internalised after 30min 
stimulation.  The co-location (yellow) of EGF and transferrin suggested that EGF 
internalisation is clathrin-dependent in hepatocytes. It shows that the inhibition of the 
formation of clathrin-coated vesicles by expression of Dn-dynamin in hepatocytes 
effectively blocked the EGF and transferrin internalisation (Figure 6.5B).  In order to 
ask whether the internalisation of the receptor (rather than the ligand) was blocked, the 
EGFR was visualised by confocal immunohistochemistry using an anti-EGFR antibody.  
As shown in Figure 6.6, treatment of cells expressing Dn-dynamin blocked the EGF-
mediated EGFR internalisation. 
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Figure 6.5 Location of EGF and transferrin after 30min stimulation in A. normal 
primary rat hepatocytes and B. Dn-dynamin expressed hepatocytes 
Hepatocytes were cultured on a plastic coverslip for 4h in WME supplemented with ITS and 10% FCS, 
which were then replaced with SF WME for 24h.  In Panel B, the replaced WME containing encoding 
kinase-dead Dn-dynamin adenovirus for 16h and further incubated for 8h without adenovirus to allow the 
protein expression.  Then cells were stimulated with 60nM 488-EGF and 20μg/ml transferrin-546 for 
30min. The reaction was stopped by fixing in 4% paraformadehyde at 4℃ for 15min.  The coverslip was 
mounted onto a slide and images collected using a confocal microscope.  Images are representative of 2 
experiments. 
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Figure 6.6 Effect of the Dn-dynamin on the ligand-mediated EGFR internalisation 
Cells were cultured on a plastic coverslip in WME supplemented with ITS and 10% FCS for 4h after 
plating, followed with changed medium to SF and further incubated for 24h. The cells were stimulated 
with 60nM EGF for 30min.  Then reaction was stopped by fixing the cells in 4% paraformadehyde at 4℃ 
for 15min, subsequently permeabilized in 0.1% Triton (in 1% BSA/PBS) for 2min on ice.  After that 
cells were incubated in 10% donkey serum (in 2% BSA/PBS) at room temperature for 1h and then 
labelled by 1:50 anti-EGFR at 4℃ overnight. The next day, cells were applied with 1:200 donkey anti-
rabbit cy5 at room temperature for 1h in the dark and the nucleus was labelled by incubation with 5mM 
SYTOX for 30s at room temperature. Finally the coverslip was mounted on a slide and images were 
collected using a confocal microscope.  Images are representative of 3 experiments. 
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6.2.2 The study of the P2Y2 receptor and EGFR location in primary rat 
hepatocytes 
6.2.2.1 The location of the P2Y2 receptors  
The previous results (Figure 5.8 and Figure 5.9) have indicated that activated-P2Y2 
stimulated down-stream proteins on the cell surface and inhibition of receptor 
internalisation may increase the extent of stimulation.  Lipofectamine-2000 or 
jetPEI
TM
-Hepatocyte DNA Transfection Reagent (Polyplus Transfection) was used to 
transiently transfect cells to express green fluorescence protein (GFP) coupled P2Y2 
receptor.  This enabled the location of the receptor to be visualised.   
 
Figure 6.7A&C show the fluorescence control levels of primary rat hepatocytes.  Figure 
6.7B shows that incubation of the cells with lipofectamine-2000 and GFP-P2Y2 
plasmid for 48h resulted in the cells being transfected with GFP-P2Y2 receptor.  
However, the GFP signal was detected over the entire cell and was not restricted to the 
cell surface.  Transfection mediated by Reagent kit (Polypus Transfection) gave a 
similar result, as shown in Figure 6.7D.  Therefore, P2Y2 receptor internalisation is not 
able to directly visualise and new method needs to be developed.   
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Figure 6.7 Confocal images of A. non-transfected cells, B. lipofectemin-2000 
transfection of GFP-P2Y2 receptor cells, C. non-transfection cells and D. jetPEI
TM
-
Hepatocyte DNA Transfection Reagent transfection of GFP-P2Y2 receptor cells 
Cells were cultured on a plastic coverslip in WME supplemented with ITS and 10% FCS for 4h after 
plating, followed with transfected of cells with GFP-P2Y2 receptor plasmid by lipofectamine-2000 or 
jetPEI
TM
-Hepatocyte DNA Transfection Reagent for 48h.  The cells were then fixed in 4% 
paraformadehyde at 4℃ for 15min and the coverslip was then mounted on a slide.  Images are 
representative of 2 independent experiments. 
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6.2.2.2 The internalisation of EGF and EGFR  
6.2.2.2.1 The location of EGF after stimulation 
The previous results (Figure 5.8) suggested the possibility that internalisation was 
necessary for EGF stimulation of ERK and Akt phosphorylation.  In order to further 
study EGF internalisation, 488-EGF was used in place of EGF to stimulate the cells and 
visualise the location of EGF.  The nucleus was labelled with PI.   
 
Figure 6.8 presents a series of images of EGF location, captured with the confocal 
microscope, in hepatocytes with different treatments.  Panel A shows the fluorescence 
in the absence of 488-EGF; hepatocyte auto-fluorescence signal was removed with 
appropriate setting of the confocal microscope.  The other images were measured with 
the same setting to eliminate the effect of hepatocyte auto-fluorescence.  In the 
experiments, the position of the optical slices (Z-dimension) was set to maximise the 
signal of the nucleus, which was counterstained with PI (Red) to ensure that the images 
collected were within the body of the cell.  Panel B shows the location of EGF in the 
cells, which were exposed to 488-EGF for 30min.  It presents a typical example of the 
punctuate appearance of Alexa-488 fluorescence in the interior of the cell, with no 
labelling of the cell surface.  The fluorescence was completely lost when cells were 
first incubated with excess unlabelled EGF for 5min before exposure to 488-EGF 
(Panel C).  There was also no Alexa-488 fluorescence detected in the cells which were 
pre-incubated with con A before stimulation (Panel D).  
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Figure 6.8 Confocal images of 488-EGF location in hepatocytes in different 
conditions: A. without 488-EGF stimulation; B.488-EGF stimulation for 30min; C. 
pre-incubation with cold-EGF for 5min and then stimulation with 488-EGF for 
30min; D. pre-incubation with con A for 15min  and then stimulation with 488-EGF 
for 30min  
Cells were cultured on a plastic coverslip in WME supplemented with ITS and 10% FCS for 4h after 
plating, followed with changed medium to SF and further incubated for 24h. Cold-EGF (60nM) was 
added 5min before while 250μM con A were added 15min before exposure of cells to 60nM 488-EGF 
for 30min. The reaction was stopped by fixing cells in 4% paraformadehyde at 4℃ for 15min; 
subsequently cells were incubated with 50μg/ml PI with 10μg/ml RNAse for 30min at 37℃ to label the 
nucleus.  After that washed extracellular PI off with PBS and the coverslip was mounted on a slide.  
Images are representative of 3 independent experiments. 
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6.2.2.2.2 The location of the EGF and EGFR at different time points after 
stimulation 
Figure 6.8 shows that exposure of cells to EGF resulted in EGF internalisation after 
30min.  Experiments were then designed to investigate when the internalisation starts 
and duration of the process.  Cells were stimulated with 488-EGF for different times 
(up to 1h) and the location of the EGFR after ligand stimulation was visualised by 
immunocytochemistry, as described in Chapter 2, Section 2.2.6.  The green 
fluorescence was from 488-conjugated EGF, the red signal was from cy5-binding to the 
EGFR and the orange image was the combined green and red fluorescence.   
 
The Figure 6.9A shows the image of the control cells (un-stimulated), which was used 
to set the sensitivity of the confocal microscope.  Figure 6.9B-F show the location of 
EGF and EGFR in the cells that were exposed to ligand for 5min, 10min, 20min, 30min 
and 1h respectively.  Internalisation of EGF and EGFR was not clearly evident during 
the first 10min.  However, a comparison images at 0min, 5min and 10min shows a pro-
increase thickening of the EGFR labelled periphery of the cells.  In Panel A, the 
periphery was sharp and thin, while, in Panel B and C, this became less sharp and 
thicker, consistent with movement of the EGFR into the cells.  EGF and EGFR 
internalisation were clearly visualised as bright punctuate green (EGF) or red (EGFR) 
spots after 20min, as shown in Panel D.  By 20min, most of the green and red 
fluorescence signals overlapped inside the cells, which indicated the association of the 
EGF and EGFR.  When the cells were stimulated by EGF for 30min (Panel E), a large 
number of co-located green and red signals were again detected inside of the cells.  
Interestingly, Panel F shows that after 1h exposure, there were relatively few co-located 
EGF and EGFR signals detected inside of the cells.  Most green fluorescence signals 
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were individually located inside of the cell and remained green, when the images (488-
EGF and cy5-receptor) were merged.  There only a few red fluorescence signals and 
formed as cluster were detected, most of which were captured on or near the cell 
surface.   
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Figure 6.9 Time course of the EGF and EGFR location after ligand stimulation for 
A. 0min (un-stimulated), B. 5min, C. 10min, D. 20min, E. 30min and F. 60min  
Cells were cultured in WME supplemented with ITS and 10% FCS on a plastic converslip for 4h after 
plating, followed with changed medium to SF and further incubated for 24h. The cells were stimulated 
with 60nM 488-EGF for different times, as indicated.  Then reaction was stopped by fixing the cells in 
4% paraformadehyde at 4℃ for 15min, subsequently permeabilised in 0.1% Triton (in 2% BSA/PBS) for 
2min on ice.  After that cells were incubated in 10% donkey serum (in 2% BSA/PBS) at room 
temperature for 1h and then labelled by 1:50 anti-EGFR at 4℃ overnight.  The next day, cells were 
labelled by 1:200 donkey anti-rabbit cy5 at room temperature for 1h in the dark.  Finally the coverslip 
was mounted on a slide and images were captured by confocal microscope.  Images are representative of 
3 independent experiments. 
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6.2.2.2.3 The location of the phospho-EGFR (Tyr1173) at different time after 
stimulation 
The previous results (Figure 6.9) have shown that the EGFR was translocated into the 
cell after ligand stimulation.  In order to study whether the internalised EGFR is 
activated, the time course of phospho-EGFR location was also investigated.  Cells were 
stimulated with EGF for different times (up to 1h) and the phospho-EGFR was 
visualised using immunocytochemistry.  The nucleus was labelled with SYTOX 
®
 
Green nucleic acid stain (SYTOX).  The green fluorescence was from SYTOX labelled 
nucleus and the red signal was from cy5-binding phospho-EGFR. 
 
Figure 6.10A shows the background image as before.  Panel B-E show a series of 
images of the location of phospho-EGFR at different times after stimulation.  Phospho-
EGFR was detected after 5min (the first time point of the experiment) and was located 
within the nucleus as shown in Panel B.  The level of the phosphorylated EGFR 
increased and reached a maximum in this experiment after 30min.  Panel D shows that 
after 30min stimulation, the signal of phospho-EGFR was seen in most cells.  The 
accumulation of signal then decreased, but could still be detected in the nucleus after 
60min, as shown in Panel E.  
  
Further evidence of EGF stimulation of the translocation of phospho-EGFR into the 
nucleus was provided by preparing cell fractionation and western blotting for either 
cytoplasmic or nuclear component.  Cells were exposed to EGF for 30min and 
cytoplasmic and nuclear solutions were separated by using NE-PER Nuclear and 
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Cytoplasmic Extraction Reagents after lysis.  EGFR and phospho-EGFR was measured 
by western blotting.   
 
As shown in Figure 6.11A, EGF stimulated phospho-EGFR was located in both 
cytoplasm and nucleus in primary rat hepatocytes.  Furthermore, exposure of the 
hepatocytes to EGF resulted in a clear increase of EGFR in nucleus compared to 
control (un-stimulated) cells (Figure 6.11B).  This indicates EGF induced translocation 
of EGFR from cytoplasm into the nucleus.  Both the phospho-EGFR and the pan-EGFR 
blots in Figure 6.11 show that EGF stimulation resulted in the enhanced appearance of 
double bands, with the upper band appearing more strongly on stimulation.  This is 
consisted with EGF-stimulated hyperphosphorylation of the EGFR.   
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Figure 6.10 Time course of the phospho-EGFR (Tyr1173) location after ligand 
stimulation for A. 0min (un-stimulated), B. 5min, C. 15min, D. 30min, E. 60min  
Cells were cultured in WME supplemented with ITS and 10% FCS on a plastic coverslip for 4h after 
plating, followed with changed medium to SF and further incubated for 24h.  The cells were stimulated 
with 60nM EGF for different times, as indicated.  Then reaction was stopped by fixing the cells in 4% 
paraformadehyde at 4℃ for 15min, subsequently permeabilised in 0.1% Triton (in 2% BSA/PBS) for 
2min on ice.  After that cells were incubated in 10% donkey serum (in 2% BSA/PBS) at room 
temperature for 1h and then labelled by 1:50 anti-P-EGFR (tyr1173) at 4℃ overnight.  The next day, 
cells were labelled by 1:200 donkey anti-rabbit cy5 at room temperature for 1h in the dark and the 
nucleus was labelled by incubation with 5mM SYTOX for 30s at room temperature.  Finally the 
coverslip was mounted on a slide and images were captured by confocal microscope.  Images are 
representative of 3 independent experiments. 
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Figure 6.11 Effect of EGF on cytoplasmic and nuclear A. phospho-EGFR and B. 
EGFR in primary rat hepatocytes 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h, 
followed with 48h SF incubation before being exposed to 3nM EGF for 30min as labelled.  Cytoplasmic 
and nuclear fractions were separated by using NE-PER Nuclear and Cytoplasmic Extraction Reagents 
(Thermo Scientific Pierce Protein Research Products) after lysis, and western blotting of phospho-EGFR 
and pan-EGFR were measured.  Western blots are representative of 2 independent experiments. 
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6.2.3 Effect of internalised EGF/EGFR on the phosphorylation of Akt, 
ERK and cell cycle progression  
6.2.3.1 The accumulation of internalised EGF/EGFR by blocking the activation of 
EGFR 
The previous results have shown that receptor internalisation is important for EGF 
stimulation of primary rat hepatocytes.  AG1478 abolished EGF stimulation of the 
phosphorylation of the EGFR and cell cycle progression in hepatocytes (Chapter 3).  In 
order to investigate whether the internalisation of the EGFR was dependent on the 
phosphorylation of the receptor, cells were incubated with AG1478 for 15min before 
stimulation with 488-EGF and the location of EGF, EGFR and phospho-EGFR were 
visualised.   
 
In Figure 6.12, the green fluorescence signal was 488-EGF, while the red signal 
presented PI-labelled nucleus.  Panel A shows that the incubation of the cells with 
AG1478 did not affect the fluorescence background of the hepatocytes.  In Panel B 
EGF was internalised after 30min stimulation.  When the cells were pre-incubated with 
AG1478 to inhibit the phosphorylation of EGFR, the EGF was also detected inside of 
the cells, as shown in Panel C.  Furthermore, the inhibition of EGFR phosphorylation 
appeared to cause the accumulation of EGF in hepatocytes.  There was more punctuate 
fluorescence within the cells, which were treated with AG1478 followed by stimulation 
(Panel C) than cells incubated with EGF but no inhibitor (Panel B).   
 
In Figure 6.13 the green fluorescence signal was 488-EGF and the red fluorescence 
signal came from cy5-binding EGFR antibody and the yellow signal presented the co-
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located EGF (green) and EGFR (red).  Panel A shows that treatment with AG1478 
alone did not affect the EGFR location and also did not affect the fluorescence 
background.  Exposure of cells to EGF for 30min resulted in the internalisation of both 
the EGF and EGFR.  Furthermore, most ligand was associated with its receptor (yellow 
signal) at this time, as presented in Panel B, suggested the EGF and EGFR forming a 
complex.  Moreover, cy5 red signals were detected at cell surface which suggested that 
some receptor were recycled to the membrane after internalisation or did not move 
from the surface while stimulation.  However, when the cells were pre-treated with 
AG1478 before EGF stimulation there was no inhibition on EGF and EGFR complex 
internalisation, as shown in Panel C.  Moreover, no red signal detected on the cell 
surface suggested that AG1478 inhibited the recycling of the receptor or caused the 
accumulation of the receptor inside cells.   
 
Figure 6.14 shows the effect of AG1478 on the EGF induced phospho-EGFR 
translocation into the nucleus in hepatocytes.  The images show that EGF-induced 
nuclear EGFR phosphorylation and/or phospho-EGFR translocation in the nucleus was 
inhibited by AG1478.   
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Figure 6.12 Effect of AG1478 on the EGF internalisation in hepatocytes 
Cells were cultured in WME supplemented with ITS and 10% FCS on a coverslip for 4h after plating, 
followed with changed medium to SF and further incubated for 24h.  300nM AG1478 was added 15min 
before exposure of the cells to 60nM 488-EGF for 30min.  Then cells were fixed in 4% paraformadehyde 
at 4℃ for 15min, subsequently incubated with 50μg/ml PI and 10μg/ml RNAse for 30min at 37℃ to 
label the nucleus.  Cells were washed with PBS to remove extra PI and the coverslip was mounted on a 
slide.  Images are representative of 3 independent experiments. 
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Figure 6.13 Effect of AG1478 on EGF and EGF-induced EGFR internalisation  
Cells were cultured in WME supplemented with ITS and 10% FCS on a coverslip for 4h after plating, 
followed with changed medium to SF and further incubated for 24h.  300nM AG1478 was added 15min 
before exposure of the cells to 60nM 488-EGF for 30min.  Then reaction was stopped by fixing the cells 
in 4% paraformadehyde at 4℃ for 15min, subsequently permeabilized in 0.1% Triton (in 2% BSA/PBS) 
for 2min on ice. After that cells were incubated in 10% donkey serum (in 2% BSA/PBS) at room 
temperature for 1h and then labelled by 1:50 anti-EGFR at 4℃ overnight. The next day, 1:200 donkey 
anti-rabbit cy5 was applied at room temperature for 1h in the dark. Finally the coverslip was mounted on 
a slide and images were captured by confocal microscope. Images are representative of 3 independent 
experiments. 
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Figure 6.14 Effect of AG1478 on EGF-induced phospho-EGFR internalisation 
Cells were cultured in WME supplemented with ITS and 10% FCS on a coverslip for 4h after plating, 
followed with changed medium to SFand further incubated for 24h.  300nM AG1478 was added 15min 
before exposure of the cells to 60nM 488-EGF for 30min.  Then reaction was stopped by fixing the cells 
in 4% paraformadehyde at 4℃ for 15min, subsequently permeabilized in 0.1% Triton (in 2% BSA/PBS) 
for 2min on ice. After that cells were incubated in 10% donkey serum (in 2% BSA/PBS) at room 
temperature for 1h and then labelled by 1:50 anti-P-EGFR (tyr1173) at 4℃ overnight.  The next day, 
1:200 donkey anti-rabbit cy5 was applied at room temperature for 1h in the dark and the nucleus was 
labelled by incubation of the cells with 5mM SYTOX for 30s at room temperature. Finally the coverslip 
was mounted on a slide and images were captured by confocal microscope.  Images are representative of 
3 independent experiments. 
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6.2.3.2 The effect of EGFR activation on ligand-induced receptor internalisation 
In order to visualise the location of EGF, 60nM 488-conjugated EGF was used to 
stimulate the cells in previous experiments as fluorescence signal could not be detected 
at lower concentration.  This concentration was 20 times higher than the concentration 
used in other experiments (western blotting, [
3
H]-thymidine and MTT assay) to 
stimulate hepatocytes.  Therefore, it was necessary to study whether the internalisation 
of EGF, EGFR and phospho-EGFR, also happened on exposure of cells to low 
concentrations (3nM) of EGF as used in other experiments.  Furthermore, the effect of 
the inhibition of the EGFR activation on the EGF/EGFR internalisation was also 
investigated.  Therefore, cells were exposed to 3nM EGF with/without AG1478, and 
the location of EGFR was investigated.   
 
Figure 6.15 shows that low concentrations of EGF also induced EGFR internalisation 
after exposure of the cells to EGF for 30min.  Furthermore, AG1478 again did not 
inhibit the EGF-mediated the EGFR internalisation in hepatocytes.  This suggested that 
the receptor internalisation was ligand dependent and not requiring receptor activation 
in primary rat hepatocytes.   
`
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Figure 6.15 The location of the EGFR in the low concentration (3nM) of EGF-
stimulated cells and effect of AG1478 on this concentration of EGF-mediated EGFR 
internalisation  
Cells were cultured in WME supplemented with ITS and 10% FCS for 4h after plating, followed with 
changed medium to SF and further incubated for 24h.  300nM AG1478 was added 15min before 
stimulation of the cells with 3nM EGF for 30min.  Then reaction was stopped by fixing the cells in 4% 
paraformadehyde at 4℃ for 15min, subsequently permeabilised in 0.1% Triton (in 1% BSA/PBS) for 
2min on ice.  After that cells were incubated in 10% donkey serum (in 1% BSA/PBS) at room 
temperature for 1h and then labelled by 1:50 anti-P-EGFR (tyr1173) at 4℃ overnight.  The next day, 
cells were labelled by 1:200 donkey anti-rabbit cy5 at room temperature for 1h in the dark and the 
nucleus was labelled by incubation of the cells with 5mM SYTOX for 30s at room temperature. Finally 
the coverslip was mounted on a slide and images were captured by confocal microscope. Images are 
representative of 3 independent experiments. 
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6.2.3.3 Recovery of the internalised EGFR activity and its effect on the 
phosphorylation of Akt and ERK 
The treatment of AG1478 blocked EGF stimulation of Akt and ERK phosphorylation 
and hepatocyte cell cycle progression (Chapter 3).  Furthermore, AG1478 did not 
inhibit ligand-mediated EGF/EGFR complex internalisation (Figure 6.12-6.15).  One 
interpretation is that AG1478 caused the accumulation of non-activated EGF/EGFR 
complexes inside of hepatocytes.  Therefore, to further study the effect of internalised 
EGF/EGFR complexes, cells were exposed to EGF with AG1478 to allow the 
internalisation of non-activated ligand/receptor complexes, followed by removing both 
AG1478 and surface bound EGF. Cells were then further incubated for several minutes 
to allow the recovery of the activation of internalised EGF/EGFR.  At this position, any 
detected stimulation response is due to the internalised EGF/EGFR complex.   
 
In the experiment, cells were pre-incubated with AG1478 for 15min before being 
exposed to EGF (3nM) for 25min to allow the process of the internalisation of EGF and 
EGFR.  Subsequently, AG1478 and EGF were both removed by 3 washes with SF 
medium (with or without AG1478, as indicated) with a 2min gap between the second 
and third washes to give time for AG1478 inside the cells to come out.  Following these 
washes the cells were incubated for another 5min with no further additions.  The 5min 
incubation was chosen, since this time it gives a strong stimulation of Akt and ERK 
phosphorylation.   
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Figure 6.16 shows that after 3 washes the cells were still able to respond to EGF (Line 
3).  When EGF/EGFR complexes had internalised in the presence of AG1478, and then 
both extracellular EGF and AG1478 were removed, signalling occurred from the 
internalised EGF/EGFR complexes.  This is endosomal signalling and can be seen with 
response to the ERK pathway.  The removal of AG1478 from the cells did not result in 
the complete recovery of the EGF stimulated phosphorylation of ERK, which was 
returned to 53.3% ± 13.8% (Figure 6.16B, Line 5).  There is no restoration of Akt 
phosphorylation detected in the experiment (Figure 6.16A, Line 5).  When the cells 
were washed with medium containing AG1478, there was neither Akt nor ERK 
phosphorylation detected (Line 6).   
 
If the signalling, which was detected after removal of AG1478, was due to the 
activation of endosomal EGF/EGFR complexes, then this internalised EGFR should at 
this point become phosphorylated.  Figure 6.17A shows the time course of the effect of 
the re-activated internalised EGF/EGFR complex on EGFR, Akt and ERK 
phosphorylation in hepatocytes.  In order to compare with, the EGF stimulation of 
EGFR, Akt and ERK phosphorylation time course was also measured in the same 
experiment, as shown in Figure 6.17B.  It shows that after removing the AG1478, the 
phosphorylation of EGFR and ERK was recovered, while Akt phosphorylation 
response was not detected.  Moreover, the duration of the internalised EGF/EGFR 
stimulation was shorter than normal EGF stimulation.  The internalised EGF/EGFR 
induced the phosphorylation of EGFR and ERK peaked at 5min and then gradually 
decreased in the following 1h; while normally EGF stimulated EGFR and ERK 
phosphorylation continually increased in the first hour.   
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Figure 6.16 Recovery of the internalised EGF stimulation of A. phospho-Akt and B. 
phospho-ERK by removal of AG1478 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 4h 
and then incubated in SF WME for the following 48h.  Cells were then pre-incubated with 300nM 
AG1478 for 15min and then exposed to 3nMEGF in well number 5 and 6 for 25min.  After that well 5 
and 6 were washed twice with SF medium, which with and without AG, respectively, and left 2min 
before the third wash.  Cells were then left in the third wash and further incubated for 5min, in the mean 
time 3nM EGF was added in well number 3 and 4 and stimulated for 5min.  Western blotting of 
phospho-ERK, phospho-Akt, pan-ERK and pan-Akt were measured. Data represented mean ± SEM (n=3) 
and were analysed by One-way ANOVA and post test was measured with Dunnett to compare all 
columns vs control column using Graphpad Prism (**p<0.01, ***p<0.001).  Western blots are 
representative of 3 independent experiments and statistic data are from 3 independent experiments. 
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Figure 6.17 Time course of A. internalised EGF/EGFR and B. EGF stimulation of 
EGFR, Akt and ERK phosphorylation 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 
4h., followed with incubation in SF WME for the next 48h.  Cells were then pre-incubated with 300nM 
AG1478 for 15min and then exposed to 3nM EGF (A) as indicated.  After that cells were washed twice 
with S.F medium and left 2min before the third wash as labelled.  Cells were then left in the third wash 
(A) or exposed to 3nM EGF (B) for different time as labelled.  Western blotting of phospho-ERK, 
phospho-Akt and phospho-EGFR were measured.  Western blots are representative of 2 independent 
experiments.  
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6.2.3.4 Effect of the method used to remove AG1478  
The previous results (Figure 6.16 and Figure 6.17) show that the phosphorylation of 
Akt did not recover after removing the AG1478 while ERK phosphorylation and 
tyrosine phosphorylation of the EGFR were partially recovered.  Since the washing 
system played an important role in the experiment, the effect of the washing system 
which used in previous (Figure 6.16 and Figure 6.17) experiment was investigated.  
Firstly, whether the recovery ERK phosphorylation response was due to remaining 
surface binding EGF was studied.  In order to answer this question, an extra acid wash 
was provided to remove the maybe surface binding of the EGF.  Secondly, whether 
three times wash provided in the experiment is sufficient to remove all the AG1478 
from hepatocytes was investigated.  In order to answer this question, cells were 
incubated with 300nM AG1478 for 15min, after that AG1478 was removed by the 
wash system, followed by exposure of the cells to EGF for 5min.  This EGF stimulation 
was then compared to the EGF-induced response in control cells, which were treated 
with three washes in the same way but without AG1478.   
 
In Figure 6.18, cells were exposed to ice-cold 0.5M NaCl/0.2M acetic acid for 5min 
before three washes with S.F medium to remove the surface-binding EGF.  It shows 
that after the acid wash cells were still able to response the EGF stimulation of ERK 
phosphorylation (Line 3).  Furthermore, internalised EGF/EGFR activation was 
recovered after the wash and stimulated the ERK phosphorylation (Line 5).  The 
response was similar to that seen in Figure 6.17, when cells were only washed with S.F 
medium but no acid wash.  This suggested that the wash system (no acid wash) we used 
in previous experiment was able to remove the surface binding EGF in hepatocytes.   
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As shown in Figure 6.19, although cells still response to EGF stimulation of Akt and 
ERK phosphorylation after removal of AG1478 by this wash system, it almost 
abolished EGF-induced Akt phosphorylation (4% ± 1%) and significantly reduced the 
level of ERK phosphorylation to 40% ± 10%.  This suggests that some AG1478 may 
remain after the wash and partially inhibited EGF stimulation in hepatocytes.   
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Figure 6.18 Effect of acid wash on EGF stimulation of ERK phosphorylation  
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 
4h., followed with incubation in SF WME for the next 48h.  Cells were then pre-incubated with 300nM 
AG1478 for 15min and exposed to 3nM EGF for 25min as indicated.  Then, cells were washed once with 
cold S.F medium, cold 0.5M NaCl/0.2M acetic acid (5min on ice) and another time of cold S.F medium.  
Subsequently, cells were washed three times with S.F medium with a 2min gap between the second and 
third wash   Cells were then further incubated with/without re-exposed to 3nM EGF for 5min as labelled.  
Western blotting of phospho-ERK was measured.  Western blots are representative of 2 independent 
experiments. 
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Figure 6.19 Effect of the EGF on A. phospho-Akt and B. phospho-ERK after 
removal of AG1478 by the wash system 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 
4h., followed with incubation in SF WME for the next 48h.  Cells were then pre-incubated with 300nM 
AG1478 for 15min in well number 3.  Cells were then washed three times with S.F medium with a 2min 
gap between the second and third wash.  Cells were then exposed to 3nM EGF for 5min at well number 2 
and 3 as indicated.  Western blotting of phospho-ERK, phospho-Akt, pan-ERK and pan-Akt were 
measured.  Data represented mean ± SEM (n=3) and were analysed by One-way ANOVA and post test 
was measured with Bonferroni‟s to compare all data sets using Graphpad Prism (*p<0.05, **p<0.01, 
***p<0.001).  Western blots are representative of 3 independent experiments and statistic data are from 3 
independent experiments. 
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6.2.3.5 Recovery of the internalised EGFR activity and its effect on the primary 
rat hepatocytes cell cycle progression 
In order to investigate whether the internalised EGF/EGFR can induce the cell cycle 
progression, cells were exposed to EGF with AG1478 present to achieve the 
internalisation of unactivated EGF/EGFR complexes.  Then the EGF and AG1478 were 
removed by the wash as described in previous experiments (Figure 6.16 and Figure 
6.17) and further incubated for 24h before measuring the level of [
3
H]-thymidine 
incorporation into DNA.   
 
With this experimental design, recovery of the internalised EGF/EGFR activity by 
washing out AG1478 did not induce cell cycle progression in primary rat hepatocytes 
in our experiment (data not shown).  However, Wang and his colleagues reported that 
endosomes-localised EGF/EGFR activation only lasted for less than 2h in MDCK and 
BT20 cells (Pennock and Wang, 2003).  Therefore, the failure of the internalised 
EGF/EGFR stimulation of hepatocyte entering S phase may be due to the short 
stimulation.  Fortunately, it has been shown that the continuous exposure of the cells to 
growth factors can be replaced with two short pulses of growth factors (Jones and 
Kazlauskas, 2001).  They claimed that the first stimulation moves the cell through the 
G0 to G1 phase at which cells can be responsive to the second pulse of growth factor.  
The second pulse of growth factor is provided to the cells during late G1 and then 
moves cell into S phase.  In many cells types, including hepatocytes, the G1 phase lasts 
approximate 7-9h.  Therefore, in the experiment, the cells were exposed to EGF for 1h, 
followed by incubation in agonist-free SF medium for 7h, then the second exposure of 
cells to EGF for 16h.  During the last 4h of this total 24h (1h+7h+16h) incubation, cells 
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were labelled with [
3
H]-thymidine and the level of [
3
H]-thymidine incorporation was 
measured.   
 
Figure 6.20 shows that only first pulse of the EGF (Column 2) or the second pulse 
(Column 3) alone could not significantly induce cell cycle progression in primary rat 
hepatocytes.  The two short pulses (1h in the beginning and 16h in the end of a total 
24h incubation) of EGF (Column 4) triggered hepatocytes to enter S phase, suggesting 
both first and second exposure were necessary for the cell cycle progression.  Column 6 
shows the result of when the first stimulation was provided by internalised EGF/EGFR.  
In this column, cells were exposed to EGF with AG1478 present to achieve the 
internalised EGF/EGFR, followed by removal of both agonist and inhibitor using our 
washing system.  Therefore, when cells were then further incubated for 1h, the 
stimulation was provided by the internalised EGF/EGFR complexes.  The first 
stimulation was terminated by 3 washes of the cells with S.F medium and further 
incubated in the last wash for 7h.  The second pulse of EGF was then provided and left 
for 16h before [
3
H]-thymidine assay.  It shows that the internalised EGF/EGFR 
complexes successfully moved quiescent hepatocytes to G1 phase and could be 
responsive to the second stimulation which then triggered cells entering S phase.   
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Figure 6.20 Effect of the internalised EGF/EGFR on hepatocyte cell cycle 
progression 
Primary rat hepatocytes were cultured in WME supplemented with ITS and 10% FCS after plating for 
4h., followed with incubation in SF WME for the next 24h.  Cells were then pre-incubated with 300nM 
AG1478 for 15min in Column 5 and 6 and then added 3nM EGF to Column 6 and left for 30min.  Cells 
were then washed three times with S.F medium with a 2min gap between the second and third wash.  
After that cells were further incubated third wash for 1h with (Column 2 and 4) or without (Column 1, 3, 
5 and 6) 3nM EGF present for 1h as labelled.  The first stimulation was terminated by washing cells with 
S.F medium for 3 times and cells were further incubated in S.F medium for 7h.  Then the second pulse of 
3nM EGF was provided into cells at Column 3, 4 and 6 and last 16h.  DNA synthesis was measured by 
thymidine assay (as described in Chapter Two).  Data represented mean ± SEM (n=4) from a single 
experiment and were analysed by One-way ANOVA and post test was measured with Bonferroni‟s to 
compare selective pairs of columns using Graphpad Prism (*p<0.05, ***p<0.001). Data are 
representative of 3 independent experiments. 
. 
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6.3 Discussion  
Inhibition of receptor internalisation by nystatin increased the UTP stimulation of Akt 
and ERK phosphorylation which suggests that P2Y receptor signal from cell membrane, 
and caveolin-mediated pathway regulates internalisation of the receptor, which results 
in termination of the receptor activation (Figure 6.1).  Furthermore, nystatin had little 
effect on EGF stimulation indicated that the ligand-induced EGFR internalisation in 
hepatocytes is caveolin-independent.  When cells were transfected to express Dn-
dynamin, which inhibited clathrin dependent internalisation, EGF stimulation of Akt 
and ERK phosphorylation was attenuated while there was no significant effect on UTP-
induced response (Figure 6.3).  These results suggested that in primary rat hepatocyte, 
EGFR internalises via clathrin-dependent pathway and its ability of stimulation of Akt 
and ERK phosphorylation at least is partially dependent on the regulation of receptor 
endocytosis.  EGF-induced EGFR internalisation is clathrin dependent (Figure 6.5), 
which has also been demonstrated in other cells as well.  For instance, in HeLa cells, 
K44A dynamin mutant expression, which used to inhibit the formation of clathrin-
coated pit and in turn blocked the clathrin-dependent internalisation, significantly 
reduced the EGF-induced ERK and PI3K activation (Vieira et al., 1996).  Contrasting 
with EGF results, UTP and P2Y receptors signal from the cell surface and receptor 
internalise, via caveolin-mediated pathway, leading to activation termination.  However, 
GPCR such as β2AR, 5-hydroxytryptamine (serotonin) receptor 1A (5-HT1A), 
m1AChR, μ and δ opioid receptors were showed to internalise after ligand-binding and 
continued signal from endosomes or even only stimulates downstream proteins from 
endocytosis (McPherson et al., 2001b; Luttrell and Lefkowitz, 2002).  This may be due 
to the activation of β-arrestin, which regulates the receptor binding to clathrin-coated 
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pits (Ferguson, 2001; Laporte et al., 2002), and is necessary for the receptor inducing 
downstream proteins (McDonald and Lefkowitz, 2001; Luttrell and Lefkowitz, 2002).  
This indicated that internalised GPCR may continue activation when the internalisation 
is clathrin-dependent.  However, when the receptor internalises via the caveolin-
dependent pathway it may lead to termination of the activation.   
 
Compared to previous results, expression of Dn-dynamin did not cause a strong 
inhibition as when cells were treated with con A.  This indicated that the almost 
abolishment of EGF-induced Akt and ERK phosphorylation in con A treated 
hepatocytes may be due to con A-mediated EGFR proteolysis rather than its inhibition 
of the receptor internalisation.  Another explanation may be the low proportion of 
transfection.  In the experiment, 20μl of HEK-293 cell lysis solution contacting Dn-
dynamin encoded adenovirus were provided to 3ml of 1*10
5 
hepatocytes and then left 
16h for RNA transcription and another 32h for protein expression.  To test the 
transfection proportion, in another experiment certain amount (up to 50μl) of HEK-293 
cell lysis solution containing green fluorescence protein (GFP) encoded adenovirus 
were added to 1ml of 1*10
5 
hepatocytes and  treated in the same way to produce GFP in 
hepatocytes.  The largest amount of adenovirus (50μl lysis solution containing GFP 
encoded adenovirus in 1ml of cells), was only transfected about 30%-40% of the cells 
(data not shown).  Although the concentration of Dn-dynamin and GFP encoded 
adenovirus were different, the result still provided a possibility that only small 
proportion of the cells were transfected and expressed Dn-dynamin which resulting in 
the only small reduction but not abolishment of EGF stimulation.   
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The confocal images illustrate that EGF and EGFR form a complex and internalise into 
the cells.  The internalisation could be clearly visualised after exposure of the cells to 
EGF for 20min and lasts about 1h.  EGFRs formed a sharp and thin loop around the cell 
plasma membrane in unstimulated hepatocytes.  It formed a thicker and faint loop after 
exposure of the cells to EGF within several minutes (Figure 6.9).  This suggested that 
EGF-induced EGFR internalisation may happen in the very early stages after ligand 
binding to its receptor.  This corresponded to another group‟s work who demonstrated 
that EGF induced ErbB1 (EGFR) rapid internalisation into endosomes, while other 
members of the ErbB family (ErbB2, ErbB3 and ErbB4) maintained activation for 
longer periods of time on the plasma membrane (Wiley, 2003).  Our results also show 
that after exposure of the cells to EGF for 1h, most ligand and receptor were 
disassociated.  Furthermore, EGF still appeared inside of the cells, while the EGFR was 
found around the cell surface although did not form the sharp and thin loop as before 
the stimulation.  This finding agreed with the work of Nikolsky and colleagues, who 
showed that in A431 cells, about 25% to 30% of the EGFR recycled to the cell surface 
after stimulation while the rest degraded in lysosomes (Sorkin et al., 1991).  Also, the 
images of phospho-EGFR (Figure 6.10) show that EGF rapidly induced the 
phosphorylation of nuclear EGFR and/or translocation of the phospho-EGFR into the 
nucleus.  Furthermore, western blots (Figure 6.11) show that the EGFRs are detected in 
both plasma and nucleus in hepatocytes.  Also the clear increase of the level of the 
EGFR in nucleus after stimulation suggested that EGF induces translocation of 
activated-EGFR into the nucleus.  Nuclear EGFR was first detected in hepatocytes at 
1991 in both normal and regenerating rat liver (Marti et al., 1991).  Nuclear expression 
of functional EGFR was further found in many other cells and tissues such as JEG-3 
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cells and placenta (Cao et al., 1995).  Nuclear EGFR/EGF might function as a 
transcription factor to activate genes required for proliferation by interaction with DNA 
transcription co-factor signal transducers and activators of transcription 3 (STAT 3) 
(Lin et al., 2001a; Lo et al., 2005b).   The ligand-induced RTKs such as EGFR, ErbB2 
and filbroblast growth factor (FGF) receptor translocation from cell surface into 
nucleus has been reported in many cells as well (Maher, 1996; Lin et al., 2001a; Giri et 
al., 2005). Moreover, back in 1987, it has been shown that EGF appeared in hepatocyte 
nuclei during rat liver regeneration (Raper, 1987).  However, our results show that 
using 60nM, 488-EGF could not be detected in the cell nucleus in vitro.  Furthermore, 
as shown in Figure 6.11, the apparent molecular weight of the EGFR, which was 
detected in the nucleus, was smaller than cytoplasmic EGFR.  Notably, many groups 
reported that nuclear EGFR appears to be the full-length receptor (Cao et al., 1995; Lin 
et al., 2001a; Lo et al., 2005b).  It is possible, therefore, that the nuclear EGFR is full 
length but has less phosphates comparing to cytoplasmic EGFR in freshly isolated rat 
hepatocytes.  These may explain the inability of hepatocytes to proliferate in vitro, 
since no EGF was appeared in nucleus and the nuclear EGFR might have less 
phosphates. 
 
Wang and colleagues showed that it was the receptor dimerisation rather than receptor 
kinase activation regulating the internalisation of EGFR (Wang et al., 2005).  In 
primary rat hepatocytes, AG1478, which inhibited EGF stimulation, did not affect 
EGF/EGFR internalisation.  In fact, inhibition of the activation of EGFR increased the 
internalisation response which may be due to cause the accumulation of inactivated 
EGF/EGFR complexes.  Wang‟s group also reported that after internalisation of the 
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inactivated-EGFR, removal of both inhibitor and inducer can provide pure endocytic 
signal (Wang et al., 2002).  Furthermore, after re-activation of internalised EGFR, the 
receptor directly stimulated further signalling at endosomes and then translocated into 
lysosomes for degradation without recycling to the membrane.  Internalised EGFR was 
sufficient to activate major signalling pathways such as ERK and Akt and to provide a 
physiological response.  From our results, internalised EGFR only partially recovered 
the phospho-ERK response and did not stimulate Akt phosphorylation (Figure 6.16).  
Wang and colleagues also showed a similar result, in which approximately 50% of the 
total phosphorylation (standard stimulation) of EGFR was activated following the re-
activation of endosomes-associated EGFR by removing surface EGF and AG1478 
(Wang et al., 2002).  This may be because of remaining AG1478 after washing.  As 
shown in Figure 6.19, when the cells were treated with AG1478 and this was then 
removed by our washing system, EGF stimulation of Akt phosphorylation was 
inhibited, while ERK phosphorylation was reduced to approximately 40%, which was 
similar as the level that induced by internalised EGFR.  Moreover, acid wash produced 
a similar result as no acid wash (Figure 6.18) indicated that EGF binding to cell surface 
EGFR is weak in primary rat hepatocytes and can be easily washed away from the 
receptor.  This may also explain why in con A treated cells, 488-EGF did not form a 
green loop around the cell surface (Figure 6.8D).  However, although re-activated 
internalised EGFR did not cause the recovery of major standard EGF stimulation 
signalling pathways, it was sufficient to provide a physiological response.  The 
endocytic stimulation successfully induced hepatocyte entry into the G1 phase and able 
to respond to the second stimulation which triggered cells into S phase (Figure 6.20).    
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7.1 Introduction  
The issue of hepatocyte proliferation is important, since this may be a key to treat 
various liver diseases.  For instance, hepatocyte transplantation can help increase the 
survival rate of patients who have lost the ability for liver regeneration after PH, as may 
occur following liver resection surgery.  The availability of human hepatocytes has 
prevented this procedure from becoming common clinical practice.  Expansion of 
hepatocyte population in culture may provide the hepatocytes needed.  Increasing the 
understanding of the signalling pathways by which cell surface receptors control 
biological effects will help to achieve the aim of producing functional proliferated 
hepatocytes in culture which may be used for cell therapy.   
 
7.2 The role of PI3K/Akt/mTOR signalling pathway in 
proliferation related effects 
The PI3K/Akt/mTOR signalling pathway plays a vital role in the hepatocytes response 
to EGF stimulation leading to cell cycle progression.  Inhibition of PI3K, Akt or mTOR 
completely blocked EGF induction of cell DNA synthesis.  This finding was partially in 
agreement with the work of Baffet and colleagues, who showed that PI3K and mTOR 
activity are necessary for EGF induction of hepatocyte DNA synthesis (Coutant et al., 
2002).  The same group also suggested that Akt activation is not necessary for EGF 
stimulation of hepatocyte cell cycle progression.  However, this conclusion might be 
due to the low transfection rate (30%-40%) of mutant Akt (Dn-Akt) in their 
experiments.  They concluded that Akt and mTOR are two downstream signals of PI3K 
while PI3K/mTOR but not PI3K/Akt is necessary for EGF induction of hepatocyte cell 
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cycle progression.  Our results show that Akt activation is critical for EGF stimulation 
since inhibition of Akt activity with either inhibitor (A443654) or expression of mutant 
Akt (Dn-Akt) blocked EGF induction of hepatocytes entering S phase.  However, the 
results in this thesis also show that the PI3K/Akt signalling pathway was not sufficient 
for the cell cycle progression, since UTP, which also activated this signalling pathway, 
failed to induce hepatocytes entering S phase.  This might seem in contrast to our other 
observations (this thesis and (Luo et al., 2007) that expression of myr-Akt itself was 
sufficient to lead to cell cycle progression.  However, in this case, there was prolonged 
and perhaps abnormally high elevated Akt activity, which may result in an 
„unphysiological‟ response that can not achieve in nature.  This means the cell cycle 
progression induced by over-expression of myr-Akt may be not able to be achieved by 
stimulating the native receptors.  Nevertheless, this myr-Akt expression study did show 
how important Akt is for cell cycle progression.  It also provided the first ever 
demonstration of enhancement of hepatocyte cell cycle progression by genetic 
manipulation (Luo et al., 2007).  These conclusions, however, may be questioned by 
the suggestion that myr-Akt reduces apoptosis, as discussed later in the next paragraph. 
 
The PI3K/Akt/mTOR signalling pathway also regulates hepatocyte survival (i.e. 
reduces apoptosis), as reported in many studies in the literature on many cell types 
(Yao and Cooper, 1995; Yao and Cooper, 1996).  Expression of myr-Akt increased of 
cell viability in the long term incubation (MTT result) and rose the level of [
3
H]-
thymidine incorporation into the DNA.  This suggested that continually activated Akt 
may increase cell survival and/or stimulate cell proliferation.  However, the level of 
EGF-induced [
3
H]-thymidine incorporation in myr-Akt expressing cells was not greater 
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than in non-expressing myr-Akt hepatocytes (control), and EGF did not further increase 
cell viability in myr-Akt expressed cells.  This indicated that continual activation of Akt 
might increase survival rather than induce cell proliferation.  However, the inhibition of 
Akt activity by either A443654 or Dn-Akt did not result in reduction of cell viability.  
Another group also showed a similar result that inhibition of PI3K/Akt/mTOR 
signalling pathway activity did not affect the ability of EGF to prevent hepatocyte 
apoptosis (Coutant et al., 2002).  This indicated that the activation of PI3K/Akt/mTOR 
signalling pathway was not necessary to prevent hepatocytes in culture from entering 
apoptosis.  However, another group showed that inhibition of the activity of this 
PI3K/Akt pathway blocked EGF suppression of TGF-β mediated hepatocyte apoptosis 
(Roberts et al., 2000).  The different conclusion might be because Coutant‟s group 
investigated the role of PI3K/Akt pathway in EGF prevention of rat hepatocyte natural 
apoptosis, while the second group (Roberts) studied the role of this signalling pathway 
in EGF suppression of TGF-β induced cell apoptosis.  Therefore, the PI3K/Akt 
pathway may still have an anti-apoptosis effect, depending on the conditions. 
 
7.3 The role of MEK/ERK signalling pathway in proliferation 
related effects 
MEK/ERK signalling pathway plays an important, but perhaps not completely 
necessary, role in EGF stimulation of cell cycle progression.  Inhibition of ERK 
phosphorylation significantly reduced EGF stimulation of hepatocyte DNA synthesis 
but it did not abolish the response (10μM UO126 study).  However, another group 
showed that inhibition of MEK/ERK activation lead to an abolishment of EGF 
induction of DNA synthesis (Coutant et al., 2002).  This might be due to the higher 
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concentration of UO126 (50μM) was used in their experiment.  Also UTP stimulated 
ERK phosphorylation in primary hepatocytes, and yet does not stimulate cell cycle 
progression, which suggested that MEK/ERK signalling pathway was not sufficient for 
cell cycle progression.  The results in this thesis show that inhibition of the MEK/ERK 
pathway did not lead to a significant reduction of the level of DNA synthesis in un-
stimulated cells.  This indicated that ERK may be important to hepatocyte proliferation 
rather than survival.  However, it was reported that ERK activity may be critical for 
EGF protection of hepatocytes from TGF-β induced apoptosis (Roberts et al., 2000), 
which leave the possibility that ERK may have an anti-apoptotic effect.   
 
7.4 Hypothesis of why P2Y receptor does not induce cell cycle 
progression 
Compared to growth factor (EGF), UTP stimulated very similar proliferation related 
signalling pathways such as PI3K/Akt/mTOR and MEK/ERK signalling pathways.  
The different biological effects induced by EGF and UTP with respond to cell cycle 
progression may be due the different stimulation, location and duration of the 
stimulated pathways.  Our results indicated that it was likely that UTP/P2Y receptor 
stimulation occured from the cell surface, since treatment with con A did not inhibit the 
stimulation of the cell; if anything it increased the size of UTP stimulation of ERK and 
Akt pathways.  EGF, on the other hand, might signal from both cell surface and 
endosomes.  Furthermore, UTP stimulation of ERK phosphorylation was quicker and 
shorter than EGF stimulation.  Taken with other results in this thesis, it suggestd that 
the EGF-induced endocytic signal prolonged the stimulation duration and this may 
contribute to different effect that EGF, but not UTP, induced cell cycle progression.  
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EGF and UTP presented a similar stimulation time course of Akt phosphorylation.  
However, EGF stimulation of the phosphorylation of GSK-3, a downstream protein of 
Akt, was more stable than the UTP induced response.  This prolonged stimulation of 
GSK-3 phosphorylation may be a result of signalling from endosomes, compared to the 
cell surface.  GSK-3 controls a number of regulators of cell cycle progression (e.g. 
cyclin D) (Diehl et al., 1998) so this difference in GSK-3 phosphorylation time course 
might contribute to the difference in regulation of the cell cycle by UTP and EGF.   
 
7.5 Hypothesis for the EGF stimulation of signalling 
pathways  
Our results show that EGF binded to the EGFR on the cell surface and resulted in the 
homo-dimerisation of the receptor with another EGFR (ErbB1).  The dimerisation of 
the receptor leaded to the auto-phosphorylation of the receptor at its intracellular 
domain and activated the receptor.  Furthermore, the observation on hepatocytes in this 
thesis shows that the activation (i.e. phosphorylation) of the EGFR was not necessary 
for the EGF/EGFR internalisation. This corresponded to the conclusion of Wang and 
colleagues who claimed that the dimerisation but not activation of the EGFR results in 
the receptor internalisation (Wang et al., 2002).  The Dn-dynamin results also show that 
ligand-induced EGFR internalisation was mainly via the clathrin-dependent pathway, 
which was in agreement with the early work of another group (Vieira et al., 1996).  The 
western blotting results show that addition of EGF rapidly resulted in the 
phosphorylation of Akt while the induction of ERK phosphorylation was slower and 
more stable.  According to the time course results of the EGF and EGFR internalisation 
(confocal work), this might be due to the EGFR inducing the phosphorylation of Akt on 
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or near the cell surface and that this Akt signalling terminated after internalisation.  
Contrasting with this, the EGF/EGFR continually stimulated ERK phosphorylation 
from endosomes.  Other results also support the hypothesis that EGF/EGFR stimulated 
Akt and ERK phosphorylation from cell surface and endosomes, respectively.  
Inhibition of EGFR activation (with AG1478) resulted in the formation of inactivated 
EGF/EGFR complexes, when this was followed by removal of both the inhibitor and 
plasma membrane bound EGF, the signal could come only from endosomes.  In these 
conditions, internalised EGF/EGFR induced ERK phosphorylation, but not Akt.  This 
partially agreed with Schmid and colleagues, who reported that inhibition of EGFR 
internalisation resulted in a significant reduction of EGF-induced PI3K and ERK1/2 
phosphorylation (Vieira et al., 1996).  However, it remained possible that the EGF 
receptor may also stimulate ERK phosphorylation from the cell surface, since EGF-
induced ERK phosphorylation could be detected at very early stage (1min), when a 
considerable proportion of the EGFRs were still on or near the cell surface.  
Furthermore, compared to natural EGF stimulation (i.e. no inhibitor), the level of 
internalised EGF/EGFR-induced ERK phosphorylation reduced to approximately 40%.  
However, this reduction may be also due to the remaining inhibitor.  We have shown 
that removal of the inhibitor with the same washing system before EGF application 
resulted in a similar reduction of EGF induction of the ERK phosphorylation.  Taking 
all these points into consideration, it seemed likely that EGF associated with EGFR 
resulted in the internalisation of EGF/EGFR complexes, and then induced ERK 
phosphorylation mainly from endosomes.   
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EGFR may also stimulate Akt phosphorylation from endosomes despite the observation 
that internalised EGF/EGFR alone did not resulted in the Akt phosphorylation.  The 
failure to see Akt phosphorylation in these experiments may be due to the remaining 
inhibitor, after the wash being sufficient to reduce the level of EGF-induced Akt 
phosphorylation lower than the western blotting detectable level.  We have shown that 
Akt was necessary for the EGF induction of hepatocyte DNA synthesis and the 
inhibition of Akt at the first hour of the total 24h EGF stimulation was sufficient to 
abolish EGF-induced cell cycle progression.  Furthermore, only a small amount of 
activated Akt was able to achieve a complete EGF-induced DNA synthesis.  The 
internalised EGF/EGFR stimulation at first hour plus another 16h EGF induction were 
sufficient to induce hepatocytes entering S phase.  This indicated that internalised 
EGF/EGFR also stimulated a small amount of activated-Akt.  As shown in the 
hypothesis in Figure 7.1, EGF stimulation of PI3K/Akt and MEK/ERK signalling 
pathways maybe from both cell surface and endosomes.  Moreover, EGF simulation of 
Akt phosphorylation was proposed to occur mainly on the cell surface, while ERK 
phosphorylation was mainly at endosomes.   
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A  The main model for Akt stimulation 
 
B The main model for ERK stimulation 
 
 
Figure 7.1 Hypothesis of EGF/EGFR stimulation signalling pathway A. from cell 
surface and B.  from endosomes in rat hepatocytes 
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7.6 Hypothesis of nuclear EGFR signal  
The activated EGFR was also detected in the nucleus, and these receptors may 
contribute to the biological effect of EGF on rat hepatocytes.  Our results showed that 
EGFRs were located on both cell membrane and nucleus in hepatocytes and were able 
to be activated.  Application of EGF to hepatocytes rapidly stimulated the EGFR both 
on the cell surface and nuclear membrane, as shown in Figure 7.2A.  However, it was 
also possible that the phosphorylation of nuclear EGFR may be due to non-ligand 
induction such as stress.  Following stimulation with EGF, the cell surface EGFR 
internalised and some translocated into the nucleus, while others recycled to the 
membrane or degradated (Figure 7.2B).  Furthermore, EGF might be removed before 
the receptor translocating into the nucleus and the receptor might also lose some 
phosphates during the import, since 60nM 488-EGF could not be detected in the 
nucleus and the nuclear phosphorylated-EGFR showed a smaller apparent molecular 
weight on gel-electrophoresis than cytoplasmic EGFR in primary rat hepatocytes.  It 
was possible that these issues may be related to why EGF does not stimulate hepatocyte 
proliferation in vitro.  In Raper‟s early work in vivo, it was showed that EGF 
translocated into the nucleus during the liver regeneration (Raper, 1987).  Furthermore, 
activated-EGFR was also detected in the nucleus of regenerating hepatocyte in vivo 
(Marti et al., 1991).  Together these suggested that liver regeneration may involve the 
presence of the EGF/EGFR complexes in the nucleus.  Therefore, EGF did not induce 
hepatocytes proliferation in vitro may be due to the different import mechanisms of the 
EGF/EGFR to nucleus between in vivo and in vitro.  Further evidences also showed 
that in other proliferating cells or cancer cells full length EGFR and in the 
phosphorylation form was detected in the nucleus (Cao et al., 1995; Lin et al., 2001b; 
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Lo et al., 2005b).  Therefore, these results suggested that the translocation of the full-
length activated-EGFR and/or EGF into the nucleus is important for EGF full activation 
to induce cell proliferation.  The results in this thesis, however, are the first to show the 
agonist-stimulated appearance of phosphorylated EGFR in cultured hepatocytes.   
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A 
 
B 
 
Figure 7.2 Hypothesis of A. EGF stimulation EGFR either on the cell surface or in 
the nucleus and B. EGFR translocation from the cell surface into the nucleus 
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7.7 Future work 
The previous work suggested that multiple signalling pathways are involved in the 
regulation of hepatocyte proliferation.  Increasing or maintaining activation of one 
signal alone, such as Akt, was not sufficiently to induce cell proliferation.  Furthermore, 
in addition to PI3K/Akt/mTOR and MEK/ERK signalling pathway, there were other 
signalling pathways or signals that may play key roles in the hepatocyte proliferation.  
For instance, translocation of EGF and/or EGFR into the nucleus, where they may 
function as transcriptional activators, might be important for the cell proliferation, since 
EGF and EGFR was found in the nucleus of regenerating liver cells in vivo (Raper, 
1987; Marti et al., 1991).  It was also necessary to investigate the regulation of other 
signalling pathways which may be involved in hepatocyte proliferation.   For example, 
our results show that EGF induced hepatocytes entry into S phase, but most cells are 
not dividing.  This indicated that the hepatocyte may arrest at S phase.  Furthermore, it 
has been shown that the apoptosis of hepatocytes following injury, such as PH, can be 
blocked by NO, which inhibited the activation of caspase 3 (Zeini et al., 2005).  This 
suggested the possibility that some apoptotic signalling pathways may be involved and 
suppress hepatocytes proliferation.   
 
The results (AG1478, AG825 study) also show that EGF stimulated EGFR homo-
dimerisation with another EGFR but not EGFR (ErbB1)/ErbB2 hetero-dimerisation in 
primary rat hepatocyte.  It has been shown that, compared to EGFR homo-dimer, 
EGFR (ErbB1)/ErbB2 hetero-dimerisation stimulation are more extensive and potent 
(Levkowitz et al., 1998).  Furthermore, overexpression of ErbB2 has been reported in 
many cancers such as of breast cancers (Slamon et al., 1987) and lung cancers (Yu et 
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al., 1994).  All these suggested that the hetero-dimerisation of EGFR with ErbB2 may 
give a more potent and extensive stimulation, which leads to cell proliferation.  
Therefore, the question of whether EGF stimulation ErbB1/ErbB2 hetero-dimerisation 
in regenerating liver (in vivo) should be answered.  And if the answer is yes, why EGF 
induced this hetero-dimerisation in vivo but not in vitro could provide a good chance to 
achieve proliferation of hepatocytes.   
 
The internalisation of EGFR appeared to be important for the EGF stimulation of 
hepatocyte proliferation.  However, several questions are still remaining.  First, the 
pathways of EGFR internalisation are still not clear.  The results show that EGFR 
might internalise via the clathrin-dependent pathway.  However, Dn-dynamin did not 
completely block the EGFR internalisation.  This could be due to either other 
internalisation pathways involved, or insufficient level of virus transfection.  Therefore, 
a reliable inhibitor or method needs to be used to further investigate the mechanism of 
the EGF/EGFR internalisation.  Also a method of assessing level of viral transfection 
and degree of blocking of dynamin-dependent pathway is needed.   
 
This thesis demonstrated the importance of PI3K/Akt/mTOR and MEK/ERK signalling 
pathways in EGF induction of rat hepatocyte cell cycle progression.  Furthermore, 
many evidences have shown that signals from endosomes and translocation of the 
receptor into the nucleus may be crucial for EGF stimulation of cell cycle progression 
and/or proliferation in rat hepatocyte.  The understanding of how growth factor (EGF) 
stimulation rat hepatocyte cell cycle progression and/or proliferation was improved.  
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There are also suggestions such as over-expression of activated Akt which may result 
in cultured hepatocytes proliferation to a level that can be used in clinic.   
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